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Abstract
Introduction

Australia has a dual public and private health insurance system in which private health insurance
plays a supplementary role in financing health care. The traditional role of the private health
insurance sector in Australia has been to cover a defined set of healthcare services largely
delivered in private hospitals. However, following legislative changes in 2007, private health
insurance funds can now cover a broader range of chronic disease management services. This
emerging role of the private health insurance sector in chronic disease management in the last
decade has not been well studied and is the focus of the research presented in this thesis.
Specifically, the research presented in this thesis examines the role of insurers in supporting the
care of high-needs patients, particularly those patients with chronic conditions.

Methods
The five studies presented in this thesis use quantitative and qualitative research methods to
examine the research topic. Multiple data sources are used including insurance claims data, health
service records and interviews with private health insurance executives. The research examines
health service use for high-needs patients claimed on private health insurance and investigates the
approach taken by private health insurers to design and implement strategies to support high-needs
patients and people with chronic conditions more broadly. A methodological contribution of the
research is a novel data linkage study using insurance claims data and hospital records linked for
the first time, allowing analysis of additional public hospital activity of the insured population that
is not claimed on private health insurance.

Results
Using three different measures of resource utilisation to identify and compare the demographic
and clinical characteristics of high-needs patients, the findings suggests that high-needs patients
account for a large proportion of total hospital utilisation for a narrow range of health conditions –
primarily related to mental health, cancer, rehabilitation and dialysis. Further examination of
claims for mental health services reveals information on the type, the organisation and the
frequency of services accessed using private health insurance, but this represents a limited picture
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of the insured population’s service utilisation. These findings demonstrate the importance of
quality, comprehensive health information to inform chronic disease management strategies and a
further study develops a conceptual framework, a theoretical contribution of this thesis, which
identifies four domains to consider when developing information systems for chronic disease
management using multiple data sources.

The data linkage study, designed using the conceptual framework, investigates the relative
contribution of private health insurance to funding hospital care for a privately insured cohort.
Although more than 70% of admissions are claimed on private health insurance, a large proportion
of this care, particularly for high-needs patients, occurs in public hospitals. There are distinct
patterns in the use of private health insurance for overnight hospital admissions for different types
of services. Medical and mental health-related services that more often occur in public hospitals
are less likely to be claimed on private health insurance than surgical services that more often
occur in private hospitals. The final study, using qualitative methods, analyses the perspectives of
private health insurance representatives on the sector’s role in chronic disease management. The
study finds there is optimism for increasing the future role of the private health insurance sector in
supporting patients to manage chronic conditions, particularly for high-needs patients, but
challenges exist in relation to targeting and evaluating interventions.

Discussion
This research describes the services used by high-need patients that are claimed on private health
insurance and investigates how health information held by insurers can be used to inform chronic
disease management strategies. The research also explores the broader policy and operational
factors affecting the support provided by the private health insurance sector for high-needs
patients. Taken together, the research findings demonstrate that the primary role of Australian
private health insurers in supporting high-needs patients is paying benefits for a narrow range of
hospital-based services. Although there has been some changes to the role of the private health
insurance sector in the last decade, the process of change has been slow and private health insurers
face challenges in expanding their role in chronic disease management due to regulatory
constraints, data availability and relationships with both patients and healthcare providers.
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Glossary
Administrative data: Data sources collected for administrative purposes without specific research
goals defined at the time of collection (Benchimol 2015). In the health sector, this refers to records
collected during healthcare interactions such as hospital admissions as well as payment data such
as insurance claims. Administrative data are also commonly referred to as routinely collected data.
Australian Refined Diagnosis Related Groups (AR-DRG): An admitted patient classification
system that provides a clinically meaningful way of relating the number and type of acute care
patients treated in a hospital to the resources required by the hospital (Australian Institute of
Health and Welfare (AIHW) 2018a). The AR-DRG coding system uses the International
Classification of Diseases (see below) as their basis.
Broader health cover: A suite of services, focussed on disease management and health and
wellness programs, that private health insurance (PHI) funds in Australia can cover following
reforms introduced in the Private Health Insurance Act 2007 (Biggs 2013).
Chronic conditions: Long lasting and persistent health conditions, across the spectrum of illness,
including mental illness, trauma, disability and genetic disorders (Australian Health Ministers’
Advisory Council 2017). The terms “chronic condition” and “chronic disease” are used
interchangeably throughout this thesis.
Chronic disease management (CDM): Interventions that are designed to manage or prevent a
chronic condition using a systematic approach to care and potentially employing multiple
treatment modalities (Weingarten et al. 2002).
Community rating: A feature of the PHI system in Australian requiring that everyone pays the
same premium for their health insurance and health funds cannot discriminate against members
based on health status, age or claims history (Private Healthcare Australia 2018a).
Data linkage: Data linkage refers to methods to bring together information about individuals from
different sources in a way that protects individual privacy for the purposes of research and analysis
(Population Health Research Network 2011).
De-identified data: Data sources that have undergone specific processes to remove direct
identifiers and alter other information that identifies an individual or is reasonably likely to
identify an individual (Office of the Information Commissioner 2018). De-identified data are also
commonly referred to as anonymised data.
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Admission: In this study, an admission refers to a period of patient care in a hospital setting from
the time of admission to discharge. Admissions may be overnight, in which admission and
discharge occur on different days, or same-day, in which admission and discharge occur on the
same day. Same-day admissions are also referred to as same-day visits. Admission is used
interchangeably with the term, hospitalisation, in this study.
General practitioner (GP): Medical practitioners practicing in community settings (outside
hospitals) that are often the first point of contact for personal health matters. In some countries
such as the United States, general practitioners are preferred to as family medicine physicians (The
Royal Australian College of General Practitioners 2018).
General treatment insurance policy: An insurance policy covering a range of dental and allied
health services including optical, physiotherapy and psychology services (Australian Government
Private Health Insurance Ombudsman 2018a).
High-needs patients: Patients with the highest level of need for health care as measured by total
accrued healthcare cost, intensity of care used over a period of time or functional limitations
(Long et al. 2017).
Hospital Casemix Protocol (HCP): A standardised data collection that the Australian
Government requires hospitals to collect for privately insured admitted patient services including
clinical, demographic and financial information (Department of Health 2018a).
Hospital insurance policy: An insurance policy to cover costs as a private patient in hospital,
including hospital accommodation and medical treatment (Private Health Insurance Ombudsman
2018a).
International Classification of Diseases (ICD): The international standard for reporting diseases
and health conditions, which defines the universe of diseases, disorders, injuries and other related
health conditions (World Health Organisation 2018). The full name of the coding system used in
this thesis is the International Statistical Classification of Diseases and Related Health Problems,
Tenth Revision, Australian Modification (ICD-10-AM).
Managed care: A type of health insurance that enrols individuals and assumes costs for health
care for a pre-paid fee. Insurers providing managed care plans attempt to manage the healthcare
utilisation of insured individuals through a variety of controls including contracts with selected
providers and hospitals and requiring authorisation for hospital admissions (Marcus 2000)
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Medicare: Australia’s tax-financed, government-operated health insurance scheme that provides
access to free or subsidised treatment by a range of health professionals in hospitals and
community settings (Healthdirect 2018).
Medicare Benefits Schedule: A listing of health services that are subsidised by the Australian
Government under Medicare.
Patient: A person receiving or registered to receive medical care.
Primary care: Healthcare services provided to non-admitted patients in community settings
including general practice and allied health services (Department of Health 2015).
Private health insurance (PHI): Coverage of a defined set of health services financed through
premiums paid to a non-governmental insuring entity. The contract between the insured individual
and the insuring entity sets out the terms and conditions for payment or reimbursement of health
services (Colombo & Tapay 2003, p. 7).
Private health insurance fund members: Private health insurance organisations are often
referred to as funds and those people holding a fund’s insurance policy are referred to as fund
members.
Private hospital: Hospitals licensed by the government as a private hospital and operated by
private (non-government) bodies including both commercial and charitable organisations (Private
Health Insurance Ombudsman 2018b).
Principal diagnosis: The diagnosis established to be chiefly responsible for occasioning a
patient’s episode of care in hospital (AIHW 2018b). Other diagnoses that may be affecting the
patient are called additional diagnoses.
Public hospital: A hospital funded by the Government and recognised as public for the purposes
of the Medicare Benefits Schedule, the Pharmaceutical Benefits Scheme and private health
insurance arrangements (Private Health Insurance Ombudsman 2018b). In Australia, some
privately-operated hospitals are recognised through legislation as public hospitals (for example,
hospitals identified under Schedule 3 of the New South Wales Health Services Act 1997).
Risk equalisation: As PHI funds in Australia cannot charge differential premiums according to
health risk (see Community Rating above), the risk equalisation scheme compensates insurers with
a riskier demographic profile by re-distributing money from those insurers paying less than
average benefits to those paying higher than average benefits. In Australia, the Australian
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Prudential Regulation Authority (APRA) administers this scheme (Private Healthcare Australia
2018b).
Risk stratification: A process of identifying target groups within a defined population for
interventions based on indicators of health risk such as age, health status and levels of health
service use. Interventions are then implemented for different target groups that are appropriate to
the level of health risk (Hewner et al. 2014).
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Chapter 1: Introduction and scope of thesis
As the population is living longer and the burden of disease is changing, the health system is under
pressure to provide services that better respond to the needs of people with chronic conditions.
The focus of healthcare interactions is increasingly shifting from curing illness to managing risk
factors and symptoms of chronic conditions and preventing health deterioration that may result in
more intensive, costly care. In Australia, the private health insurance (PHI) sector is taking a more
proactive role in chronic disease management (CDM) through targeted education, risk assessment
and programs. This is a departure from their traditional role as an insurer paying benefits for a
defined set of health services, primarily provided in hospital. This thesis examines the current and
potential role of the Australian PHI sector in supporting the care of high-needs patients. The
research analyses data held by insurers and other related datasets to determine what information
can be used to identify areas of greatest need among the insured population and better target CDM
interventions.

The research begins with an analysis of data held by PHI funds to identify the clinical and
demographic characteristics of the highest need groups within the insured population and how
insurer data can inform CDM program design and implementation. A conceptual framework is
developed that identifies the key factors in developing information systems for CDM using
multiple data sources. The framework is applied to the current information systems of the PHI
sector and tested through a pioneering linkage project using insurance claims data from a PHI fund
linked to a large dataset of public hospital records from a local health district (LHD) in New South
Wales. Analysis from this study reveals insights into the relationship between the public and
private hospital use, and the use of PHI, for the insured cohort and articulates the challenges and
benefits of linking such databases for health research, analysis and planning. In the final part of
the research, findings from the earlier studies are fed back to representatives from the PHI sector
through interviews for comment and reflection. The data collected from the interviews
complement earlier findings with detailed descriptions of the current approaches and challenges
for insurers providing CDM programs.

In this introductory chapter, a brief background and context to the research is provided, followed
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by a description of the scope of the research, its aims and research questions and an overview of
the organisation of the thesis.

1.1 Background
PHI plays a supplementary role in Australia’s healthcare financing system. Australia has a
universal, tax-financed health insurance scheme, Medicare, that covers a range of hospital and
primary care services. PHI is a voluntary scheme, although the Australian Government introduced
a number of financial incentives in the late 1990s to encourage people to take out PHI policies
(Butler 2002). Australia’s mixed public and private model of financing and delivering health
services attempts to balance two goals — universal access to health care and a degree of patient
choice (Johnston & Sadiq 2011; Podger 2007). The Australian Government closely regulates the
role of PHI including the scope of health services that insurers can cover and subsidises the
industry through tax rebates paid to individuals holding PHI that cost the government A$6 billion
per year (Commonwealth of Australia 2017). As a result, PHI remains a frequent topic of policy
debate.

Traditionally, the primary role of the Australian PHI sector has been to cover (in whole or in part)
a defined set of hospital services, primarily provided by private hospitals. However, following
changes to the Private Health Insurance Act (2007), PHI funds have expanded the range of
services they cover in the area of CDM and hospital substitution programs (Biggs 2013). The
evolving role of the PHI sector in CDM has not been well studied and is the focus of the research
presented in this thesis, specifically the role of insurers in supporting the care of high-needs
patients.

Providing appropriate care for high-needs patients, particularly those people with chronic and
complex conditions, requires more than the efforts of individual healthcare providers but also
system level changes to support coordinated care and health improvements such as new payment
models, enhanced data sharing and patient-focussed quality measures (Bodenheimer 2008;
DuGoff et al. 2013; Long et al. 2017). Initiatives that respond to multiple domains are considered
more likely to improve patient outcomes and overall system-level performance (Kodner 2009).
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For the PHI sector to have an effective role in supporting high-needs patients, it requires more
than simply funding one-off CDM services. However, the extent to which the PHI sector is driving
system-level changes in CDM and the extent of changes in the broader health system, to facilitate
insurers’ role in supporting high-needs patients, has not been investigated.

This research explores the role of the PHI sector in supporting the care of high-needs patients. The
research investigates clinical and service utilisation characteristics of high-needs patients and
factors influencing how insurers fund, and in some cases deliver, services to support high-needs
patients, given the PHI sector’s regulated role in Australia’s health system. Previous research on
the PHI sector has focused on the differences in access to services between insured and uninsured
populations, particularly for surgical procedures (Banks et al. 2009; Brameld et al. 2006; Hindle &
McAuley 2004). There has been little attention given to understanding sub-groups within the
privately insured population or the approaches insurers are taking to design and implement
strategies to support high-needs patients, including the use of health information to target and
evaluate interventions. It is the focus on these issues that distinguishes the research presented in
this thesis from previously published studies.

1.2 Research context
The research presented in this thesis was supported by a scholarship from the Health Market
Quality Program of the Capital Markets Cooperative Research Centre. The Cooperative Research
Centres Program is a program of the Australian Government designed to support collaborative
research partnerships between industry, researchers and the community (Department of Industry,
Innovation and Science 2018). The industry partner for this project is the Hospital and Medical
Benefits System (HAMBS), a company that offers technology solutions to 23 non-profit, PHI
funds in Australia. The industry partner contributed to the research by providing de-identified
insurance claims data for analysis and participating in a Steering Committee that met quarterly for
research updates. The industry partner was not otherwise involved in the design or conduct of the
research.

19

1.3 Scope of thesis
The overarching aim of this research is to contribute new knowledge on the role of the Australian
PHI sector in supporting the care of high-needs patients.

1.3.1 Research questions
The specific research questions are:
1.

What are the demographic, service utilisation and clinical characteristics of high-needs
patients with PHI? (Chapter 4)

2.

How suitable are current PHI data sources for informing strategies for better supporting
high-needs patients? (Chapter 5 and 6)

3.

For PHI funds to play a more proactive role in CDM, what factors need to be
considered when collecting data and developing information systems to support highneeds patients? (Chapter 6)

4.

What is the relative contribution of a PHI fund to paying for hospital services for an
insured population, relative to publicly funded hospital services? (Chapter 7)

5.

What strategies are PHI funds taking to support CDM, especially for high-needs
patients, and what are the factors influencing the design and implementation of
strategies? (Chapter 8)

To address these research questions, a series of five studies were conducted as depicted in Figure
1.1 below. The five studies use a mix of quantitative and qualitative research methods and use data
that allow for analysis of current patterns of service use claimed on PHI and exploration of future
strategies to support high-needs patients. Further discussion of the research design is provided in
Chapter 3.
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Figure 1.1 Overview of research design and questions

1.3.2 Organisation of thesis
The chapters in this thesis are organised as follows:

Chapter 2 presents a review of literature relevant to the thesis topic. This review covers four
areas: economic models of financing health care; the Australian healthcare system and analysis of
the operation of the PHI sector; key findings from previous research focussing on how PHI in
Australia affects health service utilisation, and definitional issues related to high-needs patients
and features of models of care for high-needs patients.

Chapter 3 describes the research methodology and design. This chapter describes the rationale for
the mixed-methods research design and explicates the links between the five studies.

Chapter 4 presents the demographic, clinical and service use characteristics of the highest service
users in a privately insured cohort, examining three different methods to measure high-needs.

Chapter 5 investigates the utilisation of privately funded mental health services as one of the top
conditions for which high-needs patients seek care. Analysis focuses on the type, organisation and
frequency of services accessed and the extent of information provided by insurance claims data
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about mental health service utilisation.

Chapter 6 examines methods for selecting target groups for CDM from PHI claims data and
reviews factors influencing the development of information systems using multiple data sources to
inform CDM interventions and support for high-needs patients. A conceptual framework is
developed that further explains the key factors identified in the review – information requirements,
data sources, data quality and integrating systems and analytics. The study concludes by assessing
the feasibility of PHI funds implementing the framework within their current operational context.

Chapter 7 uses the conceptual framework developed in Chapter 6 to conduct an innovative study
linking PHI claims data and hospital records from the public hospital sector for the first time. The
study examines hospital utilisation across both public and private hospitals, and use of PHI, to
understand the relative contribution of PHI to funding hospital care for an insured population.

Chapter 8 explores industry perspectives on the role of PHI in supporting high-needs patients and
the factors influencing the design and implementation of strategies to support this group. The
study gathers data using interviews with PHI sector representatives to reflect on the findings of the
earlier studies and examine current and future approaches to supporting high-needs patients and
CDM more broadly.

Chapter 9 discusses and synthesises findings from the five studies in relation to the original aim
and research questions. This chapter highlights the contributions of the research, outlines policy
and practice recommendations stemming from this research, limitations of the research and
directions for future research.
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Chapter 2: Literature review
To provide context to the research presented in this thesis, this chapter reviews relevant literature
in four major areas:
•

Economic models of healthcare financing;

•

Analysis of the policy context that affects the functioning of the PHI sector in Australia’s
health system;

•

An overview of major findings from previous research focussed on how PHI affects
health services utilisation in Australia; and

•

A discussion of definitional issues related to high-needs patients and features of bestpractice models of care for high-needs patients.

As the research presented in this thesis consists of a series of studies using mixed methods and
multiple data sources, additional literature that is relevant to each specific study is discussed in
subsequent chapters.

2.1 The Australian healthcare system
Australia has a universal, national health insurance scheme, Medicare, that covers the whole
population. Medicare is accompanied by a voluntary, government-supported PHI sector that pays
for additional services not covered by Medicare. Additionally, PHI covers access as a private
patient to a range of elective, or non-emergency, hospital services that often significantly reduces
waiting periods for a patient (Shmueli & Savage 2014). The government funds a majority of
health expenditure in Australia. Of the 68.7% of health funding provided by government in 201617, 41.3% came from the Australian Government and 27.4% from states, territory and local
governments. Individuals and PHI funds fund 16.5% and 8.8% respectively of total health
expenditure (Australian Institute of Health and Welfare (AIHW) 2018c). As noted by the
Organisation for Economic Co-operation and Development (OECD), although it makes up a
relatively small proportion of the overall funding of health expenditure, the PHI sector has been an
ongoing focus of health policy in Australia and is a significant funder of services, particularly
those provided by private hospitals (Colombo & Tapay 2003, p.8).
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In Australia, hospitals are operated by both public and private entities. Public hospitals are
primarily owned and operated by state and territory governments. Private hospitals are owned and
managed by private organisations, which may operate on a for-profit or not-for-profit basis. Public
hospitals account for more than half of all hospitalisations (59%) but provide a greater proportion
of overnight hospitalisations compared to private hospitals so public hospitals account for two
thirds of bed days (67%) (AIHW 2016).

Although PHI is closely associated with private hospital use, PHI can be used in both public and
private hospitals. In Australia’s mixed system of health funding, there are both demand and
supply-side drivers promoting use of the private health system. On the demand side, patients can
access certain services, particularly non-emergency elective surgery, more quickly as a private
patient in both public and private hospitals (Shmeuli & Savage 2014). Additionally, on the supplyside, because many specialist medical practitioners work in both the public and the private hospital
systems, there are perverse financial incentives for specialists to choose to provide more care in
private hospitals settings as they receive more income treating private patients compared to public
patients. However, limited coverage of PHI policies may lead patients to choose to access services
as a public patient despite having PHI due to additional co-payments and out-of-pocket costs that
would be incurred by accessing services as a private patient. The issue of variation in PHI
coverage is discussed further in Section 2.3 on page 27.

2.2 Economic models of healthcare financing
Unlike traditional economic markets, in which the supply of goods is dictated by consumer
demand, governments intervene in most healthcare markets around the world. In Australia like
most countries around the world, government revenues are the predominant funding source for
healthcare expenditure (Savedoff 2004, p. 2). Key reasons why the market for health care differs
from the market for other types of goods and services include the high degree of uncertainty in
demand for medical care and the asymmetries in knowledge about medical care between the
patient and provider that affect both the supply of, and the demand for, health services (Arrow
1963; Rice 1998).
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In a traditional economic market, the individual has control of three functions related to receiving
a good or service – receiving the benefit from the good or service, bearing the cost of the good or
service and making the decision on whether or not to purchase the good or service. However, in
the healthcare market, the individual is not in control of these three functions with decisionmaking to purchase largely delegated to the provider and with much cost-bearing being taken up
by a third party such as the government or an insurance provider (Mooney 1998, p. 10). Due to the
unpredictability of expenditure in healthcare markets (as for other economic markets such as
vehicles), health insurance schemes exist to support the costs of health care.

Insurance is intended to provide individuals exposed to certain risks with financial protection
against the consequences of specified events (OECD 2003). Offering health insurance schemes
involves managing the demand for health services across the insured population and the supply of
services by providers. There is a trade off in the scope of coverage of insurance policies between
risk spreading and incentives. By increasing the generosity of insurance, an insurer can spread the
risk among more people, so that the costs of the unwell are offset by the premiums paid of the
relatively healthy. However, there is also the risk of increasing the demand for unnecessary
services (Cutler & Zeckhauser 1999, p. 16). As a result, most health insurance plans, even those
provided by government, incorporate a mix of controls such as patient co-payments, benefit limits
or service exclusions to manage supply and demand factors from patients and providers in an
effort to optimise use of health services, in an economic sense (Cutler & Zeckhauser 1999, pp. 402). Government health insurance schemes often pay for a base level of services for the general
population that are either free or subsidised at the point of care with expenditure for additional
services met by private contributions paid through PHI or patient contributions.

2.3 PHI in Australia
Australia’s hybrid insurance system attempts to strike a balance between universal healthcare
access for necessary services funded by Medicare and support for consumer choice in service
access through the availability of PHI (Johnston & Sadiq 2011, p. 636). This dual healthcare
financing system has resulted in complex regulatory arrangements for PHI coverage, which are
summarised in Table 2.1. As noted by Colombo and Tapay (2003, p. 15), PHI both duplicates
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Medicare (in the case of public hospital care) and complements Medicare by funding health
services such as dental and allied health services that are not funded by Medicare for most of the
population. Both Medicare and PHI can cover hospital-based care but there are differences in
coverage for health care provided in community settings. A key difference is that PHI funds are
prevented by legislation from paying benefits for consultations provided by general practitioners
and specialist medical physicians outside of hospital. PHI can also not cover pharmaceuticals that
are listed on the Pharmaceutical Benefits Scheme (PBS) and subsidised by the Australian
government.

Table 2.1 Comparison of government-funded and PHI-funded services in Australia
Private health
insurance

Government

1. Hospital-based care

✓

Public patients in public
hospitals

✓

Private patients in
public and private
hospitals

2. Community-based care
a) General practitioners &
specialist physicians

✓

b) Dental

X

c) Diagnostic services (e.g.
pathology)

✓

c) Allied health services (e.g.
physiotherapy &
psychology)

✓

Limited cover through
general practitioner (GP)managed plans, and public
hospital community health
centre and outpatient
departments

✓

d) Chronic disease
management programs

✓

Limited cover through GPmanaged plans

✓

3. Medications

✓

Through Pharmaceutical
Benefits Scheme (PBS)

✓

X

Limited public dental
scheme for general
population

✓

X

Limited cover of
non-PBS
medications

PHI policies in Australia are divided into two major categories – hospital and general treatment
policies. For both types of policies, there are different levels of cover ranging from comprehensive
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to basic (Private Health Insurance Ombudsman 2018c). The majority of PHI benefits (75%) are
paid for hospital services, with hospital insurance policies held by 46% of the Australian
population (Australian Prudential Regulation Authority (APRA) 2018). An increasing number of
hospital policies offered by PHI funds have exclusions for certain health conditions or procedures
and/or require co-payments by the patient (Thomas 2012, pp. 273-4). The rise in PHI hospital
policies with exclusions and restrictions has resulted in a high degree of variation in coverage of
PHI coverage with estimates that there are more than 40,000 different PHI policies that exist for
less than 40 PHI funds (Davey 2017). The Commonwealth Ombudsman notes that complaints
related to PHI have increased significantly over the past decade and that complaints most
commonly relate to unexpected exclusions and restrictions in hospital insurance policies for
services that many consumers assume are covered by PHI (Private Health Insurance Ombudsman
2018d).

From 1 April 2019, the Australian Government will introduce a system of three tiers of hospital
product categories in an attempt to standardise coverage levels across different PHI funds.
Additional reforms introduced at the same time also aim to lessen the variation in access to private
hospital services as a result of geographical location as people living in rural and regional areas
often have no, or little, choice of private services without significant self-funded travel costs
(Department of Health 2018b). The PHI sector is funding an increasing proportion of hospital
admissions in Australia. In 2015-16, PHI contributed funding to 42% of all hospitalisations, up
from 36% of all hospitalisations a decade earlier in 2006-07 (AIHW 2017, p.18). Given hospital
care is the health service most frequently funded by PHI and is the most costly form of treatment,
it is the focus of analysis in this research.

General treatment insurance policies cover both necessary health services such as dental care,
physiotherapy, podiatry and psychology but also discretionary or complementary health services
that have little evidence of clinical effectiveness such as massage and acupuncture, provided by
practitioners that are not regulated under the National Registration and Accreditation Scheme for
health practitioners (Australian Health Practitioner Regulation Agency 2018). In the research
presented in this thesis, claims for services covered by general treatment policies are excluded
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from analysis with the exception of psychology services in the study presented in Chapter 5 on the
utilisation patterns of mental health services claimed on PHI.

2.4 Policy reforms affecting the role of the PHI sector, 1973-2006
While healthcare financing arrangements in Australia have been fairly stable for the past three
decades, the current arrangements with Medicare and PHI are a relatively recent development in
Australia’s history. Medicare, Australia’s public insurer, was introduced in 1984 and, following its
introduction, the role of PHI was reduced as Medicare offered free public hospital care and
subsidised GP and specialist medical services. Individuals could still take out PHI to be treated as
a private patient in either a private or a public hospital, but insurers were no longer subsidised by
government and there was a steady decline in PHI membership (Martins 2009, p. 16). A shortlived precursor to Medicare was Medibank introduced in 1973. Medibank was introduced by the
Labor Government, and was similar to Medicare, but it did not have bipartisan support and was
progressively dismantled before been formally abolished by the Liberal-National Government in
1981 before Medicare was introduced by a subsequent Labor government in 1984 (Palmer &
Short 2010, pp. 62-3).

By 1996, PHI membership had fallen to approximately one third of the population and the LiberalNational Government, elected in 1996, took measures to halt the decline. Policy reforms with the
aim of encouraging individuals to take out PHI introduced both financial incentives and penalties,
described as a ‘carrot and stick’ approach (Ellis & Savage 2008, p. 262). Reforms to PHI in
Australia have tried to reduce demand for public hospitals by increasing incentives for individuals
to take out PHI, indirectly supporting greater private hospital use (Colombo & Tapay 2003, p. 9).

The series of reforms undoubtedly had the effect of raising the proportion of the Australian
population with PHI for hospital treatment, from 32% in 1996 to almost 45% in 2006 (Martins
2009, p. 17), a proportion that has remained stable to the present time. However, this increase in
the proportion of people with PHI has come at substantial recurrent cost for the Australian
Government with government expenditure on the PHI rebate costing over $6 billion annually,
representing 9% of the total health budget (Commonwealth of Australia 2017, p.6-21).
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This history of government policy reforms is important for understanding the current role of PHI
in financing health care in Australia. Reforms to health insurance arrangements in Australia,
particularly the introduction of first Medibank and then Medicare, were layered on top of existing
insurance arrangements (Boxall & Gillespie 2013, p. 182). As a result, the role of the PHI sector in
Australia is not clearly defined, as it both duplicates and supplements Medicare for different types
of health services.

The composition of the PHI sector has changed markedly over the last two decades with a marked
consolidation across the sector. The number of PHI funds registered in Australia dropped from 59
funds in 1990 to 33 in 2016. Market concentration in the PHI sector is high with the two largest
insurers, Medibank Private and Bupa accounting for more than 50% of all policies held in
Australia. Although approximately 70% of the sector operates as non-profit funds, the for-profit
market share was 68.5% in 2015 (Private Health Insurance Administration Council 2015).

Due to Australia’s dual health insurance system and the existence of Medicare, PHI does not
provide comprehensive coverage across both hospital and community-based health services.
However, additional reforms have been introduced to broaden PHI coverage in the area of CDM.
These reforms give the PHI sector a broader remit in supporting the health and health care of the
insured population but also introduce new challenges.

2.5 PHI reforms following the Private Health Insurance Act 2007
The regulation of the PHI sector remained fairly stable after the reforms of the late 1990s until
2007 when the Private Health Insurance Act 2007 was introduced. This new legislation
consolidated previous legislation regulating the PHI sector into one Act and introduced new
regulations for the sector. One of the major changes in the new Act was the introduction of
“broader health cover” provisions that allow PHI funds to cover a wider range of out-of-hospital
healthcare services. These services include programs to manage or prevent chronic diseases and
provide clinically appropriate alternatives to hospital treatment such as home-based wound care
and home nursing (Private Health Insurance Ombudsman 2018e). “Broader health cover” is not
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specifically defined in the Private Health Insurance Act 2007 but importantly, it excludes
coverage of services where a Medicare benefit is already payable such as GP consultations (Biggs
2013, p. 3).

These reforms to the scope of coverage of PHI were expected to improve the management of
chronic conditions resulting in health improvements and subsequent reductions in hospital claims
(Biggs 2013, p. 1). Although these programs provide the PHI sector with a mechanism to increase
its remit as an insurer, PHI funds were initially slow to offer CDM programs. The number of
individuals enrolled in programs has grown in recent years but these programs still make up a
small proportion of insured services in terms of benefits paid (Biggs 2013, pp. 7-8). Only $54
million in benefits were paid for CDM programs by PHI funds for the 12 month period up to
March 2018, compared to $14.9 billion for hospital services and $5.1 billion for general treatment
services including dental and physiotherapy for the same period (APRA 2018). Factors
influencing the approach of insurers in providing CDM programs are explored in the study
presented in Chapter 8.

Australia is not unique in having a PHI sector offering CDM programs. Insurers in other countries
have offered these programs for a number of years, including in the United States (McCall &
Cromwell 2011) and Germany (Hamar et al. 2010). Further information of the activities included
in CDM programs is provided in Section 2.8 on page 35.

The PHI sector has recently gone through another period of policy review and reform. Following
the establishment of a Private Health Ministerial Advisory Committee in 2016, the Australian
Government introduced a range of policy reforms in October 2017 with a staged implementation
timeline (Department of Health 2018c). These reform efforts attempt to clarify, and improve the
transparency of, PHI policies for consumers through standardising policy categories across
insurance funds and improving access to privately insured health care for certain population
groups (people living with mental health conditions and people living in rural and regional areas).
The reforms do not include any specific provisions to enhance the role of insurers in CDM or
change existing restrictions related to insurers funding primary care services that attract a
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Medicare rebate.

There are two additional issues related to current healthcare financing arrangements that may
affect the role of the PHI sector in supporting high-needs patients, particularly those with chronic
conditions. First, due to the limited scope of coverage of PHI, insurers only have a partial view of
the health service use of insured individuals, primarily relating to hospital use as a private patient.
As discussed further in Section 2.9 on page 37, comprehensive health information is an important
component of CDM care models that emphasise proactive, preventive interventions and
community-based care, rather than hospital-based care (Wagner et al. 2001; Wagner et al. 1996b).
The extent to which insurance claims information provides useful information for informing the
design and implementation of services to support high-needs patients with chronic conditions is
examined in the studies presented in Chapters 5 and 6.

Second, a risk equalisation scheme operates in the PHI sector in Australia due to the principle of
community rating enshrined in PHI legislation. The purpose of the scheme is to help protect funds
that may be exposed to high levels of financial risk based on the demographic composition and
health status of their membership. The scheme has an age-based pool for people aged 55 years and
over and a high-cost claimants pool (Connelly et al. 2010, p. 7). A consequence of the risk
equalisation scheme in Australia is a lack of financial incentive for funds to improve the health of
high-need members because they are paid retrospectively for costs incurred for older and highclaiming individuals (Colombo & Tapay 2003, p. 32).

Additionally, although the PHI sector is tightly regulated, government performance metrics for the
PHI sector focus on levels of PHI membership and benefits paid rather than the quality, efficiency
and effectiveness of services covered. Few mechanisms currently exist for insurers to hold
providers to account for the quality and value of services providers to members (Podger 2016, p.
34).

Policy reforms for the PHI sector in the last decade have not addressed this issue and reforms in
the area of CDM have potentially exacerbated this issue and increased the lack of clarity of the
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role of the PHI sector in Australia’s health system. Insurers cannot only pay benefits for a wider
range of “broader health cover” services, but many also now directly provide CDM services,
aiming to more proactively support members to manage their health. The extent to which insurers
have transitioned into this new role is examined in Chapter 8. The next section reviews relevant
research conducted on the PHI sector in Australia to date.

2.6 Brief synthesis of research conducted on the Australia PHI
sector
Research on the PHI sector in Australia has been conducted from a number of disciplinary
perspectives including epidemiology, economics and sociology. This reflects the interdisciplinary
nature of health services research (Lohr & Steinwachs 2002, p. 8). Epidemiological research has
focussed on differences in service use between people with and without PHI. People with PHI
have been found to have higher levels of health service use compared to those without PHI,
particularly related to surgical procedures (Brameld et al. 2006, p. 97; Hindle & McAuley 2004, p.
121). Moorin and Holman (2006b) found condition-specific differences in health services
utilisation for privately insured patients. For patients in the final stages of life, admission as a
private patient did not consistently affect healthcare utilisation for five common conditions.
Healthcare utilisation rates were significantly higher for private patients with colorectal cancer and
cerebrovascular disease compared to public patients but utilisation rates for private patients were
not significantly higher for heart disease, lung cancer and breast cancer.

Health economics research has focussed on assessing the effects of changes in health policy, such
as the efficiency of resource allocation via the PHI rebate (Duckett 2005; Eckermann et al. 2016;
Ellis & Savage 2008). Research has also investigated differences in hospital use funded by PHI
versus services funded by government sources. Research into the movement between private and
public patient categories based on hospital admissions has found a relatively low level of
movement between public and private categories, and unsurprisingly, those people that do move
tend to have PHI. Gu and Johar (2017) profiled patients admitted for nervous, respiratory and
circulatory conditions according to public and private hospital usage. For the three conditions,
they found patients most commonly used either a public or a private hospital almost exclusively.
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Patients tended to be admitted to the hospital sector they had used in the past, however, there was
a patient type that used both public and private hospitals making up between 10-20% of the
population. Moorin and Holman (2006a, p. 293) investigated a patient’s movement between
private and public patient status and found that the shorter the duration between hospital episodes,
the less likely patients were to switch between public and private patient categories. This is an
important finding given that those with a higher burden of disease tend to have a shorter duration
between hospital episodes. Cheng and colleagues (2014) found that patients using a mix of public
and private hospital care tend to have higher average hospital utilisation than those that used
exclusively public or private care. Possible explanations for this finding offered by the authors are
that a mixed system makes continuity of care difficult to maintain and may result in duplication of
diagnostic tests and investigations.

Epidemiological and health economics research has been complemented by qualitative studies
conducted from a sociological perspective. These studies add an important consumer perspective
on factors affecting both take up and use of PHI policies (Natalier & Willis 2008; Willis et al.
2016) and patients’ perspectives on the use of public and private hospital services (Meyer 2015).
These studies have not focussed specifically on patients with high healthcare needs, although Jeon
and colleagues (2012) did examine the perspectives of older Australians with multiple chronic
conditions in relation to PHI. Despite financial pressures as a result of having PHI, participants in
this study believed PHI provided benefits in relation to timely access to, and choice of, healthcare
providers.

Qualitative research reporting the perspective of the PHI sector is limited, although Willcox
(2005) interviewed PHI representatives in a study examining the evolution of insurer approaches
to health services purchasing. Wilcox found that among insurers, innovation in healthcare
payment models was limited and insurers faced a complex web of regulation, some of which
appeared to impede more efficient purchasing.

A range of factors, beyond financing mechanisms, influences the utilisation of health services. The
Behavioural Model of Health Service Use is an important model that organises these individual
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and contextual factors affecting health service use (Aday & Andersen 1974; Andersen 1995;
Andersen et al. 2014). The influence of contextual, enabling factors identified in the Model such
as the policies, financing and organisation of the health system that affect access to health care
frames the analysis and measurement of utilisation patterns in the research presented in this thesis.
Other factors, referred to as predisposing factors, such as social characteristics and health beliefs
also influence service use but are not the focus of this research.

The research presented in this thesis builds on the body of prior research on the Australian PHI
sector that has been reviewed in this section. The research presents five studies that together
comprise a mixed-methods, interdisciplinary investigation into the role of the Australian PHI
sector in supporting the care of high-needs patients. Quantitative, epidemiological analysis is
conducted using PHI claims data that have rarely been used in published Australian research, with
the exception of Xie and colleagues (2015) in a study predicting hospital stays using claims data,
and Hamar and colleagues (2017; 2015) reporting on health service utilisation changes as part of
an evaluation of an insurer-supported CDM program.

To complement the claims data analysis, a study using linked insurance claims data and public
hospital records is conducted to investigate the relative contribution of PHI to funding hospital use
of an insured cohort compared with government funding. Additionally, two qualitative studies
examine data and information requirements to support planning and delivering services to highneeds patients and the perspectives of insurers on their current approaches to designing CDM
programs and supporting high-needs patients. A more detailed description of the research
methodology and design is provided in Chapter 3. Before moving to this chapter, the concept of
high-needs patients and models of care to support this patient group is reviewed.

2.7 Who are high-needs patients?
International studies, primarily from North America, have found that a small proportion of the
population represent a disproportionately large amount of health service utilisation and spending
(Cohen 2014; Mitchell 2016; Roos et al. 2003). This population of high-needs patients also report
greater levels of cost-related access issues compared to the general population (Sarnak & Ryan
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2016). These findings have led to a focus in both research and policymaking on healthcare
delivery and funding for high-needs patients. A recent report from the National Academy of
Medicine in the United States noted that there is not a consistent definition of high-needs patients.
This report identified three criteria commonly used for defining high-needs patients – total accrued
healthcare cost, intensity of care used over a period of time and functional limitations in
completing activities of daily living such as bathing or dressing (Long et al. 2017, p. 2). Other
reports have defined “high-need” more precisely with specific reference to chronic conditions. For
example, a recent international comparative study defined “high-need” as having three or more
chronic conditions or a functional limitation (Sarnak & Ryan 2016, p. 10). The research presented
in this thesis uses two of the National Academy of Medicine criteria, namely healthcare cost and
service utilisation, to identify the high-needs population due to the availability of information on
these measures in the data sources used in this research (Chapter 3 provides further detail on the
data sources used).

Although the term “chronic disease management programs,” was used to describe some of the
activities that can be covered by PHI funds in the Private Health Insurance Act 2007, the
adequacy of characterising illness disease-by-disease has been challenged because evidence
suggests that health resource use is most strongly impacted by comorbidity, that is, the number of
different types of conditions, rather than the specific disease that a person has (Charlson et al.
2007; Starfield 2011, pp. 471-2). Consistent with these findings, rather than focus on specific
chronic diseases, this research focuses on characterising the health services utilisation of highneed patients and strategies implemented by PHI funds to support this group. To further define the
high-needs patient population in this research, the first study presented in Chapter 4 develops a
profile of high-needs patients using three measures to better understand the demographics and
service use characteristics of the population with high needs.

2.8 Features of models of care for high-needs patients
Models of care for high-needs patients with the best evidence of effectiveness include common
elements such as accounting for patient heterogeneity or differences, centring interventions around
relationships and enhancing primary care (Chokshi 2017). These elements challenge the
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traditional organisation of the healthcare delivery system that allocates the greatest amount of
resources to hospital-based care but now needs to take a greater role in prevention, coordinating
care between providers and educating individuals on strategies to better manage their health
(Jacobson & Teutsch 2008, pp. 9-10).

Approaches to account for patient heterogeneity shift attention from individual patients to the
health status of the broader population. These approaches generally involve categorising a
population and identifying cohorts based on health risk (a process known as risk stratification),
and then using different care management pathways that are appropriate to the level of risk
(Hewner et al. 2014, p. 251). The Kaiser Permanente Medical Group in the United States was one
of the first organisations to introduce risk stratification methods (Garfield 1970). The original
Kaiser method categorised people into three groups based on their anticipated healthcare needs
and tailored interventions to each group – high-need, at-risk and generally healthy. The high-needs
group require active care coordination and case management to monitor and manage disease
symptoms. The Kaiser method has been the model for approaches introduced in a number of other
countries including Australia and the United Kingdom (Agency for Clinical Innovation 2015, p.
16; Ham 2010, p. 80).

One of the most widely cited models outlining the key elements of a system of care for people
with chronic and complex needs is the Chronic Care Model (Wagner et al. 2001; Wagner et al.
1996a). The Chronic Care Model identifies six areas that need to be addressed to encourage and
enable productive interactions between the patients and the care team: healthcare organisation,
community resources, self-management support, delivery system design, decision support and
clinical information systems. As recognised by the authors of the model, the Chronic Care Model
is not an explanatory theory, it is a synthesis of the best available evidence (Wagner et al. 2001, p.
69). While the model’s strengths include general clinical consensus around the core elements of
care, it lacks specificity in terms of implementing system redesign and addressing unexpected
consequences of the redesign process (Martin et al. 2011, p. 573).

Various terms are used to describe intervention approaches to providing care for high-needs
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patients including CDM and integrated care. These two terms have been described as two ends of
a spectrum of approaches that ultimately “aim to ensure cost-effective quality care for service
users with varied needs” (Nolte & McKee 2008, p. 65). Although, CDM programs traditionally
targeted single diseases, more recent approaches have taken a broader view and become more
population-based (Nolte & McKee 2008, p. 69). As a result, there is now considerable overlap
between the concepts of CDM and integrated care. CDM, defined as “interventions designed to
manage or prevent a chronic condition using a systematic approach to care and potentially
employing multiple treatment modalities” (Weingarten et al. 2002, p. 926), is used in this thesis to
refer to care that supports people with chronic conditions, including high-needs patients, due to the
term’s reference in the Private Health Insurance Act 2007.

CDM activities can be targeted at people diagnosed with, or at risk of, developing chronic
conditions and includes activities such as the development of customised care plans, support for
care coordination and health coaching to teach behaviour change techniques. CDM activities can
also be targeted at broader population groups regardless of disease status such as the distribution
of educational resources and questionnaires to assess health status (Mays et al. 2007, p. 1685).
Central to both risk stratification approaches and the specific activities that form part of CDM
programs is comprehensive information on an individual’s health status, risk factors and health
service use.

2.9 Using health information to target high-needs patients
The need for high quality information has been recognised as a key feature of models of care for
people with chronic conditions and high needs. As described above in Section 2.8, clinical
information systems and decision support are two of the six system-level factors that need to be
considered in supporting people in the Chronic Care Model (Wagner et al. 2001; Wagner et al.
1996a).

High quality information requires access to, and analysis of, data. Although, the terms “data”,
“knowledge” and “information” are often used interchangeably, they each have a distinct and
precise definition in informatics research and it is important to clarify the difference between each
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term. “Data” consist of facts that are observations or measurements about the world, while
“knowledge” defines the relationships between data. “Information” is obtained by the application
of knowledge to data (Coiera 2003, p. 13). In this respect, data can be considered as the building
blocks of information.

There is considerable excitement presently over the ability of data to transform healthcare delivery
especially for people with chronic conditions and high needs (Rumsfeld et al. 2016, pp. 351-2).
This has resulted in increased efforts to use administrative data for research, analysis and planning
purposes. Administrative data refer to data sources collected for administrative purposes without
specific research goals defined at the time of collection, which for the health sector includes
medical records and insurance claims data (Benchimol 2015). However, the accumulation and
availability of administrative data alone are not sufficient to inform healthcare approaches.
Administrative data need to be transformed into accurate and reliable information to be reliably
used to improve the delivery of health services including CDM programs. Features of
administrative data and the original purpose for which data are collected are important
considerations that influence data quality and the appropriateness of using a data source for
secondary purposes (Curtis et al. 2014, p. 1183). Further review of the literature related to
assessing data quality for use in health analytics is provided in Chapter 6.

Additionally, effectively using data collected in service delivery to inform health policy and
planning often requires linking records from disparate data sources at the individual level, which
builds a more comprehensive picture of a person’s health and healthcare journey (Weber et al.
2014, p. 2479). An increasing health system focus on CDM directs specific attention to the
detailed processes of collecting, managing and sharing data across organisations and providers
(Solberg et al. 2016, p. 495). Linking data sources are particularly pertinent for the PHI sector as
they do not generate health data or have direct access to clinical information but instead, rely on
both patients and healthcare providers to share data with them (Kohli & Tan 2016, p. 556). Issues
pertaining to linking data in the healthcare sector is examined in more detail in the background to
the data linkage study presented in Chapter 7. While the research in this thesis seeks to examine
the role of the PHI sector in supporting the care of high-needs patients, it also analyses factors
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influencing PHI funds in fulfilling their stated goals in CDM, specifically the challenges posed by
the availability of quality health information.

2.10 Conclusion
Australia has a dual health insurance system, with a universal public insurance system existing
alongside a regulated PHI system. A series of policy reforms have modified the role of the PHI
sector in the Australian health system to encourage more people to take out PHI and also broaden
the remit of insurers in the area of CDM. Best practice CDM models emphasise the importance of
primary care, coordinating services and ensuring interventions are well targeted through effective
use of data. These elements of best practice models challenge the Australian PHI sector due to its
complementary role in funding health care alongside Medicare and the strict regulations on PHI
coverage. As a result, the current and potential role of PHI in supporting the care of high-needs
patients requires further examination. The next chapter outlines the mixed-method research
design developed to explore this topic.
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Chapter 3: Research methodology and design
The research presented in this thesis incorporates five studies conducted using both quantitative
and qualitative research methods to analyse diverse data sources. This chapter introduces and
provides the rationale for the research design, describing how the five studies fit together and
complement each other in responding to the overarching research aim. Commencing with a
methodological discussion, the chapter then provides an overview of the research design, the
selection of data sources and ethical considerations in undertaking the research.

3.1 Research methodology
The research was designed with a genuine curiosity to understand the PHI sector’s current role in
supporting high-needs patients in Australia’s health system as relatively little research has been
conducted on this topic. After reviewing relevant international and Australian literature and
discussing the current policy and operational context of the PHI sector with representatives
working in the sector, it became apparent that many PHI funds were attempting to do more than
simply pay benefits for a defined set of health services (the traditional function of insurers).
Insurers are also attempting to more actively support members with chronic conditions to manage
and improve their health with the aim of reducing utilisation of more costly health services, such
as hospital admissions. This context influenced the approach taken to designing this research.
Rather than simply looking at the insurer’s role from the perspective of insurance benefits paid,
the research was designed to:
•

Examine health service use for high-needs patients claimed on PHI;

•

Investigate the approach taken by PHI funds to design and implement CDM strategies to
support high-needs patients, and;

•

Explore broader policy and contextual factors affecting the support provided by the PHI
sector to high-needs patients such as the availability of health information on the insured
population.

This research falls within the discipline of health services research that, “studies how social
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factors, financing systems, organisational structures and processes, health technologies, and
personal behaviours affect access to health care, the quality and cost of health care, and ultimately
our health and wellbeing” (Lohr & Steinwachs 2002, p. 8). Consistent with the multi-disciplinary
nature of health services research, this research draws on methods from epidemiology, information
systems research and health policy and management research.

A mixed-methods research design was selected to comprehensively investigate the research topic
using both quantitative and qualitative research methods in the research stages of data collection,
analysis and interpretation. The research was designed with multiple data sources and methods to
triangulate findings to more comprehensively understand the research problem (Creswell et al.
2004, p. 11). The research process combined exploratory and descriptive data analysis using
quantitative data sources and qualitative methods of interviews and targeted literature reviews to
complement and add depth to the quantitative research. The use of mixed-methods designs has
gained popularity in health services research, due to the difficulty of fully answering a research
question using one method (Creswell 2015; Guetterman et al. 2015). Based on the mixed-methods
research categories developed by Creswell (2015), the research presented in this thesis most
closely aligns with an explanatory sequential design. This type of research design commences
with quantitative methods and is then followed by qualitative methods, which are used to help
explain the quantitative results in more depth (Creswell 2015, p. 5).

3.2 Outline of mixed-methods design and rationale
The research design has three phases with five studies presented sequentially in Chapters 4 to 8 as
depicted in Figure 3.1 below.
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Figure 3.1 Diagram of research design, phases and studies

The first phase of the research seeks to understand health service utilisation patterns and clinical
characteristics of high-needs patients through the analysis of insurance claims data. This research
phase investigates the quality and comprehensiveness of insurance claims data for informing
strategies to better support high-needs patients (Research questions 1 and 2, see Section 1.3.1 on
page 20). The first study (reported in Chapter 4) was conducted to identify the demographic,
admission and clinical characteristics of patients with the highest levels of hospital resource
utilisation. The findings of this first study led to the selection of mental health conditions as the
focus of analysis in the second study (reported in Chapter 5) as hospitalisations related to mental
health conditions accounted for a large proportion of hospital use for high-need patients. The
second study examines differences in service utilisation within this high-needs patient population
and how insurers may use trends identified through claims data analysis to better understand and
target interventions for specific groups.

At the end of the first research phase, it became apparent that limitations in PHI data sources could
have an important impact on insurer decision-making in relation to CDM programs. Insurance
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claims data do not provide information on hospital services not claimed on PHI or on most aspects
of members’ non-hospital service utilisation. Additionally, analysis of hospital claims data found
that diagnosis information was incomplete for many admissions to public hospitals. Public
hospital admissions account for approximately 16% of all hospital admissions and a greater
proportion of overnight admissions. This consideration triggered the second research phase.

The second research phase consists of the third study (reported in Chapter 6) that reviews the
considerations for developing information systems for CDM to support high-needs patients. The
study has a mixed methods design incorporating further analysis of insurance claims data for
selected disease risk factors, a literatue and policy review and group interviews. The study
develops a conceptual framework of the key domains to consider in transforming data into useful
information for CDM programs (Research question 3, see Section 1.3.1 on page 20). This
framework is a key theoretical contribution of the thesis.

The third research phase comprises two studies that are strongly informed by, and expand upon,
the earlier research phases. The conceptual framework developed in the third study (reported in
Chapter 6) is used in the research design of the study presented in Chapter 7. In this study,
insurance claims data from one PHI fund are combined with public hospital records from a LHD
to examine the relative contribution of the PHI fund to funding hospital services for insured
individuals, including high-needs patients (Research question 4, see Section 1.3.1 on page 20).
This study provides a different perspective on the health services utilisation of a privately insured
population compared to the earlier analysis using only insurance claims data. The analysis in the
study reveals the extent of hospital care funded by PHI and by other government sources. This
study describes the process, challenges and analytic results of combining multiple data sources to
develop a more comprehensive understanding of health service use across the public and private
sectors. This study is a methodological contribution of the thesis as it is the first time in Australia
that a study has analysed the health service utilisation of a privately insured cohort with data
linked from a PHI fund and a LHD.

The final study in Chapter 8 uses qualitative methods to explore insurer perspectives on their role
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in supporting the care of high-needs patients. The study presents findings of earlier studies to
insurer representatives including the hospitalisation patterns of high-needs patients and the
limitations of insurance claims data for understanding the health status of the insured population.
Study participants discuss and reflect on the impact of findings for both their insurance operations
and the design of CDM programs. This study complements the findings of earlier studies through
detailed examination of the approaches that insurers are taking to designing and implementing
CDM programs and the factors influencing the design and implementation of these programs
(Research question 5, see Section 1.3.1 on page 20).

3.3 Selection of data sources
The research presented in this thesis is situated in the operational context of the PHI sector. The
research uses real-world administrative data and examines the benefits and challenges of using
these data for research purposes. The use of administrative data for secondary purposes has many
benefits including gaining access to data on a large population that would be infeasible to study
using other research data collection methods.

However, there are also potential data limitations and the need to consider that breadth of data
may come at the expense of depth or detail (Weber et al. 2014, p. 2479). Throughout the research
process, the capabilities and limitations of using insurance claims data for the secondary purposes
of informing health services policy and planning were investigated. Documenting the strengths,
limitations and associated biases of individual data sources has been noted as a gap in the
expanding field of research using administrative health data (Benchimol et al. 2015, p. 2).

The first phase of research sought to understand the health services use of a privately-insured
high-needs patient population. Insurance claims data were selected as the primary data source
analysed in the first research phase. Claims data contain administrative information relating to a
hospital admission and clinical information including the diagnosis for which they sought care.
These data are also the primary source of data used by PHI funds to identify target populations for
CDM programs.
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From a health system perspective, the role of the PHI sector also requires understanding broader
health service utilisation of an insured population including when PHI is not used. A novel data
linkage study was conducted that combined PHI claims and LHD hospital records for an insured
population (Chapter 7). To complement administrative data analysis and expand on findings from
earlier studies, interviews were conducted to gather information on the emerging role of insurers
in supporting CDM programs (Chapter 8).

A description of the three data sources used in this research, and justification for their selection, is
included in Table 3.1. Further information on data sources is provided in the methods section for
each study presented in subsequent chapters.

Table 3.1 Summary of data sources used in research

PHI claims
data

Linked PHI
claims and
public hospital
data

Interview data

Justification for
selection

Data source
characteristics

Limitations

Use

Analyse hospital
use of high-needs
patients claimed on
PHI and assess
suitability of claims
data for identifying
high-needs patients

De-identified
insurance claims
data from 13 PHI
funds for the
period of 20092015

Only captures
health service use
claimed on PHI.

Chapters
4, 5 & 6

Investigate the
relative
contribution of
insurers to funding
hospital use of
high-needs patients

Linked, deidentified dataset
containing public
and private
hospital use of an
insured cohort
from one PHI
fund for the
period 2010-2016

Only captures
data relating to
one PHI fund and
one LHD.

Explore
perspectives of PHI
funds on their role
in supporting highneeds patients

Qualitative data
collected via eight
semi-structured
telephone
interviews

Relatively small
sample size.
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Data are not
completely
recorded for some
variables such as
diagnosis.
Chapter 7

Does not capture
public hospital
use outside the
LHD (estimated
to be small)

Primarily,
presents the
perspective of
smaller, nonprofit PHI funds.

Chapter 8

3.4 Ethical considerations related to research design
The research reported in Chapters 4, 5 and 6 received ethics approval from the University of
Wollongong and Illawarra Shoalhaven Local Health District (ISLHD) Health and Medical Human
Research Ethics Committee (No: HE16/211). The ethics and research approval processes for the
study presented in Chapter 7 were more complex and is described in Chapter 7. The study protocol
for the research presented in Chapter 8 was reviewed by the University Institute that the PhD
researcher is affiliated with, the Australian Health Services Research Institute (AHSRI). The study
was deemed to be negligible risk research and thus exempted from ethical review.

In addition to specific ethics approvals for the research conducted, there are two broader ethical
issues relating to the research design that deserve discussion and clarification. The first issue
relates to the sensitivity of the data analysed. The research involves analyses of administrative data
relating to a large population that did not provide specific consent for involvement in the research.
A number of risk mitigation methods were implemented to address potential issues related to the
sensitivity of the data analysed. First, datasets were de-identified and stripped of identifying
information such as names, addresses and exact date of birth before researcher access was granted.
Second, all analyses of administrative data were carried out in a secure access environment in
which research outputs were vetted by an authorised individual before being released. Third,
results presented in this thesis and submitted for journal publications were reviewed to ensure that
there is no risk of individual re-identification, such as through the presentation of tables with small
cell frequencies. Cell sizes less than five are not reported as per frequency rules for managing
statistical disclosure risks (Australian Bureau of Statistics 2017). Fourth, for the linked data study,
strict protocols were followed in the development of the linked dataset to protect individual
privacy, described in Chapter 7.

The second ethical issue relates to the use and interpretation of the research findings by the
project’s industry partner that works closely with a number of PHI funds. The risk that findings
may be used to restrict insured individuals’ use of services or limit benefits paid is mitigated
through industry regulation and the agreed topic of the research. The PHI industry operates under
the principle of community rating that is enshrined in the Private Health Insurance Act 2007.
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Community rating does not allow insurers to discriminate between individuals based on a range of
characteristics including age, presence of chronic conditions and the frequency of hospital
treatment. This includes charging differential premiums or restricting access to services for
individuals with specific health characteristics.

Although there is legislation that mitigates the risk for individuals with PHI, there is the possibility
that the research findings may be used to modify the inclusion or exclusion of benefits for certain
services in insurance policies that may affect subgroups within the insured population. The
actuarial process of health insurance policy development considers many different factors
including the health profile and health services use of the insured membership. When designing
the research and reporting on study findings, the researcher focussed on results relevant to the
agreed topic of the research. The agreed topic was to better understand the role of the PHI sector
in supporting the care of high-needs patients and identify groups within the privately insured
population that may be better served by improved targeting or alignment of services. In relation to
this risk, it should be noted that all PHI funds associated with the industry partner of this research
are not-for-profit companies. They are not publicly listed companies with shareholders that may
expect dividends to be paid from company profits.

3.5 Conclusion
This chapter provides context to the studies presented in the subsequent chapters by describing the
methodology and the approach taken to designing the research. The chapter provides the rationale
for the five studies and explains the links between the studies and how they contribute to
responding to the overall research aim. This research project is designed to take advantage of
available administrative data sources but seeks to assess the quality of these data sources for
analysis for secondary purposes. Analysis of administrative data is complemented with additional
studies using qualitative data sources. Finally, the context of this research has some distinct ethical
issues that have been considered in the design and conduct of the research to ensure that the risk of
indirect harm to individuals as a result of the research is minimised.
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Chapter 4: Examining hospital utilisation patterns of
high-needs patients using PHI claims data
The study presented in this chapter describes the demographic, hospital admission and clinical
characteristics for high-needs patients based on three measures of resource utilisation. This study
is part of the first phase of research described in Section 3.2 and Figure 3.1 on page 42. Using PHI
claims data described in Table 3.1 on page 45, the top 1% of hospital users in this dataset were
selected and compared based on three measures of resource utilisation – number of admissions,
total bed days and total insurance benefits paid. The study is foundational to the further studies
presented in this thesis and its findings improve knowledge on the subgroup within the insured
population with the highest healthcare needs including the frequency, duration and reasons for
seeking hospital care.

4.1 Study background
As described in Chapter 2, previous Australian research has compared the health services
utilisation of people with and without PHI for a range of conditions and interventions. People with
PHI have been found to have higher levels of health service utilisation than those without PHI,
particularly for surgical procedures (Brameld et al. 2006, p. 96; Hindle & McAuley 2004, p. 121).

Although critiques of government policies that provide financial subsidies to the PHI industry are
plentiful (Butler 2002; Duckett & Jackson 2000; Eckermann et al. 2016; Thomas 2012), there has
been surprisingly little research that details the patterns of hospital utilisation associated with PHI,
and none that looks at the demographic, hospital admission and clinical characteristics associated
with the highest use of hospital resources among the insured population.

International research on CDM programs suggests that targeting those most at risk is an important
implementation strategy to ensure that programs are most effective, from both a health outcomes
and cost perspective (Aljutaili et al. 2014, p. 1; Russell 2009, p. 45). Although PHI funds in
Australia generally do not have detailed health and medical information on their members, they do
have information on hospital admissions used for the payment of insurance claims. By
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investigating the patterns of hospital resource utilisation among the insured population, results
could inform CDM and other support strategies by identifying the group of individuals that has the
highest level of resource utilisation and the conditions for which people are seeking care.

To create a profile of the high-needs population within the insured population, this study selected
and compared three top-1% samples using three different measures of resource utilisation —
number of admissions, total bed days and total benefits paid. These three measures are commonly
used as proxy measures to identify high-needs patients (Long et al. 2017, p. 2). These measures
have been used in a range of studies in both Australia and internationally to measure resource
utilisation but have generally not been used together (Cheng et al. 2014; Harris et al. 2016; Roos et
al. 2003; Wodchis et al. 2016).

4.2 Methods
4.2.1 Data sources
This study used insurance claims data from 13 Australian PHI funds. The dataset covered a period
of more than five years, with the earliest hospital discharge date being 1 September 2009 and the
latest date being 2 June 2015. The dataset contained 1,387,173 admissions relating to 405,428
individuals. The claims dataset is primarily comprised of information provided by hospitals to
facilitate the payment of insurance claims such as admission date, length of stay and clinical
services provided. Diagnostic and clinical information are generated by hospital clinical coders
based on medical records. Insurer records may be supplemented by medical practitioners, allied
health professionals and patients who provide details on services provided and billing information.

The dataset included items at three levels relating to the individual patient, hospital admission and
insurance claim. The data were de-identified prior to researcher analysis with original identifiers
removed from the dataset and replaced with encrypted identifiers to protect the privacy of
individuals, PHI funds and hospitals. The variables used in the analysis were:
•

Individual patient information: person identifier, fund identifier, year of birth, sex

•

Admission administrative information: admission identifier, date of admission, date of
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separation, hospital type, same-day status
•

Admission clinical information: diagnosis, code index (code index of 1 used to indicate
principal diagnosis)

•

Claims information: benefits paid (used to derive total insurer benefits paid per person).

The level of insurance cover held by each individual was not available so the precise impact of
different types of PHI policies on the services claimed is not known. However, there is no reason
to suspect that the level of insurance cover would result in systematic bias in the analysis
conducted in this study.

4.2.2 Cohort selection
From the full study population, three cohorts were identified as the top 1% of users based on
hospital resource utilisation defined by total number of admissions, total bed days or total benefits
paid. Table 4.1 provides further information on the method of calculation and selection criteria for
each of the high-needs cohorts. As 405,428 people had a hospital admission in the study period, a
1% sample is 4,054 people. Due to the number of people that shared cut-off values for admissions
and length of stay, the three cohort sizes vary in size. The cohort sizes are included in Table 4.2.

Table 4.1 Selection criteria for high-needs cohorts
High-needs
cohort

Method of calculation

Selection criteria for inclusion

Highadmissions1

Sum the total number of admissions per
individual

Individuals with >28 admissions
in the study period

High-beddays

Calculate length of stay for each
admission using admission and
separation data1. Create total bed days
for each individual by summing length
of stay for each admission

Individuals with >98 bed days in
the study period

High-cost

Sum all benefits paid for each individual
with a hospital admission

Individuals with total benefits
paid >A$87,623 in the study
period

1A

hospital admission in which the admission and separation date occurred on the same day was allocated a
length of stay of one day. This is consistent with methods used by the AIHW for hospital statistics (AIHW
2016).
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4.2.3 Data limitations
A limitation of the dataset used for this analysis is the completeness of clinical information on
diagnosis, particularly relating to public hospital admissions. The analysis uses insurance claims
data sent to PHI funds as part of the Hospital Casemix Protocol (HCP) collection. The HCP is the
national standard for information on privately insured patients admitted to hospital, provided by
hospitals to both PHI funds and the Australian Government. Historically, public hospitals have
only been required to provide information used to pay the insurance claim rather than the complete
set of HCP data to insurers. This arrangement has been modified from 1 July 2018 with public
hospitals being required to provide the full set of HCP for privately insured admissions to PHI
funds (Department of Health 2018a). However, this limitation on HCP data on public hospital
admissions still applies to the insurance claims data analysed in this research and this issue has
been noted by other researchers using data obtained directly from another Australian PHI fund
(Xie et al. 2015, p. 1226). Although admission administrative information for public hospitals was
complete, admission clinical information was only 48% complete. As a result, public hospital
information was excluded from the analysis of clinical information and the results presented on
the most common diagnosis categories for the study population only relate to admissions to
private hospitals.

4.2.4 Statistical analysis
After cohort selection, descriptive statistics were generated to profile the three high-needs cohorts
and the full study population. For demographic statistics, sex and age distribution of the cohorts
were analysed. Hospital admissions were analysed by hospital type (public hospital or private
hospital, including private day hospitals) and by same-day or overnight admission status. Where
data were available, the principal diagnosis of each private hospital admission was investigated
(principal diagnosis data were available for 95.9% of private hospital admissions). The percentage
of hospital admissions included in the clinical profile is detailed in Table 4.2.

The principal diagnosis for each admission was grouped according to the 21 chapters of the
International Statistical Classification of Diseases and Related Health Problems, Tenth Revision,
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Australian Modification (ICD-10-AM) (Australian Consortium for Classification Development
(ACCD 2018a). For all cohorts, Chapter 21 (Factors affecting health status and contact with health
services) had the highest proportion of admissions. Due to the heterogeneous nature of this ICD10-AM chapter, specific ICD-10-AM codes for principal diagnosis for this chapter were further
investigated. It was found that three ICD-10-AM codes (Z509: care involving use of rehabilitation
procedure, unspecified, Z511: pharmacotherapy session for neoplasm, Z491: extracorporeal
dialysis) made up the majority of Chapter 21 entries (more than 90% for the three high-needs
cohorts). Although these codes do not represent specific health conditions, there are circumstances
in which the Australian coding standards require specific therapies or interventions to be coded as
the principal diagnosis, rather than a health condition (National Casemix and Classification Centre
(NCCC) 2013). The coding of these three items represents three such circumstances. These three
codes were treated as their own diagnosis grouping in the clinical profile analysis due to the large
proportion of admissions in which they were listed as the principal diagnosis.

The resource utilisation statistics for each high-needs cohort were then compared with those of the
full study population. Finally, overlap in individual membership of the three cohorts was
investigated by identifying the common individuals that appeared in each high-needs cohort based
on assigned person identifiers. All statistical analysis was performed using R version 3.2.2 (The R
Foundation, 2018).

4.3 Results
4.3.1. Demographic and hospital admission profile of high-needs cohorts
Table 4.2 summarises key demographic and hospital admission characteristics of each of the three
high-needs cohorts and the full study population. As may be expected, the high-needs cohorts are
older than the full study population with approximately double the proportion of individuals aged
65 years and over (high-needs cohorts ranged from 60-72% of individuals aged 65 years and over
compared with 32% for the full study population). The high-cost cohort has the highest proportion
of individuals aged 65 years and over at 72%. There are a greater proportion of females in the
high-admissions and high-bed-days cohorts compared to the full study population.
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Each of the high-needs cohorts has a higher proportion of admissions to public hospitals compared
to the full study population (16% of all admissions). For the high-bed-days and high-cost cohorts,
public hospital admissions as a proportion of total hospital admissions represent approximately
one-quarter of all admissions (27% and 24% respectively). The proportion of same-day
admissions for the high-needs cohorts is higher than the total study population. The highest
proportion of same-day admissions is for the high-admission cohort, with 80% of their admissions
being same-day.

Table 4.2 Demographic and hospital admission characteristics of high-needs cohorts and full
study population
Full study
population

High-admissions

High-bed-days

High-cost

Demographic characteristics
Cohort size

405,428

4,225

4,098

4,055

Median age (mean)

56 years (51.3)

68 years (65.1)

72 years (67.9)

73 years
(70.0)

Proportion aged 65
years and over

31.6%

59.5%

64.9%

72.3%

Proportion female

55.4%

57.6%

58.2%

49.8%

Hospital admission characteristics

1

Number of hospital
admissions

1,387,173

263,322

187,407

158,865

Proportion public
hospital

16.0%

20.5%

27.4%

24.0%

Proportion sameday admissions

60.4%

80.3%

70.7%

67.1%

Number of hospital
admissions used in
clinical profile (% of
total)1

1,109,154
(80.0%)

185,514 (70.5%)

116,800
(62.3%)

115,032
(72.4%)

Public hospital information was excluded from the analysis of clinical information.
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4.3.2 Clinical profile of high-needs cohorts
Figure 4.1 shows the top five principal diagnosis categories for hospital admissions to a private
facility for each of the high-needs cohorts and the total study population where data were
available.

Figure 4.1 Top five principal diagnosis categories for each high-needs cohort and total study
population for private hospital admissions (based on ICD-10-AM chapters (ACCD 2018a)).

The same five categories account for the top principal diagnoses for admissions in all three highneeds cohorts – mental health, dialysis, rehabilitation, pharmacotherapy for neoplasms, and
neoplasms (principal diagnosis other than pharmacotherapy for neoplasms). With the exception of
mental health and dialysis, the same principal diagnosis categories are also represented in the top
five categories for the total study population. Mental-health-related conditions account for the
highest proportion of admissions in all high-needs cohorts, but if the categories of
pharmacotherapy for neoplasms and neoplasms are combined then cancer-related diagnoses are
responsible for the highest proportion of admissions for the high-admission and high-cost cohorts.

54

Although there are 21 ICD-10-AM chapters, the top five principal diagnosis categories, from only
three chapters, make up a remarkably high proportion of all admissions in the high-needs cohorts
– 67.8% for high-cost, 74.4% for high-admission and 78.1% for high-bed-days.

4.3.3 The contribution of high-needs cohorts to overall resource utilisation
The high-needs cohorts represent the top 1% of individuals using the most hospital resources
however measured, but they account for much more than 1% of total resource utilisation. The
highest proportion overall is for bed days, with the high-bed-days cohort representing 21.2% of
total bed days. The high-admission cohort represents 19.0% of total admissions and the high-cost
cohort represents 13.3% of total costs paid by the insurers.

4.3.4 The relationship between the three measures of high resource utilisation
Figure 4.2 depicts the relationship between each of the three high-needs cohorts and the degree of
overlapping membership of the three cohorts. Within the three high-needs cohorts, there are 8,199
unique individuals. Thirteen percent of individuals are represented in all three high-needs cohorts
(n = 1,106) and 24% of individuals are represented in two of the three cohorts (n = 1,965). There
is greater overlap in membership of the high-cost and high-bed-days cohorts with 15% of the
individuals represented in both cohorts, compared to only 7% of individuals in both the high-cost
and high-admission cohorts and only 2% of individuals in both the high-bed-days and the highadmission cohorts. Almost one third of people (29%) are only represented in the high-admissions
cohort (n = 2,359). This finding may reflect a greater number of same-day visits for the highadmission cohort that have the shortest length of stay and are less resource-intensive resulting in
less overlap among group members with the high-bed-days and high-cost cohorts.

Figure 4.2 demonstrates a high degree of variation in resource utilisation even within the top 1%
cohorts. The 13% of individuals who are represented in all three high-needs cohorts have an
average of 103 hospital admissions in the study period, more than 10 times the number of
admissions of those individuals that are represented only in the high-cost cohort (average of 12
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admissions) or only in the high-bed-days cohorts (average of 11 admissions).

Similarly, the subgroup of individuals represented in all three high-needs cohorts has an average
of 238 bed days in the study period, which is four times the number of bed days of those
individuals represented only in the high-admission cohort (average of 59 bed days) or only in the
high-cost cohort (average of 53 bed days).

With respect to benefits paid, the average amount of benefits paid for the group represented in all
three high-needs cohorts was highest at $159,832 (Australian dollars). This is almost four times
the average benefits paid for individuals in the high-admission cohort only ($41,864) and two and
half times more than the average for the individuals represented in the high-bed-days cohort only
($61,513).

Figure 4.2 Individuals in each high-needs cohort as a proportion of the total number of
individuals in the three high-needs cohorts (Number of individuals (n), mean admissions,
benefits (A$) and bed days for specific subgroups included).
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4.4 Discussion
This study examines the demographic, hospital admission and clinical characteristics associated
with the highest levels of hospital resource utilisation among a large privately insured cohort.
Despite some differences in the demographic and admission characteristics of the three high-needs
cohorts, the same top five principal diagnosis categories are found for each cohort and for each
cohort, they account for more than two thirds of hospital admissions.

The study results suggest that the highest users of hospital resources have a distinct profile. The
highest levels of resources are being used for a narrow range of health conditions and use is highly
concentrated within a small group of individuals accounting for a large proportion of the total
resource utilisation. These results are consistent with research on a Victorian public health
organisation in which it was found that 20% of costs are spent by 3% of the population (Heslop et
al. 2005, p. 232). Mental health conditions were strongly represented among the high-needs
groups in this study and were selected as the condition for detailed analysis of patterns of service
utilisation. This analysis is presented in Chapter 5. The coverage of mental health treatment by
PHI funds has received both policy and media attention with government reforms for the PHI
sector announced in October 2017 including several measures related specifically to mental health
(Department of Health 2018d).

Although previous studies have examined differences in demographic and hospitalisation
characteristics between those with and without PHI in Australia, the differences within the
privately insured population has not been explored in detail. As might be expected, those with the
highest levels of hospital resource utilisation are, on average, older than the general insured
population. They also have a higher rate of admissions to public hospitals and a higher rate of
same-day admissions.

The higher rate of public hospital admissions may be influenced by several factors including a
higher rate of admission via emergency department presentations (which are located primarily in
public hospitals); previous selection of PHI in a public hospital making it more likely that the
payment category is selected on a subsequent admission; or the location in which services were
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provided, such as rural and regional areas that have less private hospitals.

Few studies have compared the three measures of hospital resource utilisation used in this study.
Similar to the present study but for a different outcome of interest, a recent study by Cheng and
colleagues (2014) also found that using different hospital resource utilisation measures –
admission numbers, bed days and costs – produced similar results in relation to public and private
hospital utilisation for heart disease patients. The degree of cohort membership overlap between
the different high-needs cohorts may explain the similar results between resource utilisation
measures.

The profile reported in this study complements national hospitalisation statistics that analyse the
use of PHI for hospital admissions in Australia (AIHW 2017). This study focuses on the top 1% of
patients with PHI and the conditions that patients are seeking treatment for in the private sector. A
notable finding in this study is that the proportion of same-day admissions for each of the highneeds cohorts is higher than the rate for the full study population. Although this in part reflects the
frequency with which some services need to be delivered (for example, dialysis several times per
week), it also reflects the high proportion of people requiring frequent, but usually time-limited,
same-day services such as mental health programs, rehabilitation and chemotherapy. Although the
clinical profile is based on admissions to private hospitals, which have higher rates of surgical
procedures compared to public hospitals (AIHW 2016), the top five categories for the high-needs
cohorts represent conditions requiring primarily non-surgical interventions.

There is a strong focus within the Australian health sector at present on reducing potentially
preventable hospitalisations and moving care for certain chronic conditions outside of hospitals to
the community (AIHW 2018d). Although the results of both insurer- and government-funded
CDM programs in Australia have been mixed (Billot et al. 2016; Hamar et al. 2015; Morello et al.
2016), the findings of the present study indicate that the highest users of hospital resources are
seeking services for a narrow range of conditions that are not the target of traditional CDM
programs. However, frequent hospital admissions are often a key selection criterion used by PHI
funds to target individuals for CDM enrolment. The findings of this study highlight the difference
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between potentially preventable hospitalisations and potentially preventable conditions. The major
reasons for accessing health services in the top 1% of privately insured hospital users in this study
– including chemotherapy, dialysis and most rehabilitation – are not preventable. However, the
mode of treatment may be modified, for example from overnight to same-day or from same-day to
outpatient care.

The majority of hospital admissions for the high-needs cohorts are on a same-day basis, which
raises questions as to how, and if, admissions could be further reduced or made more efficient.
Although only a narrow set of health conditions account for the majority of hospital admissions
among high-needs groups, these conditions relate to a diverse set of care needs so different
strategies will likely be required. This is similar to the conclusion drawn by Wodchis and
colleagues in a recent study of high health costs in Canada (Wodchis et al. 2016, p. 187). Insurer
approaches to designing and evaluating CDM programs and support strategies for high-needs
patients are further examined in Chapter 8.

A caveat of this study is that it used insurance claims data from a group of PHI funds so was not
able to investigate hospital admissions for the cohort as a public patient and there were gaps in the
clinical information available for public hospital admissions claimed on PHI. The study presented
in Chapter 7 examines hospital utilisation using linked insurance claims and public hospital data
sources to capture missing information on public hospital use for a smaller insured cohort.

The variation in coverage of PHI policies, described in section 2.3 on page 27 should be
considered in the interpretation of results of this study. In an effort to manage costs, an increasing
proportion of PHI policies have exclusions or limits on the levels of services covered. This has
been noted as a particular issue for mental health services. Although under the Private Health
Insurance Act 2007, PHI funds are required to pay a minimum benefit for psychiatric services,
benefits may be restricted for outpatient consultations following hospital discharge and outreach
services in community setting (Royal Australian and New Zealand College of Psychiatrists 2017).

Another limitation of this study relates to the completeness of clinical information. It is worth
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noting that the insurance claims data used for this study are the main source of data available to
PHI funds for the purposes of understanding and targeting health interventions for their members.
The fact that a substantial proportion of claims records have missing clinical information is an
important finding, particularly as many insurers seek to offer CDM services to high-needs
population groups. The implications of these information gaps and further exploration of
mechanisms to incorporate additional information to inform CDM strategies are examined in
Chapter 6.

4.5 Conclusion
Examining the profile of high-needs patients is an important first step in understanding differences
in the health services utilisation and care needs of people with PHI. The study findings show that
the high-needs patient groups have a narrow demographic and clinical profile. Four conditions,
mental health, cancers, rehabilitation and dialysis, account for more than two thirds of hospital
admissions in the high-needs groups. These conditions are not the target of traditional CDM
programs and are less amenable to preventive measures. Using claims data to identify individuals
with conditions that are the target of traditional CDM programs is the focus of the first part of the
study presented in Chapter 6. The findings suggest that different strategies may be required to
target the high-needs patients identified in this study. The study presented in the next chapter
builds on the findings of the study presented in this chapter by investigating detailed service use
patterns for one high-needs group, individuals with mental health-related treatment claimed on
PHI.
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Chapter 5: Utilisation patterns of mental health services
claimed on PHI
The study presented in this chapter analyses insurance claims data to examine the type, the
organisation and the frequency of mental health services accessed by patients and claimed on PHI.
Mental health conditions were selected as the focus condition because they were found to be one
of the top conditions for which high-needs patients sought hospital treatment claimed on PHI in
Chapter 4. This chapter presents the second study of Phase 2 (see Section 3.2 and Figure 3.1 on
page 42). The study also assesses data quality including the challenges in analysing and
interpreting insurance claims data to better understand mental health service utilisation.

5.1 Study background
The term “mental health condition” refers to a diverse spectrum of disorders including anxiety,
depression, substance use disorders and schizophrenia. These conditions vary in their severity,
duration and prevalence in the general population. Some people living with a mental health
condition require care over a long period of time provided by health professionals in both hospital
and community settings, due to the chronic and persistent nature of many mental health
conditions.

In Australia’s mixed public-private health insurance and service delivery system, mental health
care is funded by both government and private sources through PHI and patient contributions.
Although Australia dedicates a greater level of resources to mental health care than many other
countries (Saxena et al. 2007), national figures report only 65% of people with a mental health
disorder classified as severe accessed health services for the issue in the previous 12 months
(Department of Health 2013). As characterised by the model of health service use described in
Section 2.6 on page 33, a range of factors influences the utilisation of health services (Aday &
Andersen 1974; Andersen et al. 2014). The influence of contextual factors such as the policies,
financing and organisation of the health system that enable or impede access to care frames the
analysis and measurement of utilisation patterns in this study.
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Mental health services funded by PHI fall into two categories – hospital-based services (both
overnight and same-day admissions) and general services such as psychologist consultations. Due
to regulatory arrangements, there are a number of mental health services that PHI cannot cover
including medical services provided by psychiatrists and GPs outside of hospitals. Additionally,
costs for medication to manage mental health conditions are not paid by PHI due to the existence
of the Pharmaceutical Benefits Scheme as shown in Table 2.1 on page 26 that compares
government-funded and PHI-funded health services.

Achieving more integrated planning and delivery of mental health care is a national priority but
currently, there is relatively little known about mental health services delivered in the Australian
private hospital sector (Department of Health 2017). Significant work has been done on
standardising the collection and reporting of information on mental health care provided in
Australia’s public sector through the development of the Australian Mental Health Care
Classification (Independent Hospital Pricing Authority (IHPA) 2018) and the Key Performance
Indicators for Australian Public Mental Health Services that measure the average length of
admissions, delivery of follow-up care and readmission rates for services provided in the public
sector (AIHW 2018e). The private sector does not publish this information and is lagging behind,
despite growing activity in the sector. Mental health services delivered in the private sector need
to be better understood, particularly hospital-based services, as private expenditure has increased
steadily in recent years (AIHW 2018f) and PHI sector reforms introduced in October 2017 by the
Australian Government may exacerbate the incentive for consumers to access hospital-based
services. Regulation changes now allow people to upgrade their insurance policies for mental
health treatment in hospitals without waiting periods, but there have been no changes to improve
access to community-based mental health care (Rosenberg 2017).

PHI claims are a potential data source to provide information on private, hospital-based mental
health service use. Under the Private Health Insurance Act 2007, hospital insurance policies must
include a minimum benefit for mental health care. PHI funds cover 88% of private hospital
activity for mental health conditions (AIHW 2017). Insurance claims data can also be used to
analyse utilisation patterns over time at the patient-level, information that has not previously been
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reported for patients accessing mental health care in private hospitals.

Building on the high-needs profile developed in Chapter 4, this study further investigates
utilisation of mental health services of a privately insured cohort, focussing on the type and
frequency of services accessed. Utilisation patterns are presented for hospital-based services,
examining the demographic characteristics of patients accessing services and the average level of
service utilisation per patient in terms of number of overnight admissions and same-day visits,
length of stay per admission and insurer costs. This study compares:
1.

Demographic and hospitalisation characteristics of patients with mental healthrelated hospital claims: The number of patients with mental health-related claims are
identified and the characteristics of people with mental health-related hospital claims
are compared to insured patients with other types of hospital claims.

2.

Differences in service utilisation patterns for patients with mental health-related
hospital claims: Trends in hospital claims for the group of patients with mental healthrelated hospital claims are examined in relation to:
a)

Mental health-related and non-mental health-related hospital claims,

b)

Combinations of care for mental health-related hospitalisations, and;

c)

Mental health claims in the 28 days following an overnight admission discharge.

Following analysis, the implications of the profile findings and the appropriateness of using
insurance claims data for analysing mental health service use, not only for research, but also for
policy and planning decisions are considered. Assessing the appropriateness of using insurance
claims data for the secondary purpose of understanding mental health service use is an important
contribution of this study. Insurance claims data are appealing data sources for research and
analysis because of their large size, their longitudinal perspective, and their episode-based
information (Smeets et al. 2011, p. 428). However, inadequate attention is often given to the
quality of administrative data sources, such as claims data, and the challenges to reliably use the
data (Benchimol et al. 2013, p. 703).
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5.2 Methods
5.2.1 Data sources and study population
De-identified hospital and general treatment insurance claims data from a group of 13 Australian
PHI funds were analysed. PHI funds can pay benefits for services provided by psychologists
outside of hospital settings as part of general treatment policies. Psychology claims were included
in the analysis examining mental health-related claims following discharge from an overnight
hospital admission (see (c) in Section 5.2.4). The insurance claims data extract used for this study
was different to the data extract used in the study presented in Chapter 4 due to the need to have a
common identifier to link hospital and general treatment claims datasets. The final dataset
analysed included 236,910 patients with at least one hospital admission (574,589 admissions in
total). The claims data related to individuals residing in all Australian states and territories for
services received between 1 May 2014 and 30 April 2016 in more than 60 private hospitals. Each
person and hospital admission had a unique identifier.

In this study, a “patient” is defined as a person accessing privately funded mental health services
from a hospital during the study period. Privately funded services are those for which PHI funds
pay a benefit. Overnight admissions and same-day visits are used to distinguish between the two
main types of hospital services provided based on length of stay. In this study, mental health
services include services treating people with drug and alcohol use disorders.

When referring to all hospital services, both overnight admissions and same-day visits, the term
“mental health hospitalisation” is used. Same-day visits cover a range of services including
individual consultations and group programs that may be provided, and classified, as outpatient or
ambulatory services in the public hospital sector in Australia and in other countries (AIHW
2018g). Only private hospital utilisation was included to examine mental health service utilisation
(see (b) in Section 5.2.4) due to differences in coding same-day visits in private and public
hospitals. As shown in Figure 5.1, the majority of patients (97.8% or 3,137 patients) accessed
mental health services in a private hospital.
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5.2.2 Dataset preparation: Establishing the population with a hospital claim
for mental health services within the insured population
Insurance claims were analysed using both cross-sectional and longitudinal analysis methods.
Data analysis occurred in multiple stages described below. All statistical analysis was conducted
using R version 3.2.2 (The R Foundation 2018).

Patient classification codes were used as the primary method to categorise the group of patients
with a mental health-related hospitalisation. Claims records coded as “PY” denote a mental healthrelated (or psychiatric) hospitalisation. Although mental health diagnosis information recorded by
Australian Refined Diagnosis Related Groups (AR-DRG) was included for some claims records
(ACCD 2018b), this information was not consistently available for all claims records, so the
analysis could not examine differences in utilisation patterns based on the type of mental health
condition. AR-DRG information, where available, was used to check for missing mental healthrelated hospitalisations. Two additional hospitalisations were found by searching codes relating to
mental health or drug and alcohol use, U40-U68: Mental diseases and disorders and V60-V64:
Alcohol and drug use (ACCD 2018b). A full list of AR-DRG codes is included as Appendix 1. All
patients with at least one overnight admission or same-day visit not categorised as mental healthrelated were included in the comparison group of patients without a mental health-related
hospitalisation.

5.2.3 Demographic and hospitalisation characteristics of patients with mental
health-related hospital claims
The demographic and hospital resource utilisation characteristics of the two groups were
compared. The demographic variables analysed were sex, age and location of residence. Hospital
resource utilisation was measured by the following indicators: number of same-day visits and
overnight admissions per patient, average length of stay per admission and hospital costs paid by
the insurer per patient. Same-day visits, where hospital admission and separation dates occur on
the same day, were allocated a length of stay of one day consistent with methods for calculating
national hospital statistics (AIHW 2016). A measure of bed days was calculated by summing the
length of stay for overnight admissions for each patient. Annual measures for resource utilisation
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were obtained by halving total results for the two-year study period. Pearson Chi-square (χ2) tests
were used to compare categorical variables and Wilcoxon rank-sum (Mann-Whitney) tests were
used for continuous variables, as variables were not normally distributed.

5.2.4 Differences in service use for patients with mental health-related
hospital claims
a) Mental health-related and non-mental health-related claims
Hospital use for the group with at least one mental health-related hospital claim was analysed.
Two groups were formed based on whether or not a patient had any non-mental health related
hospitalisations in the study period. Demographic and hospitalisation characteristics were
compared using the same statistical methods described in 5.2.3.

b) Combinations of care for mental health-related hospitalisations
Hospital use for the mental health group was further analysed with three groups formed according
to whether a person claimed for only same-day visits, only overnight admissions or a combination
of same-day visits and overnight hospital admissions in the study period. For the two groups with
overnight admissions, hospital utilisation characteristics were compared using the same statistical
methods described in 5.2.3. For the group with both overnight admissions and same-day visits,
analysis was completed on the proportion of patients with their first hospitalisation in the study
period as an overnight admission followed by a same-day visit versus patients with their first
hospitalisation as a same-day visit followed by an overnight admission.

c) Mental health claims in the 28 days following an overnight admission discharge
To investigate claims following an overnight hospital admission, each patient’s first claim in the
study period was investigated, recognising that the dataset covered a two-year period and patients
may have multiple hospital claims during the study period. For patients with an overnight
hospitalisation as their first admission in the dataset (n = 2,101, 67% of patients with a mental
health-related hospitalisation), the type and timing of the next mental health-related claim was
analysed, specifically whether the claim occurred within 28 days after discharge. Patients who
were discharged from their first overnight admission within 28 days of the end of the study period
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were excluded from analysis. Overnight admissions, same-day visits and community-based
psychology services claimed on PHI general treatment policies were included in the analysis.

5.3 Results
5.3.1 Mental health-related claims within the insured population
Figure 5.1 shows the number of insured patients with a hospital claim and further categorises the
group with mental health-related hospitalisations according to the type of services accessed. Only
a small proportion (1.4%) of patients have a mental health-related hospitalisation, overwhelmingly
in private hospitals. The majority of patients only claim for overnight admissions in the study
period. Differences in patients’ use of privately funded mental health services are further
described in Section 5.3.2, b) Combinations of care for mental health-related hospitalisations.

Figure 5.1 Study population with hospitalisations for 2014-2016 showing patients with
mental health-related hospitalisations
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5.3.2 Demographic and hospitalisation characteristics of patients with mental
health-related hospital claims
Table 5.1 compares demographic and hospital resource utilisation statistics for the group of
patients with a mental health-related hospital claim (n = 3,209) and the comparison group with
other types of hospital claims (n = 233,701).

Table 5.1 Descriptive statistics for patients with and without mental health-related
hospitalisations
1a) Demographic characteristics
Mental health
hospitalisation

No mental health
hospitalisation

(n = 3,209)

(n = 233,701)

p-value

1,990 (62.0)

130,432 (55.8)

< 0.01

0-24, n (%)

380 (11.8)

29,925 (12.8)

< 0.01

25-34, n (%)

627 (19.5)

20,269 (8.7)

35-44, n (%)

587 (18.3)

24,015 (10.3)

45-54, n (%)

568 (17.7)

25,935 (11.1)

55-64, n (%)

559 (17.4)

47,501 (20.3)

65-74, n (%)

343 (10.7)

50,959 (21.8)

75+, n (%)

145 (4.5)

35,097 (15.0)

New South Wales, n (%)

1,343 (41.9)

85,564 (36.6)

Victoria, n (%)

1,024 (31.9)

70,500 (30.2)

Queensland, n (%)

592 (18.4)

45,228 (19.4)

All other states and territories, n
(%)

250 (7.8)

32,409 (13.9)

Sexa
Female, n (%)
Age groupsa

Location of residencea
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< 0.01

1b) Hospital resource utilisation characteristics
Mental health
hospitalisation
(n = 3,209)

No mental
health
hospitalisation
(n = 233,701)

Total hospitalisations (two years), n

p-value

33,134

541,455

Overnight admissions a, n (% total)

7,321 (22.1)

181,516 (33.5)

Same-day visits, n (% total)

25,813 (77.9)

359,939 (66.5)

Mean annual overnight admissions per
patientb,c, n (SD)

1.3 (1.2)

0.8 (0.6)

< 0.01

Mean annual same-day visits per patientb,d, n
(SD)

6.4 (8.9)

1.1 (3.6)

< 0.01

Mean length of stay for overnight
admissionsb, days (SD)

15.0 (14.1)

4.6 (7.3)

< 0.01

Mean annual bed days for overnight
admissions per personb,c, days (SD)

19.7 (20.3)

3.6 (7.2)

< 0.01

Mean annual hospital costs paid by insurerb,
A$ (SD)

$13,192
(13,457)

$2,065 (4,346)

< 0.01

< 0.01

Abbreviations: SD: standard deviation
a
Pearson Chi-square (χ2) test used to compare categorical and proportional variables.
b
Wilcoxon rank-sum (Mann-Whitney) test used to compare means of continuous variables.
c
Mean calculated based on patients with an overnight admission (2,795 patients with mental
health-related admissions and 115,910 patients with other admissions)
d
Mean calculated based on patients with a same-day visit (2,021 patients with mental healthrelated visits and 162,907 patients with other visits).

The group with mental health-related hospital utilisation has a greater proportion of females and
are also significantly younger. Only 32.6% of the group with a mental health-related hospital
utilisation are aged 55 years and over compared to 57.1% of the group with other types of
hospitalisations. Geographically, there are relatively more patients with a mental health-related
hospital claim in New South Wales compared to other types of hospital claims, and relatively
fewer patients from states and territories other than New South Wales, Victoria and Queensland
with a mental health-related hospital claim compared to other types of hospital claims.

The mental health group has a significantly higher level of hospital use for all utilisation measures
– number of admissions, length of stay per admission and costs to the insurer. Although the mental
health group has a lower proportion of overnight admissions as a proportion of total
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hospitalisation (22.1% compared to 33.5% for the group with other types of hospitalisations), the
mental health group has significantly more overnight admissions in the study period than the
group with other types of hospitalisations (an average of 1.3 overnight admissions per year
compared to 0.8 admissions per year for the group with other types of hospitalisations). The
mental health group has an annual average of 6.4 same-day visits compared to 1.1 for the group
with other types of hospitalisations. The mental health group has an average length of stay for
overnight admissions of 15.0 days compared to 4.6 days for the group with other types of
hospitalisations. Additionally, on average, the annual number of bed days for overnight
admissions for the mental health group is 19.7 days compared to 3.6 days for the group with other
types of hospitalisations. Finally, mean annual hospital costs paid by the insurer are six times
higher for the mental health group.

5.3.3 Differences in service use for patients with mental health-related
hospital claims
a) Mental health-related and non-mental health-related claims
Table 5.2 compares demographic and hospital resource utilisation within the mental health group
for two groups – patients with only mental health-related hospitalisations and patients with mental
health-related and other hospitalisations. Just over half of the mental health group (1,633 patients,
51%) only claim for mental health-related hospitalisations. The group with only mental healthrelated hospitalisations are significantly younger and less likely to be female. Although the group
with only mental health-related hospitalisations has a significantly longer length of stay per
overnight admission and higher average annual number of same-day visits, the group with mental
health-related and other hospitalisations has a significantly higher average number of overnight
admissions per year, higher average number of bed days per year for overnight admissions and
significantly higher average hospital costs paid by insurers per year. Overall, 64% of
hospitalisations for the group with both mental health-related and other types of hospitalisations
are mental health-related.
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Table 5.2 Descriptive statistics for patients with mental health-related hospitalisations, with
and without other types of hospitalisations
Only mental health
hospitalisations

Mental health and
other hospitalisations

(n = 1,633)

(n = 1,576)

Femalea, n (%)

963 (59)

1,024 (65)

< 0.01

Mean age b, years (SD)

42.2 (15.6)

49.1 (17.2)

<0.01

Total hospitalisations (two
years), n

12,473

20,661

Overnight admissions a, n (%
total)

2,288 (18)

5,031 (24)

Same-day visits, n (% total)

10,185 (82)

15,630 (76)

Mean annual overnight
admissions per patientb,c, n (SD)

0.9 (0.8)

1.7 (1.4)

<0.01

Mean annual same-day visits
per patientb,d, n (SD)

6.6 (7.7)

6.3 (9.6)

<0.01

Mean length of stay for
overnight admissionsb, days
(SD)

18.7 (13.5)

13.3 (14.1)

<0.01

Mean annual bed days for
overnight admissions per
patientb,c, days (SD)

16.2 (15.5)

22.8 (23.3)

<0.01

Mean annual hospital costs paid
by insurerb, $ (SD)

$10,071 (10,599)

$16,425 (15,228)

<0.01

p-value

<0.01

Abbreviations: SD: standard deviation
a
Pearson Chi-square (χ2) test used to compare categorical and proportional variables
b
Wilcoxon rank-sum (Mann-Whitney) test used to compare means of continuous variables
c
Mean calculated based on patients with an overnight admission (774 patients with only mental
health-related hospitalisations and 1,248 patients with mental health-related and other
hospitalisations)
d
Mean calculated based on patients with a same-day visit (1,322 patients with only mental healthrelated hospitalisations and 1,472 patients with mental health-related and other hospitalisations).

b) Combinations of care for mental health-related hospitalisations
Categorising patients admitted to private hospitals according to the type of mental health-related
hospitalisation claimed during the study period shows the majority of patients (52.6%) only claim
for overnight admissions, 30.4% of patients claim for both same-day visits and overnight
admissions and 17.0% of patients only claim for same-day visits. The number of patients for the
three groups is shown in Figure 5.1. Eighty percent of all hospitalisations are same-day visits. For

71

the two groups with overnight admissions in the study period, the group of patients with both
overnight admissions and same-day visits have significantly higher levels of service use with an
average of 1.2 admissions per year (SD = 1.1) and an average of 20.1 days per overnight
admission (SD = 14.1), compared to 0.9 admissions per year (SD = 0.9, p<0.01) and 17.8 days per
overnight admission (SD = 13.9, p<0.01) for the overnight-only group.

For the 952 patients with both overnight admissions and same-day visits, 78% have an overnight
admission occur first in the study period followed by a same-day visits and 22% have a same-day
visit first followed by an overnight admission.

c) Mental health claims following an overnight admission discharge
Of the 2,101 patients with an overnight admission as their first hospitalisation during the study
period, Figure 5.2 shows the majority of patients (68%) do not claim for additional mental healthrelated services on their PHI in the 28 days following discharge. Nineteen percent of patients
claim for a same-day visit within 28 days and 12% of patients claim for another overnight
admission. Only 1% of patients claim for a psychology consultation as their first claim after a
hospital discharge within 28 days.

Figure 5.2 Service claims within 28 days after discharge from first overnight hospital
admission
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5.4 Discussion
In this privately insured population, the group of patients with mental health-related hospital
claims only account for 1.4% of all patients with a hospital claim but have significantly higher
levels of hospital utilisation compared to the group of patients with claims for other types of
hospitalisations. Consistent with the findings of a recent study among patients in Tasmanian
public hospitals that patients with a comorbidity of mental illness have a significantly longer
length of stay for admissions related to five chronic conditions (Siddiqui et al. 2018), patients with
both mental health-related and non-mental health-related hospitalisations have significantly higher
levels of hospital utilisation in this study. Access to, and use of, appropriate ambulatory care
targeting mental health and other presenting health conditions should be encouraged for this
group.

The type of mental health-related services accessed varies across the insured population. Rather
than most patients accessing both overnight admissions and same-day visits as would be expected
if same-day visits were primarily provided as follow-up care in conjunction with treatment
provided during overnight admissions, this study finds three distinct groups of service users –
same-day visits only, overnight admissions only and a combination of same-day visits and
overnight admissions. More than half of the patients with a mental health-related hospitalisation
only claim for overnight admissions in the two-year study period and only one third of patients
make an additional mental health-related PHI claim within 28 days after discharge from their first
overnight admission in the study period.

5.4.1 Implications of study findings for research and planning
The findings from Chapter 4 identified mental health conditions as one of the top reasons for
hospital claims among high-needs patients. Further analysis of mental health-related claims
presented in this chapter reveals demographic and service utilisation differences within the group
of patients with mental health-related hospitalisations that may inform intervention strategies. The
groups with the highest levels of utilisation:
•

Have both mental health and non-mental health-related hospital claims
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•

Claim for both overnight and same-day mental health-related hospitalisations.

The study findings report measures of utilisation including the type, combination and frequency of
mental health services accessed by patients with PHI. It is more challenging to understand the
specific factors associated with the utilisation patterns observed and the outcomes of the care
received in private hospitals as discussed further in the next section, which focuses on the
implications for research and planning.

Interpreting factors contributing to observed service use patterns is challenging
The study reveals information on the demographic characteristics of patients accessing private
mental health services and patterns of mental health service use in private hospitals in Australia.
The organisation of mental health service delivery in the private sector and the regulation of the
PHI sector seem to affect utilisation of services but the specific influence of clinical, organisation
and policy factors that may affect the use of mental health services cannot be ascertained due to
limitations in the data collected by insurers. For example, the mix of claims for overnight and
same-day hospitalisations, specifically the high proportion of patients with only overnight
admission claims, may be affected by a number of different factors outlined in the Behavioural
Model of Health Service Use – patient need, insurance policy coverage, hospital treatment
policies or service availability (Aday & Andersen 1974; Andersen et al. 2014). All of these factors
may be important contributors to mental health service use but the influence of these different
factors on service utilisation cannot be distinguished using the claims data analysed.

The fragmented funding of mental health care is reflected in the type of services claimed on PHI
The data analysed reveals only a limited picture of the care journey of patients with mental health
conditions. The limitations observed in this study reflect the complex financing mechanisms that
people with a mental health condition and their carers have to navigate to access different forms of
mental health care. The finding that only one third of patients made a mental health-related claim
within 28 days after discharge is important. However, it cannot be interpreted that patients are not
receiving any mental health services, just that they are not claimed on PHI. This is because the
extent of Medicare-funded mental health care that privately insured people access is not known.
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Ideally, patients would be connected with community-based support as part of hospital discharge
regardless of funding arrangements, consistent with stepped care models (Cross & Hickie 2017),
but the extent of this care coordination in practice cannot be assessed using PHI claims data alone.

A more comprehensive picture of mental health treatment could be built through analysing linked
PHI and Medicare Benefits Schedule data. This analysis would capture community-based
psychiatry services and mental health services funded through the government-funded Better
Access scheme that funds a limited amount of GP-referred psychological care (Department of
Health 2012). The feasibility and results of a pilot study linking insurance claims data and health
data from a public sector organisation are reported in Chapter 7.

Claims data provide little information on the outcomes of mental health care
Monitoring care received following hospital discharge is difficult using claims data. There are no
indicators of other outcomes of mental health care in claims data, despite the fact measures are
collected for the private sector via the Australian Private Hospitals Association Private Psychiatric
Hospitals Data Reporting and Analysis Service (known as PPHDRAS). The standardised
measures of patients’ clinical status collected include the Health of the Nation Outcome Scale
(HoNOS) administered by clinicians and the Mental Health Questionnaire-14 completed by
consumers (Burgess et al. 2015). However, reports on these outcome measures for the private
sector are released to the public irregularly and participation by private hospitals is voluntary
(Australian Private Hospitals Association 2018). There is an opportunity to better understand
outcomes of mental health care delivered in private hospitals through the longitudinal analysis of
this data collection, although as for insurance claims data, data quality needs to be assessed.

Based on analyses using insurance claims data, PHI funds have little visibility of the mental health
care that patients receive following hospital discharge. It is encouraging that a number of insurers
have started to introduce mental health support programs for patients leaving hospital such as the
MindStep program (Remedy Healthcare 2018). However, determining participant eligibility,
assessing individual care needs and ensuring alignment with a patient’s other mental health care
providers are important considerations for insurers offering these programs. Additionally, these
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mental health support programs are generally short-term (lasting 6-12 weeks) so programs need to
be evaluated to assess their impact on health outcomes and service use.

5.4.2 Caveats of analysis
This study has a number of limitations. This study used two years of insurance claims data (20142016) but does not account for service utilisation before or after that period. Additionally, clinical
diagnoses were not consistently recorded in the claims dataset analysed so differences in patterns
of service utilisation of patients with different types of mental health conditions could not be
analysed. Research examining longitudinal service utilisation accessed by patients with mental
health-related hospitalisations over a longer time period, differences in service use based on the
type of mental health conditions for which care is sought and the factors influencing access to care
would be valuable areas of future research.

5.5 Conclusion
Despite mental health conditions being one of the top reasons for hospital use among high-needs
patients, detailed information on utilisation patterns of mental health services claimed on PHI is
lacking. Analysing insurance claims reveals information on mental health-related hospitalisations
but information on community-based care is not available due to the regulated role of the PHI
sector in Australia. Examining insurance claims data from a sample of Australian PHI funds
shows that the proportion of the insured population claiming for mental health-related hospital
services is small but hospital resource utilisation for this group is much higher than for people
with insurance claims for other types of hospitalisations.

Investigating the potential factors contributing to patterns of mental health-related hospital claims,
such as the large proportion of patients that only claim for overnight admissions, is challenging
due to the scope of claims data. The factors contributing to trends in mental health service
utilisation claimed on PHI, and the performance and outcomes of care, needs to be better
understood given the high levels of hospital resource utilisation. Linking multiple data sources on
service use and outcomes is required as insurance claims data only provide information on a
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limited part of service utilisation. The study presented in the next chapter picks up on this topic.
The study examines considerations for developing information systems using multiple data
sources to support people with chronic conditions and high healthcare needs.
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Chapter 6: Analysing data and information system
requirements for CDM programs of health insurers
This chapter presents a mixed-methods study that examines methods for selecting chronic disease
groups from PHI claims data and reviews the requirements for developing information systems
using multiple data sources to inform CDM interventions. This chapter presents the second phase
of research described in Section 3.2 and Figure 3.1 on page 42. As a key theoretical contribution
of this thesis, a conceptual framework is developed in this study and the feasibility of applying the
framework to the Australian PHI sector is discussed.

6.1 Study background
The findings of the studies presented in Chapters 4 and 5 reveal limitations in using PHI claims
data to understand the health service utilisation of high-needs patients, providing only a partial
view of a patient’s health service journey due to the regulated scope of insurance coverage. The
PHI sector is increasingly offering new CDM services targeted at high-need patients and people
with, or at risk of developing, chronic conditions. However, evidence suggests that comprehensive
and high quality health information is crucial for CDM interventions. Implementing CDM
programs typically involves using risk categorisation, or stratification, which targets individuals,
based on their care needs, with different levels of support. Risk stratification is an important
implementation strategy to ensure that CDM programs are effective, from both a health outcomes
and cost perspective (Aljutaili et al. 2014; Russell 2009).

Administrative health data are increasingly used to identify target populations for CDM programs.
This method is already used among PHI funds in Australia due to the availability of hospital
claims data (Hamar et al. 2015; Morello et al. 2016). The first phase of research in this chapter
expands on the assessment of claims data from Chapters 4 and 5 relating to health service
utilisation. The research examines the suitability of hospital claims data for selecting target groups
for CDM programs.

Given that insurance claims data offer only a partial view of health service utilisation and people
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at-risk of developing chronic conditions are unlikely to be identified through hospital claims
records alone, the second phase of the research in this study considers the data and information
system requirements for insurers seeking to provide CDM programs and build a more
comprehensive profile of the health status of the insured population. For successful
implementation, it is important to not only consider sources of data but also, how data sources can
be meaningfully combined and analysed to inform CDM decisions.

This chapter is divided into three sections following the three research stages described in 6.2
below:
Stage 1: Selecting chronic disease groups using insurance claims data
Stage 2: Identifying the key domains in developing information systems for CDM using multiple
data sources
Stage 3: Developing a framework for designing and implementing information systems for CDM
using multiple data sources.

6.2 Study design
The study has a sequential, mixed methods design, as shown in Figure 6.1. The first research stage
uses quantitative methods, examining methods of selecting target populations for CDM
interventions from insurance claims data for three common chronic conditions – diabetes,
cardiovascular disease and mental health conditions. The analysis assesses data quality features
including how well selection methods predict future hospital use.

The second research stage uses qualitative methods including instructed interviews with PHI fund
representatives and a targeted review of published and grey literature to identify key domains in
assessing and using data sources for CDM decision-making. The third interpretive stage pulls
together the four domains identified in the second research stage into a conceptual framework for
developing information systems for CDM using multiple data sources. The third stage also
considers implementation of the framework in the PHI sector to improve the quality of
information available to inform CDM decisions.
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1. Quantitative

2. Qualitative

•Hospital
claims data
analysis
•Methods of
selecting
target groups
for CDM

3.Interpretation

•Literature
review
•Interviews
•Identify key
domains

•Develop
Framework
•Application and
implementation
of Framework

Figure 6.1 Diagram of research stages and methods for mixed-methods study

6.3 Stage 1: Selecting chronic disease groups using insurance
claims data
This stage assesses the suitability of using hospital claims data to select CDM groups. The three
chronic conditions, diabetes, cardiovascular disease and mental health conditions, were selected
because the systems of care and clinical symptoms for each condition differ so it was anticipated
there could be differences in the classification of the three conditions in hospital claims data.
Cardiovascular disease and diabetes are often the focus of CDM programs of PHI funds in
Australia (Hamar et al. 2015, p. 2). However, the two chronic conditions typically require
accessing different types of health care.

Unlike cardiovascular disease, diabetes is generally not the primary cause of a hospital admission
but is associated with a range of health complications. In Australia, there were over 1 million
diabetes-related hospitalisations in 2015-16 but in only 5% of cases was diabetes listed as the
principal diagnosis (AIHW 2018h). In comparison, there were a similar number of hospitalisations
related to cardiovascular disease in 2015-16 but cardiovascular disease was listed as the principal
diagnosis in almost 50% of cases (AIHW 2018i).

Mental health conditions are treated differently to other chronic health conditions, with different
risk assessment, treatment interventions and in some circumstances, entirely separate healthcare
facilities. In Australia, mental health conditions have not traditionally been the target of CDM
programs, although mental health conditions account for a large number of hospital claims among
patients with the highest levels of hospital use, as shown in Chapters 4 and 5.
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In addition to analysing diagnosis codes for specific chronic conditions in hospital claims data,
many chronic conditions share common, preventable risk factors that include smoking, harmful
alcohol use, poor nutrition and physical inactivity that lead to biomedical risk factors for the
development of chronic conditions such as obesity, hypertension and high cholesterol levels
(Moodie et al. 2016, p. 223). Clinical codes exist for these risk factors and they can be added as
codes in hospital admission records if it is expected that the risk factors are affecting the health
status of the patient. The extent to which codes for chronic disease risk factors are recorded in
hospital claims records is not known. Previous research was conducted in the United States
examining the utilisation of ICD diagnosis codes in hospital admission data to identify people with
unmet social needs. This research found these codes were infrequently used (Torres et al. 2017).

6.3.1 Methods: Data sources and analysis
Hospital claims data for a two-year period between 1 May 2013 and 30 April 2015 were analysed,
using a two-year subset of the data described in Chapter 4. The data subset contained 573,684
hospital admissions relating to 234,780 individuals, capturing both same-day and overnight
hospitalisations. Eligible admissions were classified according to admission start date with
admissions that commenced on or after 1 May 2013 and on or before 30 April 2015 included in
the study dataset.

Disease diagnosis information is contained in two different variables – diagnosis payment code for
each hospital admission (AR-DRG), and diagnosis of admission coded using ICD-10-AM (ACCD
2018a). The method used to select the three chronic condition groups used both diagnosis
variables, searching for either relevant AR-DRG or ICD-10-AM codes (for principal and
additional diagnoses) for each condition in hospital claims data.

In addition to diagnosis codes, Chapter 21 of ICD-10-AM (Factors affecting health status and
contact with health services) includes specific sub-groupings that may provide indicators of
disease risk. The broad grouping of codes investigated were Z55–Z65: persons with potential
health hazards related to socioeconomic and psychosocial circumstances and Z70–Z76: persons
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encountering health services in other circumstances. The specific codes used to identify each
chronic condition and additional risk factors are listed in Table 6.1.

Table 6.1 Disease codes used to identify target chronic condition populations and disease risk
and social factors

Diabetes

AR-DRG codes

ICD-10-AM codes

K01 - Operating Room
procedures related to diabetic
complications

E10, E11, E13, E14 Diabetes mellitus

K60 – Diabetes
Mental health disorders

U40 - U68 Mental diseases and
disorders

F00 - F99 Mental and
behavioural disorders1

V60 - V64 Alcohol and drug use
Cardiovascular disease

F01 - F75 Diseases and
disorders of the circulatory
system

I00 - I99 Diseases of the
circulatory systems

Disease risk and social
factors

N/A

Z55 - Z65 and Z70 - Z76
Specific disease risk codes
Z72.0 Tobacco use
Z72.1 Alcohol use
Z72.2 Drug use
Z72.3 Lack of appropriate
exercise
Z72.4 Inappropriate diet and
eating habits

1

F00-F99 includes disorders related to alcohol and drug use

A one-year data sample (1 May 2013 - 30 April 2014) was used to calculate the number of
hospital admissions and unique individuals identified for each chronic condition. To assess how
well the selection method predicts future hospital use, the proportion of people identified in 201314 who were also hospitalised in 2014-15 was compared for the three conditions. For 2014-15,
both disease-specific hospitalisations and all-cause hospitalisations were calculated.

For the analysis of disease risk and social factors, the full two-year sample of data was used to
identify the number of admissions in which the five specific disease risk indicators and the broader
social risk sub-grouping were coded in the hospital claims data provided to PHI funds. As the
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disease risk and social factors are not the reason for hospitalisation, the principal diagnosis of
admissions related to these factors was also examined.

6.3.2 Results of data analysis
The number of hospital admissions and unique individuals identified using 2013-14 hospital
claims data is included in Table 6.2. Of the three chronic conditions investigated, cardiovascular
disease was recorded most frequently in terms of number of hospital admissions and number of
individuals with a hospitalisation. Although the number of hospital admissions listing mental
health conditions as a diagnosis is higher than diabetes, almost double the number of individuals
with diabetes are identified. This finding suggests that a greater number of people with mental
health disorders had multiple hospital admissions in the stud period, consistent with the utilisation
findings reported in the study presented in Chapter 5.

Another factor to consider in the coding of hospital admissions is that national clinical coding
rules require diabetes to be listed as an additional diagnosis where it is known for all individuals
hospitalised. For other diagnoses, coding rules only require the listing of additional diagnoses if
the condition has the potential to impact on care for the admission (NCCC 2013).

Table 6.2 Number of admissions and individuals identified with chronic conditions in 201314 using diagnosis codes (ICD-10-AM or AR-DRG)
Admissions

Individuals

Diabetes

14,324

7,766

Mental health disorders

16,213

3,445

Cardiovascular disease

20,555

13,691

To assess data quality, the number of admissions in 2013-14 with complete AR-DRG and ICD-10AM information was compared to the total number of hospital admissions. Of 227,786
admissions, only 77% of admissions have DRG information and 84% of admissions have ICD-10AM information. As identified in Chapter 4, diagnosis information was missing for a greater
proportion of admissions to public hospitals compared to private hospitals.
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Further statistical analysis calculated the proportion of individuals identified in 2013-14 who were
also admitted in 2014-15 for the same condition, or for any condition (all-cause hospitalisation).
The results are shown in Figure 6.2. Thirty-seven percent of individuals identified with diabetes in
2013-14 had at least one subsequent admission in 2014-15 with diabetes listed, compared to 29%
of individuals admitted for a mental health condition and 16% of individuals admitted for
cardiovascular disease in 2014-15. Expanding the criteria to any hospital admission claimed in
2014-15 by an individual identified in 2013-14, the proportion of individuals admitted increases to
49% for diabetes, 46% cardiovascular disease and 51% for mental health conditions.

Percent of hospital admissions

100

Same condition
Any condition

80

60

51

49
40

46

37
29
16

20

0
Diabetes

Mental Health

Cardiovascular
Disease

Chronic condition
Figure 6.2 Percentage of individuals selected with a chronic condition in 2013-14 with
hospitalisations in 2014-15 for the same condition or for any condition

Further, individuals with an admission for the same chronic condition in 2013-14 and 2014-15
account for only a minority of all patients admitted for the three conditions in 2014-15. For
diabetes, the group of individuals identified in 2013-14 account for 33% of all individuals with an
admission for diabetes in 2014-15, and only 23% and 15% of all individuals with admissions for a
mental health condition and cardiovascular disease respectively.
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In relation to the recording of codes related to disease risk and social factors in hospital claims
data, results are shown in Table 6.3. With the exception of tobacco use, only a small proportion of
admissions contained codes for the other four disease risk factors related to alcohol use, drug use,
exercise and diet.

Table 6.3 Number of hospital admissions with disease risk codes listed in 2013-15
Disease risk code and description

No. Admissions

Z72.0 Tobacco use

16,404 (2.8)

Z72.1 Alcohol use

113 (<0.1)

Z72.2 Drug use

37 (<0.1)

Z72.3 Lack of appropriate exercise

<10 (<0.1)

Z72.4 Inappropriate diet and eating habits

<10 (<0.1)

Total hospital admissions in 2013-2015

573,684

Table 6.4 shows the number of admissions with codes recorded for the broader set of social risk
factors and also the top five principal diagnosis codes for admissions related to the top five social
risk categories. Tobacco use is still the condition coded most frequently in the broader grouping of
social risk factors. The remaining top five codes relate to mobility and relationship issues. Mental
health conditions are strongly represented among the top conditions for which social risk factors
are coded. The other conditions relate to conditions that have a high prevalence of hospital
admissions such as rehabilitation, chemotherapy and cataract surgery. Overall, only 2.9% of
hospital admissions include disease risk codes and only 3.8% of admissions included codes related
to the broader social risk categories.
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Table 6.4 Top five social risk codes listed in hospital admissions in 2013-15 and top five
principal diagnosis of admissions related to top five social codes
Social risk code

Admissions

Z72.0 Tobacco use

16,404

Z60.2 Living alone

1605

Z74.0 Need for assistance due to reduced mobility

483

Z63.0 Problems in relationship with spouse or partner

438

Z61.8 Other negative life events in childhood

293

Total number of admissions

19,223

Principal diagnosis related to top five social codes
Z50.9 Care involving use of rehabilitation procedure, unspecified

944

F32.20 Severe depressive episode without psychotic symptoms, not specified
as arising in postnatal period

589

H23.9 Cataract, unspecified

466

F10.2 Mental and behavioural disorders due to use of alcohol: unspecified
mental and behavioural disorder

424

Z5.11 Chemotherapy session for neoplasm

370

Total number of admissions (% of all social risk coded admissions)

2,793 (15)

6.3.3 Implications of data analysis
Selecting target populations is the first step in implementing CDM programs but its importance is
often overlooked. Hospital claims data are the most comprehensive data source available to
insurers in Australia, but this data source only captures health status information on people with
hospital claims, a minority of the insured population. Additionally, the number of people
identified with each chronic condition using insurance claims data is affected by coding rules for
the condition. There are rules in place for coding specific conditions such as diabetes but not for
other chronic conditions.

Documentation (and thus coding) of disease risk and social factors in hospital admission data by
medical and nursing practitioners was poor, with only 3.8% of admissions including these code
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groupings, most often for mental health-related admissions. This is consistent with the findings of
Torres and colleagues in the United States who also found that codes were most frequently listed
for hospitalisations for mental health and substance use issues (Torres et al. 2017). These findings
suggest that insurance claims data are not a comprehensive data source for identifying target
groups for CDM programs. Previous research has critiqued the use of health service records as the
sole method of chronic disease selection as it misses people at earlier risk stages and is reliant on
coding practices of health service providers (Linden & Goldberg 2007, p. 949).

Examining how well selection methods predict future health service use for the three chronic
conditions of interest show that only a minority of individuals hospitalised for the three chronic
conditions in 2013-14, also made a claim for the same conditions in 2014-15. The group identified
with a chronic condition in 2013-14 also made up only a minority of individuals (15-33%)
admitted with the three chronic conditions in 2014-15. Although the methods used in this analysis
focus on specific disease categories and could be refined to look for more complex chronic disease
cases based on a combination of conditions or levels of hospitals use such as number of
admissions per year or length of stay per admission, refining the method does not resolve the issue
that hospital claims data only provide information on a small proportion of the insured population.

The findings of this analysis indicate it would be beneficial to use additional data sources in
selecting target groups for CDM programs. Selecting which data sources to use, and how to most
effectively combine and analyse multiple data sources to support CDM strategy requires careful
consideration of a number of factors. The second research stage was conducted to identify the
factors to consider for selecting and using multiple data sources to develop information systems
for CDM.

6.4 Stage 2: Key domains for developing information systems for
CDM using multiple data sources
The next stage of research in the study used multiple qualitative methods summarised in Table 6.5
to identify factors related to developing information systems for CDM including selecting and
using data sources. Data were collected through a review of published and grey literature and via
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group interviews conducted with representatives of three PHI funds. Interviews took place in a
group setting with between two and five participants, with participating PHI funds chosen from
the 13 funds that contributed to the dataset analysed in the first research stage. These group
interviews took place prior to the individual interviews that are part of the study reported in
Chapter 8. The purpose of the group interviews were to orient the researcher to the operations of
the Australian PHI sector to test issues raised in the literature review for their Australian
relevance, particularly issues related to designing information systems for CDM such as data
sources used by the PHI sector and data analytics infrastructure and capabilities. A synthesis of the
key domains identified in the qualitative review is described in the next section.

Table 6.5 Summary of data collection methods and sources used in Stage 2
Data collection method

Description of specific sources

Literature review

Targeted review focussed on three areas:
• Information systems literature on the use of routinely
collected health data for secondary purposes
• Published evaluations of CDM programs implemented by
health insurers in Australia and internationally
• Epidemiological research using Australian disease registries
and cohorts with specific chronic conditions.

Group interviews conducted
with representatives of three
PHI funds

• Interviews took place in a group setting with two to five
participants.
• Questions focussed on the design of current CDM
programs, current challenges in targeting relevant segments
of the insured population and future directions for CDM
strategy.

Appraisal of grey literature
including websites, reports
and policy documents

CDM program information published on websites of Australian
PHI funds, media articles on PHI, company annual reports and
government regulations for the PHI industry.

Note. Data collection performed between May 2016 and July 2017.

Information systems have been recognised as an important element of effective CDM for almost
two decades. As discussed in Section 2.8 on page 35, the influential Chronic Care Model,
developed by Wagner and colleagues, includes both clinical information systems and decision
support as two of the six key elements to improve the design of healthcare delivery systems for
CDM (Coleman et al. 2009; Wagner 1998; Wagner et al. 2001). The model describes the need to
establish patient registries that enable individuals to be monitored over time, across different types
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of providers (Wagner et al. 1996b, p. 527), and to use individual and population-based information
for care planning (Struckmann et al. 2018, p. 26), but does not specify the components of effective
CDM information systems.

The development of the framework presented in this study was guided by the approach adopted by
Embi and colleagues who developed a model that describes the data, information and knowledge
management factors influencing the design and conduct of comparative effectiveness research in
health care (Embi et al. 2013, p. s42). Their framework was developed after analysis of the
informatics challenges related to aggregating different types of health data such as clinical data,
health financing data and patient reported measures. Their research identified four domains related
to the secondary use of data for research purposes: (1) data quality, (2) data preparation, (3) sociotechnical factors, and (4) organisational factors.

The domains of the current framework are: (1) defining information requirements, (2) assessing
potential data sources, (3) ensuring quality data collections, and (4) integrating systems and
analytics. The domains identified through this review focus on linking multiple data sources for
CDM service planning and delivery. Key considerations for each of these four domains are
identified to explicate the conceptual framework.

6.4.1 Defining information requirements
Differences exist in the information needed for providing acute illness and chronic disease care
(Clarke et al. 2017, p. 12). However, information requirements for CDM programs also vary
according to the group that is being targeted – whether the target is the population at risk of
developing a chronic condition or the group of people who already has a diagnosed chronic
condition. To identify the at risk group, comprehensive information on risks for the entire
population of interest including demographic, clinical and health service use is required (Haas et
al. 2013, p. 730). A risk assessment is not useful for someone who already has a diagnosed chronic
condition. However, clinical indicators collected over time are an important indicator of long-term
health management for people living with chronic conditions. Records of health services use are
also important information for this group because regular, coordinated care can prevent episodes
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of ill health. Appropriate targeting of high-risk patients is one of the main attributes of successful
programs for patients with complex, chronic needs (Anderson et al. 2015, p. e598).

The review identified three major areas to consider when defining information requirements for
information systems to support CDM. The first area is demographic and social information such as
age and lifestyle factors including diet, physical activity, tobacco use and alcohol consumption
(Moodie et al. 2016). The second area is clinical indicators such as blood pressure, cholesterol
level and levels of stress and anxiety (Luo et al. 2016) and the third area is information on health
service use including the type of health professional seen, the date the service was received, and
the treatment received (Martin et al. 2011).

6.4.2 Assessing potential data sources
Information is produced by making sense of data (Hersh et al. 2013, p. e35). A large amount of
health-related data is routinely generated during healthcare activities but as health insurers operate
outside these direct interactions, they are secondary recipients of data and rely on other parties to
share these data (Kohli & Tan 2016, p. 556). The three main sources of data for the PHI sector
with the potential to inform CDM are from patients (and increasingly from their digital devices),
from healthcare providers and from researchers.

1. Patient-provided data
Private health insurers are seeking to increase health and social data supplied by patients. This
information is provided on a voluntary basis through self-reported health risk assessments or
invitations for free check-ups that collect information on clinical measures such as blood pressure
and cholesterol. PHI funds are also taking advantage of advances in information technology,
offering digital applications to their members to track health and activity levels (HCF 2018,
Medibank 2018a).

2. Healthcare provider data
Private health insurers receive claims data from hospitals and allied health providers. There are
opportunities to enhance data collected from these sources to improve data content and quality,
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particularly for newly covered services that insurers now pay benefits for such as CDM programs.
Provider data could supply additional information on early stage risk indicators of chronic disease
including clinical measures or provide more comprehensive data on treatment plans for high-needs
patients.

3. Research and quality improvement data
Data collected by researchers such as cohort studies and clinical and disease registries may inform
CDM programs, particularly relating to health outcomes and disease risk factors. Cohort studies
follow a group of people over time to investigate specific health issues. Some limited Australian
cohort studies have already conducted research with PHI as a topic of interest (Banks et al. 2009;
Herbert et al. 2010). Clinical and disease registries collect data on people diagnosed with a
specific condition or receiving a specific type of treatment. Registries have been established to
collect data relevant for CDM such as the Australasian Rehabilitation Outcomes Centre Dataset
(Australian Health Services Research Institute 2017) and the Private Psychiatric Hospitals Data
Reporting and Analysis Service (Australian Private Hospitals Association 2018).

6.4.3 Ensuring quality data collections
Private health insurers are reliant on data from different sources that are collected for a variety of
reasons such as service payment or providing care. The original purpose for which data are
collected influences data quality and how appropriate a data source is for secondary use (Curtis et
al. 2014, pp. 1183-4). Data quality factors such as consistency in definitions between data sources
and over time, and accuracy of data collected contribute to the utility of information that the data
can provide. The information that a particular data source provides such as its relevance,
completeness and timeliness often cannot be assessed until the data are used for a particular
purpose. Data quality factors are important considerations in the use of data for secondary
purposes. If the purpose of the original data collection is not well understood, or its quality for
secondary use is not assessed, then use of the data may produce misleading insights (Clarke 2016;
Shah et al. 2018). Furthermore, combining datasets of poor or uncertain quality may exacerbate
problems in original datasets (Boyd & Crawford 2012, p. 670).
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Another consideration of using data sources for secondary purposes, such as informing CDM
interventions, is that the granularity of available data may not be sufficient for the proposed use
(Hersh et al. 2013, p. s33). Health data are often subject to specific privacy and legal compliance
requirements that restrict the way data can be shared and used (Ebad et al. 2016; Sherer et al.
2016). Due to this reason, data may only be available at an aggregated level. Aggregated data may
be appropriate for some purposes such as informing program planning or some types of predictive
modelling but are insufficient for tracking the patterns of health service use of individuals over
time.

The final consideration is how frequently the data are collected. Some information is required on
an ongoing basis, so data need to be regularly updated such as health service use and diet and
physical activity levels. Other information only needs to be recorded once, or periodically
updated, such as age and disease status. The impact of time delays in collection also needs to be
considered, that is, whether data are available in real-time (or near real-time) or whether there is a
time lag in receiving data following collection.

The review highlights three key considerations for developing quality data collections that are fit
for purpose for CDM programs and planning. It is important to note that the availability of data
does not guarantee high quality data to inform CDM programs. First, if routinely collected data are
being used for secondary purposes, the original purpose of collection must be known as this may
affect the utility of the data (based on factors such as original collection standards, data
completeness and data accuracy). Second, the level of granularity of available data is also an
important consideration. Whether or not data are available for individuals or only aggregated into
groups will affect how the data can be used to design and tailor CDM services. Third, the time
period when the data are available is also important as targeting programs depends on up-to-date
knowledge of the health status and service use of the individuals within the target group. If there is
a significant time lag in the collection of raw data and its processing for use in CDM programs,
this may influence the targeting of programs.
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6.4.4 Integrating systems and analytics
Due to the progressive and persistent nature of many chronic conditions, CDM information
systems need to be able to track and monitor people over time and incorporate data from different
sources. Creating a person-centred information system with an integrated view of a person’s
health and social information relevant to CDM is a complex, technical task (Dixon et al. 2015;
Dykes et al. 2014). Data are collected for different purposes so combining these data sources in a
meaningful way is challenging. Previous research has documented specific barriers in relation to
the exploitation of information systems and technology for business value in the health sector
compared to other industries (Devaraj & Kohli 2000; Newell 2011).

CDM often involves the care of a multidisciplinary team, often operating in different settings
(Wagner 2000). Although improvements have been made to improve data sharing such as the
meaningful use provisions in the United States (Blumenthal & Tavenner 2010), a unified summary
health record used across health settings is rare, with notable failed attempts (Mora 2012).
Research involving data linked from different sources is a growing health research field (Ford et
al. 2009; Kelman et al. 2002) but sharing and linking data among healthcare providers and payers
is still limited by privacy and commercial considerations. From a technical perspective, for data
sharing and linking to occur, information systems need to be interoperable with coordination of
information technology architecture and data standards such as the type and form of the data
collected (Gauld 2004, pp. 127-8).

Information technology advances now allow for the collection and storage of large amounts of
data, but data availability does not directly lead to business value. Value is created from effective
decision-making, which relies on the meaningful analysis of data (Sharma et al. 2014, p. 434).
This process from data to value emphasises the importance of the quality of the original data.
Advances in computer processing facilitate more sophisticated analyses but if the underlying data
quality is poor, data analytics will not produce reliable results.

Once information requirements have been defined, appropriate data sources identified and
assessed for quality, the data need to be bought together to allow for analysis. The review
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identified that information systems for CDM need to be able to monitor people over time to
understand changes in health status and interventions that support health management. Systems
should have data available at the person level and ideally be linked from different data sources
(reflecting a person’s comprehensive health journey). The establishment of such systems will
allow for more accurate and tailored analytics to be conducted that reflect a population’s use of
different health services over time.

6.5 Stage 3: A framework for developing information systems for
CDM using multiple data sources
The qualitative review in Stage 2 identified four domains to consider in the development of
information systems for CDM using multiple data sources: defining information requirements,
assessing potential data sources, ensuring quality data collections and integrating systems and
analytics. Each domain was associated with three key considerations.

Through further analysis, a conceptual framework depicting these domains and considerations was
developed and is presented in Figure 6.3. A description of how the framework could be applied to
the PHI sector, including feasibility and policy implications, is provided. Analysing each of the
four domains of the conceptual framework when defining the information systems strategy for
CDM introduces a structured process by which to identify, collect and use different data sources.

The CDM program goal is central and underpins all domains of the framework. The goal is the
anticipated value or outcome that the program will have. In particular, information requirements
and data sources will vary depending on the specific goal and target group of a program, which
has flow-on implications for data quality features and the development of integrated information
systems and analytics. The goal of CDM programs exists along a continuum from early
identification of at-risk populations to improved case management of the chronically ill.
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Figure 6.3 Conceptual framework for developing information systems for CDM using
multiple data sources

6.6 Discussion: Feasibility and policy implications of framework
implementation
6.6.1 Defining information requirements
Information requirements for private health insurer systems incorporating multiple data sources
are defined after first assessing the information available from existing data sources. For PHI
funds, the main source of data to inform CDM are hospital claims, which provide information on
hospital use claimed on insurance and diagnosed health conditions. Insurers also have basic
demographic information related to age, sex and location of residence but lack broader social
information, clinical indicators and comprehensive health service use (for all services used, not
just those claimed on PHI). Once information gaps are identified, data sources can be prioritised
for collection based on the CDM program goal. For programs with a broad goal across the chronic
disease continuum, information across the insured population is important to identify and
categorise people with a diagnosed chronic condition and people at-risk of developing a chronic
condition. Although PHI funds in Australia traditionally have little experience in CDM, many
funds have expanded their clinical expertise through employing staff with a clinical background
such as nurses and dieticians and in some cases, setting up separate healthcare services (Medibank
2018b).
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6.6.2 Assessing potential data sources
Hospitals, allied healthcare providers and patients are currently the main sources of data for health
insurers. Although there are numerous potential sources of data, feasibility needs to be carefully
assessed due to the nature of PHI funds as commercial businesses with a traditional role of paying
for health services (although many smaller PHI funds in Australia operate on a not-for-profit
basis).

Healthcare providers and patients view the primary function of insurers as health service payers.
Insurers are often in negotiations with both providers and patients as a result of this payer role.
Hospitals enter into contractual agreements with insurers to pay for services and may resist efforts
by insurers to expand data collected without new incentives. Due to the increasing number of
insurance policies with excess co-payments and exclusions (Butler 2002, p. 36), patients may be
wary of insurer motives in trying to enhance data collected and unwilling to disclose additional
information to insurers without incentives.

In relation to the breadth of health service data collected, particularly information on services
provided outside of hospitals in primary healthcare settings, the regulated scope of the PHI sector
in Australia limits the services for which benefits can be paid. It is unlikely that there will be
significant changes to the regulated role of insurers in Australia in the near future as recent policy
reforms for the PHI sector introduced in 2017 did little to expand the scope of insurers’ role to
better support CDM (Department of Health 2018c). As a result, information on primary healthcare
services will continue to be limited for insurers.

Research and quality data collections may only be available for analysis subject to ethical
approval. As the ethics process requires careful assessment of the public interest nature of the
research, the risk of harm to participants and the commercial interests of the data requestor, access
to research data (particularly detailed, patient-level data) may be limited for private health insurers
(National Health and Medical Research Council (NHMRC) 2015a).

The best opportunities for PHI funds to collect new data may be in building on existing data
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collected. Insurers could introduce new data requirements for processing claims with existing
healthcare providers, or patients may be offered new services such as access to medical check-ups
or digital applications in exchange for providing data. Relationship and reputation factors are
crucial for these initiatives, as insurers will need to negotiate and work more collaboratively with
both providers and patients to improve and enhance the data supplied to them.

6.6.3 Ensuring quality data collections
When seeking to use data sources for CDM, understanding the original data provenance is
important. The original purpose of the data collection, including data processing techniques and
changes to the collection standards over time, needs to be understood. Otherwise there is a risk in
misinterpreting the data or a risk that the data source will not provide the required information.
The availability of detailed unit-record data, at the patient and/or service level, for PHI funds to
use in planning CDM initiatives is limited but the possibility of using aggregated population
statistics to complement existing information could be considered. Additionally, the timeliness of
data collection for the specific secondary purposes needs to align with the intended use, as there
are often time lags in insurers receiving data from healthcare providers.

The studies presented in Chapters 4 and 5 found numerous data quality issues that need to be
addressed to increase the value that insurers derive from hospital claims data for CDM strategy.
The quality of claims data could be enhanced through changes to the predominant fee-for-service
payment model. Payment models that emphasise health outcomes or value resulting from care
increase the amount of health information collected because changes to health status following
treatment are directly linked to payment (Chernew et al. 2007; Porter & Lee 2013). Currently,
private health insurers in Australia use a variety of payment models and in the past, have resisted
moves to standardise claims payment models using AR-DRG (Willcox 2005). Efforts to enhance
the quality of existing data sources may also introduce internal tensions for insurers. While teams
responsible for insurance policy design may advocate restricting service coverage due to potential
short-term financial benefits, this action limits the information that PHI funds collect on health
service use over time. These commercial considerations need to be balanced with the priority of
building information systems with quality data if insurers want to expand their CDM role.
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6.6.4 Integrating systems and analytics
Information systems for CDM should be person-centred, providing information on patients
accessing services from different providers over time. The process of information systems
development needs to include a phase dedicated to determining how new and existing data sources
are linked and how system components are integrated to produce meaningful information from
analytics. Existing information systems could be modified, particularly if new data collections
build on existing data sources such as enhanced claims data. However, if more fundamental
changes to information systems are required then this may have large resource implications.

Legacy systems used by PHI funds are an important consideration. As the information systems of
the PHI sector were originally designed for processing claims, reconfiguring or replacing these
systems to enable enhanced chronic disease analytic capabilities requires technical, financial and
human resources investment. Data collection and management activities require new skills, not
only in analytic techniques but also a contextual understanding of the capacity and limits of these
data, the genuine insights that can be derived from data for management decisions and where
caution is needed in the interpretation of findings.

In relation to broader initiatives to improve data sharing and information exchange within the
healthcare sector, initiatives in Australia tend to focus on providers and patients. Australia is in the
process of rolling out a national personal health record system, My Health Record. The framework
guiding the secondary use of My Health Record system data released in 2018 explicitly excludes
insurance agencies from applying to access My Health Record data (Department of Health 2018e).

6.6.5 Caveats of framework development
While the research design of this study has strengths in relation to the application of both
quantitative and qualitative methods to assessing data sources and information system
requirements for CDM, there are also limitations. In relation to the framework development, a
targeted, rather than a systematic, review of the literature was undertaken to assess the knowledge

98

base relevant to developing information systems for CDM and identify the key domains for the
framework. To complement the literature review, interviews with PHI fund representatives were
conducted to gain a more practice-focussed and up-to-date context. Despite the dual methods
employed, there may be other domains relevant to the framework developed in this study that
were not identified.

6.7 Conclusion
Quality information systems are crucial to inform management decisions to deliver appropriate
support for high-needs patients and people with chronic conditions. Analysis of claims data found
that PHI funds currently have a limited view of health information required to select target groups
for CDM interventions. There are opportunities to improve the quality of health information used
by PHI funds in planning and implementing CDM programs. A conceptual framework is
developed and presented with four domains that need to be considered when developing
information systems for CDM using multiple data sources – information requirements, data
sources, data quality and integrating systems and analytics. However, there are feasibility and
policy implications that need to be addressed for implementation in the PHI sector. A clear goal
for CDM programs underpins this framework.

The next chapter applies the framework developed in this chapter. The study links insurer and
other data sources to enhance the information on health service utilisation and better understand
the health service journey of insured individuals in Australia’s mixed public and private health
system. Hospital claims data from one private health insurer are linked with health service records
from one LHD. The qualitative study in Chapter 8 also builds on the study presented in this
chapter seeking perspectives directly from insurers about their role in CDM and the factors
influencing the design and implementation of CDM strategies, particularly in relation to data and
information requirements.
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Chapter 7: Data linkage to understand the hospital
utilisation of a privately insured cohort
This chapter presents an implementation case study of the conceptual framework developed in
Chapter 6. It is the first study in Phase 3 of this research (see Section 3.2 and Figure 3.1 on page
42). This novel study uses administrative data sources from a PHI fund and a LHD in New South
Wales that were linked together for the first time. The study investigates hospital utilisation across
public and private hospitals for a privately insured cohort and examines the relative contribution
of PHI to funding hospital care for an insured population. The analysis in the studies presented in
the previous chapters used insurance claims data that only contain records of hospital utilisation
for which PHI pays a benefit. By linking and analysing data from multiple sources, this study
builds a more comprehensive picture of hospital utilisation for a privately insured population.

The first section of the chapter outlines the study rationale and study design using linked
administrative data sources. The process of designing the study is framed using the four domains
of the conceptual framework presented in the previous chapter in Section 6.5 on page 94. The
second section presents the methods and results of the analysis using the linked dataset. The
analysis investigates two areas:
1.

How an insured population accesses hospital services across hospital types (public and
private) and insurance status (PHI or public patient);

2.

Service utilisation of a subset of high-needs patients that relates back to the focus of
previous studies presented in Chapters 4 and 5.

7.1 Study background
7.1.1 Study rationale
As discussed in Chapter 2 in Section 2.1 on page 23, the responsibility for funding and delivering
health services in Australia is split between the public and private sectors. Public hospitals account
for a greater proportion of hospitalisations (59%) than private hospitals in Australia. (AIHW
2016). As almost all emergency departments in Australia are located in public hospitals and
ambulances are required to direct patients requiring medical attention to the nearest public hospital
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(Healthdirect 2019), if people with PHI require urgent medical care, they are likely to be treated in
a public hospital. The extent of public hospital utilisation of a privately insured population group
is not known. Additionally, it is not known for public hospital use, the proportion of services
accessed as a private or a public patient.

This study is unique in Australia as it involves linking data from private and public sector
organisations, a PHI fund and a government-operated LHD, to capture hospital use of a privately
insured cohort across public and private hospitals, funded by the public sector and by PHI.
Although administrative data sources are regularly linked for research purposes across Australia
(Tew et al. 2017), the linkage generally occurs with data sources that are managed by government
custodians such as public hospitals, or with data sources that have collection rules mandated by
government such as cancer registries. Most data linkage research occurs at a state or national level
independently of the organisations providing or funding care. In contrast, the present study was
designed as a regional study with the direct involvement of the two organisations that are
contributing data to the study.

Differences in the types of hospital services claimed on PHI are investigated in this study to
understand the relative contribution of a PHI fund to funding hospital care of its members and at a
broader level, to examine the alignment of current health insurance policy arrangements and the
organisation of delivery systems in Australia. As described in Section 2.4 on page 28, a series of
policy reforms introduced in the late 1990s incentivises Australians over 30 years of age to hold
PHI policies. The rationale provided for the government funding these financial incentives was
that PHI would strengthen the health system overall by taking pressure off the public system
through facilitating private hospital access for people with PHI (Colombo & Tapay 2003, p. 9;
Elliot 2006, pp. 136-7).

Previous research has examined changes in the use of private and public hospitals following the
introduction of the PHI rebate and accompanying policy measures to encourage uptake of PHI in
the late 1990s. Findings report a broadening in the specialisation of private hospitals, although
public hospitals still provide services for a broader range of conditions (Martins 2009). As PHI
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and government funding duplicates public hospital admissions, privately insured individuals can
elect whether or not to use their PHI when they access services in a public hospital. Recent
national reports have noted a rise in admissions to public hospitals where patients elect to be a
private patient (AIHW 2017; IHPA 2017). This study, focussing on the hospital utilisation of a
privately insured cohort, provides an important contribution in understanding how this population
accesses services across public and private hospitals and investigates differences in the use of PHI
by type of service.

The second part of the analysis focuses specifically on the service utilisation of high-need patients.
From the perspective of PHI funds, findings from the analysis presented in Chapter 4 on the
characteristics of high-needs patients highlighted the dearth of information on public hospital
admissions in insurance claims data. The study in Chapter 4 found that high-needs patients have a
greater proportion of admissions to public hospitals than the general insured population with a
hospital claim. However, due to missing data, the insurance claims data revealed little information
about the specific conditions for which care was sought in public hospitals. The additional
category of hospital use that insurers do not have any information on relates to admissions in
public hospitals as a public patient. The linked data sources used in this study includes
comprehensive information on public hospital admissions as both a public and a private patient.

7.1.2 Applying the framework for developing information systems for CDM
using multiple data sources
The studies in Phase 1 of the research presented in this thesis identified that insurers have a limited
view of hospital utilisation of the insured population. A number of gaps in health information for
different targets groups such as high-need patients were identified in the studies. Using the
conceptual framework developed in Phase 2 (see Figure 6.3 in Section 6.5 on page 95), this study
was designed to provide information on hospital utilisation across the insured population in both
public and private hospitals. Table 7.1 shows the study design considerations for each of the four
domains of the framework.

Information required for the analysis included demographic, clinical and service use
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characteristics. The data sources used for the study were PHI hospital claims data and LHD
service records for hospital admissions and emergency department visits. Consideration of the
original purpose of collection of the PHI hospital claims data and data quality issues identified in
analyses presented in the previous chapters led to linking these data with LHD records. Linking
these data sources filled in gaps in missing data for public hospital admissions in PHI claims data
and added records for admissions not claimed on PHI. Patient-level data were available in each
data source for a common period of 2010-2015. To maintain the person-centred nature of the data
collection but maintain privacy, a unique identifier was assigned to each individual to replace
personal information. A data linkage methodology linked the data to allow for meaningful analysis
to be conducted.
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Table 7.1 Study design considerations for the four domains of the Conceptual Framework
Domain

Considerations influencing study design

Information
requirements

• Hospital utilisation information for public and private hospitals for
a privately insured cohort covering:
o Patient demographics (age, sex)
o Service use information (dates for each hospital admission,
hospital type and insurance status)
o Clinical diagnosis information

Data sources

• PHI fund hospital claims data
• LHD service records: Admitted hospital data and emergency
department records

Data quality

Original purpose of collection
• PHI fund: Payment of insurance claims for hospital use. Claims
data capture required hospital utilisation information for services
claimed on insurance although some information (e.g. clinical
diagnosis) is not complete for all records
• LHD: Administrative record of hospital use. LHD data capture
required hospital utilisation information for services provided by
hospitals administered by the LHD for planning and reporting
purposes
Level of granularity
• Individual, patient-level data (de-identified) available for each
hospital admission
Timespan of datasets
• Datasets available for the same multi-year time period (2010-2015)

Integrating
systems and
analytics

• Datasets can be linked so that each individual has the same
identifier across both datasets
• Privacy considerations: Common identifier used to extract health
data replacing personal information, see Figure 7.1
• Insurer and LHD collaborate and share data to develop the linked
dataset. Analysis conducted on separate analytics infrastructure
independent of either organisation

7.1.3 Methods of linking health data sources to preserve privacy
Linking administrative data sources that are collected by different organisations is a complex
process because sharing these data in their original format are generally subject to privacy
legislation, which pertains to the collection, use and sharing of personal information. In Australia,
both state and national privacy legislation exists. The national privacy legislation is the Privacy
Act 1988, and in New South Wales, the state in which this research was conducted, there is also
separate health privacy legislation, the Health Records Information Privacy Act 2002. Australian
privacy laws have guidelines for using personal information for health and medical research
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purposes (NHMRC 2015b). Consistent with these guidelines, health service researchers have
developed methods of data linkage that assign a common identifier to an individual across
different datasets while removing identifying information such as name, address and date of birth
to protect individual privacy (Kelman et al. 2002). Figure 7.1 presents a diagram of this process,
which involves the separation of personal information such as names and addresses from health
information such as service records dates and clinical information. The researcher only receives
the health information with a common identifier across the different data sources, but the personal
information is not shared.

Figure 7.1 Process of separating personal identifiers and health data when linking datasets
to preserve privacy

7.1.4 Linked data infrastructure used in this study
Australia has established state and national level systems for linking administrative health data at
the individual person level (Moore et al. 2016). However, data linkage at a regional level is a new
endeavour that is being pioneered in the Illawarra Shoalhaven region of New South Wales. The
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Illawarra Health Information Platform (IHIP) has been designed for the analysis of administrative
health data sources for research purposes. IHIP consists of a databank with non-identifiable data
and a health records linkage system. Due to the existence of a unique Medical Record Number
used across public health facilities in the Illawarra Shoalhaven region since 1986, a longitudinal
record of service use across both public hospitals and community health services has been
generated in the region with records for almost 675,000. These individuals 675,000 individuals
represent all patients attending any public health facility in the region (hospital or community
health) over more than 30 years. The research databank does not contain personal identifiers and
when linking health data, a separation of roles is implemented so there are different individuals
responsible for handling personal identifiers in the first stage and extracting health data in the
second stage, in accordance with the best practice process shown in Figure 7.1. The establishment
of IHIP and the data linkage protocol received ethical approval from the University of
Wollongong (UOW) and Illawarra Shoalhaven Local Health District (ISLHD) Health and Medical
Human Research Ethics Committee (HREC) in 2016.

This is the first project in which data from an external data source (PHI claims data) were linked
with data from the IHIP databank. As this study involved linking an additional data source with
data from the IHIP databank, separate approval for this study was received from the UOW and
ISLHD Health and Medical HREC (no. 2017/231) and from the IHIP data custodian (Centre for
Health Research Illawarra Shoalhaven Population Executive Steering Committee).

7.2 Process of linking insurance claims and health district records
The development of the linked research data extract for this study involved a detailed process to
match individuals within each data source. Data management personnel from the PHI fund and the
LHD undertook the process. The linkage of datasets took place in a staged approach, to minimise
privacy risks, depicted in Figure 7.2 and described below.

7.2.1 Stage 1: Creating a project-specific identifier key
In the first stage, the PHI fund data manager sent a file containing personal identifiers to IHIP data
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management personnel to create a common set of project identifiers across the data sources used
for the study. The file contained name, date of birth and address details to allow common
individuals in the dataset to be matched and assigned a project-specific identifier. There was no
health information exchanged at this stage.

In the dataset sent by the insurance fund, there were 22,555 unique individual identifiers
representing each fund member living in the Illawarra Shoalhaven catchment area. In the LHD
records, there were 674,456 unique individual identifiers. Following the data matching process,
there were 14,276 unique identifier matches. The matching process involved nine ‘pass-throughs’
that examined the data using different data variable items such as name, address and date of birth.
To ensure accuracy in the matching process, manual review was undertaken with 1,000 records
(every 14th record). During the manual review process, less than five records were identified as
incorrectly matched. Additionally, there were eight instances where one record number from the
LHD file matched multiple identifiers in the insurance fund dataset. Multiple matching related to
twins, duplicate records and name changes and these erroneous records were removed from the
matched data file. Once the data matching process was complete, a project-specific identifier was
assigned to each matched individual record replacing personal identifying information in the data
extracts supplied to the researcher.

7.2.2 Stage 2: Extraction of health and claims data
In the next stage, the data file with the matched identifiers and the project-specific identifier key
was sent back to the PHI fund and to the responsible data manager for IHIP health information.
The common time period for which data were available for each data source was 1 January 2010
to 31 December 2015. Insurance claims and hospital admission data were extracted for the
matched cohort. For the LHD, records came from data collections for admitted patient
hospitalisations and emergency department attendances. More information on the variables used in
the analysis from each data collection is included in Appendix 2. The number of linked individuals
represented in each data collection for the study period is shown in Figure 7.2 that summarises the
linkage process. The 14,276 matched individuals may be represented in 0, 1 or more than 1 of the
data sources. The researcher only received records for individuals who accessed health services
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during the study period so demographic information for the full population with PHI was not
available.

7.2.3 Stage 3: Linkage of de-identified datasets
Prior to the researcher gaining access to the research data extracts, additional checks and
perturbation were applied to minimise privacy risks including grouping age into five-year age
groups and perturbing the service data across the datasets by a random number between +/- two
days. Records with the same individual identifier had the same time perturbation applied to ensure
the pattern of health service utilisation was consistent for each individual.

Figure 7.2 Linkage process of insurance claims and LHD data sources including number of
individuals for each data source

7.3 Methods
The first stage of analysis focussed on hospital utilisation of all insured patients with at least one
hospital admission in the study period and the second stage focussed specifically on the hospital
utilisation of high-needs patients as defined in Section 7.3.3. Patients with only emergency
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department attendances (without a hospitalisation) in the study period were excluded from
analysis.

7.3.1 Insured individuals’ use of public and private hospitals
The purpose of the analysis was to understand the insured cohort’s use of public and private
hospital services as an admitted patient and the use of PHI for hospital admissions. Differences in
hospital utilisation for different types of services categories were also investigated. During the
study period, there were 9,004 unique patients with a same-day or overnight hospital admission.
To examine hospital admissions across the entire study period for this cohort, three mutually
exclusive groups were formed based on an individuals’s use of hospital services – patients with
private hospital admissions only, patients with public hospital admissions only, and patients with
both public and private hospital admissions.

Health insurance joining and termination dates were used to remove public hospital admissions
that occurred when an individual did not hold a PHI policy. Public hospital admissions that
occurred before an individual joined the fund or after termination of fund membership were
removed. This process removed 1,439 admissions (5% of admissions during the study period).
When preparing the linked dataset for analysis, some admissions records, for public hospital
admissions claimed on PHI, appeared in both the insurance claims and LHD datasets. These
records were de-duplicated in the dataset analysed.

Hospital utilisation and demographic characteristics were compared for the three groups. Due to
the differences in coding same-day hospital admissions between public and private hospitals
(discussed in Chapter 5), utilisation statistics and the service category analysis were undertaken
using overnight hospital admissions only. Utilisation statistics calculated for each of the three
hospital-use groups included the number of admissions per group, the mean number of admissions
per patient and the mean length of stay per admission. Statistical tests were run using Pearson Chisquare tests for categorical variables and Kruskal-Wallis tests for continuous variables to check
the significance in observed differences between the three groups.
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Emergency department utilisation in the LHD for the insured population was also analysed.
Analysis included all emergency department visits for the 9,004 patients with a hospitalisation
(whether or not the emergency department visit resulted in an admission). The proportion of
patients in each group with an emergency department visit and the proportion of their emergency
department visits that resulted in an admission were calculated.

In addition to utilisation measures, differences in the casemix or complexity of overnight
admissions in public and private hospitals were assessed by allocating a weight to each hospital
admission based on the assigned AR-DRG. AR-DRG is a classification system that relates the
number and types of patients treated in hospital to the resources required by the hospital to provide
the treatment. In contrast to the previous studies in Chapters 4, 5 and 6 with missing clinical data
for public hospital admissions, AR-DRG information was 95% complete for the overnight hospital
admissions for the insured cohort in this study due to the linking of the two data sources. The
weights assigned to overnight admissions to measure complexity were those developed for the
purpose of public hospital funding through the National Hospital Cost Data Collection. In this
study, weights were not used to assign costs to hospital admissions, as there are differences in both
costing and pricing resources across public and private hospitals. Instead, weights were used to
apply a consistent unit that is a proxy for admissions complexity across the datasets.

Cost weights for the National Hospital Cost Data Collection are developed using a sample of
hospitals around Australia to assess the cost and mix of resources used to deliver patient care. The
average admission weight is 1.0 and each AR-DRG is assigned a weight indicating whether on
average, the resources required to deliver care for that AR-DRG is greater than the average
(weight greater than 1.0) or less than the average (weight less than 1.0). The LHD data were coded
using AR-DRG version 6 (ACCD 2018b) so AR-DRG weights from the National Hospital Cost
Data Collection Round 17 (2012-13) developed using that AR-DRG version (IHPA 2013) were
mapped to each admission in the LHD data.

Exploratory analysis found that the PHI claims data included AR-DRG information from different
versions. To ensure valid comparison, insurance claims data were remapped using diagnosis
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information (listed ICD-10-AM codes for principal and additional diagnosis) and demographic
variables to AR-DRG version 6 using commercial DRG grouping software, 3M. There were 603
overnight admissions (5%) that could not be re-grouped due to missing AR-DRG information that
were excluded from analysis of admission complexity. Admissions with missing AR-DRG
information were public hospital admissions claimed on PHI. These admissions occurred in public
hospitals located outside of the LHD for which admission data were available (and for which ARDRG information was not provided to the health insurer).

7.3.2 Insured individuals’ use of public and private hospitals by admission
service category
Following the examination of hospital utilisation trends for the insured population, analysis by
admission service category was undertaken. The five categories used were childbirth, mental
health, medical, surgical, and other1 hospital admissions, which are standard classification
categories used nationally. The criteria for categorisation based on AR-DRG codes, with examples
for each service category, are shown in Table 7.2 and a list of AR-DRGs from Version 6 is
included as Appendix 1. The AIHW uses these categories, determined based on the AR-DRG
assigned to each admission, to calculate national admitted patient statistics (AIHW 2016).
Utilisation and admission complexity statistics were calculated for each service category based on
the three hospital use groups – individuals with private hospital admissions only, individuals with
public hospital admissions only and individuals with public and private hospital admissions for the
service category.

The “other” category refers to hospital admissions involving use of devices, such as ventilator support, or
procedures that are not categorised in the medical or surgical categories
1
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Table 7.2 AR-DRG criteria used to assign admission service categories
AR-DRG codes
Childbirth

Admissions with AR-DRG codes starting with O01, O02 or O60
Examples: O01A: Caesarean delivery with catastrophic complication or
comorbidity; O60B: Vaginal delivery without catastrophic or severe
complication or comorbidity

Mental health

Admissions with AR-DRG codes starting with U or V (includes both
mental health and drug and alcohol-related DRG codes)
Examples: U63B: Major affective disorders Age <70 without catastrophic
or severe complication or comorbidity; V62B: Alcohol use and
dependence, minor complexity

Medical

Admissions (excluding child birth and mental health) with numeric values
(2nd and 3rd values) between 60 and 99
Examples: E63Z: Sleep apnoea; F74Z: Chest pain

Surgical

Admissions (excluding child birth and mental health) with numeric values
(2nd and 3rd values) between 01 and 39
Examples: C16B: Lens Procedures, Sameday; I04B: Knee replacement
without catastrophic or severe complication or comorbidity

Other

Admissions (excluding child birth and mental health) with numeric values
(2nd and 3rd values) between 40 and 59
Examples: B42A: Nervous System Diagnosis W Ventilator Support with
catastrophic complication or comorbidity; G44C: Other Colonoscopy,
Sameday

Error

Admissions with AR-DRG codes starting with 8 or 9.
Examples: 801C: Operating room procedures unrelated to principal
diagnosis without complication or comorbidity. 961Z: Unacceptable
principal diagnosis

7.3.3 High-need patients’ demographic and service utilisation characteristics
Similar to the methods used in Chapter 4, resource utilisation measures were used to define the
high-needs patient group in the second stage of analysis. However, there were some differences in
the methods used in this study compared to those described in Chapter 4 due to different features
of the data sources used.

Due to the smaller sample size, the high-needs population was selected using the top 5% of
patients, rather than the top 1%. Analysis results are presented for the group with the highest
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number of hospital bed days for overnight admissions during the study period (calculated by
summing the length of stay of each admission for a patient). Characteristics of high-needs groups
based on alternate measures of resource utilisation such as number of admissions or cost to insurer
are not reported in this study because the findings in Chapter 4 reported similar results for all three
high-needs measures. This was confirmed for the study population analysed in the research
presented in this chapter with additional analysis conducted for the group with the highest number
of overnight admissions. The selection criterion for the high-needs cohort in this study was
patients with 39 or more bed days for overnight hospitalisations in the study period (n = 296
patients).

The demographic and hospital resource utilisation statistics were calculated using the same
methods described in Section 7.3.1. In this research stage, Mann-Whitney Wilcoxon tests were
used to test the significance of differences in utilisation between the two groups. The high-needs
group was compared to the rest of the study population with an overnight hospital admission.
Hospital utilisation for the high-needs group by service category were analysed. The number of
patients in the high-needs group accessing emergency department services and the proportion of
their emergency visits that resulted in an admission were also analysed.

7.4 Results
7.4.1 Insured individuals’ use of public and private hospitals
Figure 7.3 shows the breakdown of patients with an overnight and/or same-day hospital admission
during the study period. A similar proportion of people have only private hospital admissions
(42%) or only public hospital admissions (40%). Despite the study population holding PHI, the
proportion of people that only use public hospitals during the study period is considerable.

A smaller proportion of patients (18%) have admissions to both public and private hospitals in the
study period. However, this group with both public and private hospital admissions account for the
highest proportion of hospital admissions of the three groups (39%) shown in Table 7.3.
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Overall, 72% of all hospital admissions are claimed on PHI. When considering overnight
admissions only, less than two thirds (62%) of admissions are claimed on PHI. Although 43% of
all admissions occur in public hospitals, 62% of overnight admissions occur in public hospitals.

Figure 7.3 Insured individuals’ use of public and private hospital services

Table 7.3 shows demographic and resource utilisation characteristics of the three types of hospital
user groups. Differences between the three groups are statistically significant for all
characteristics, with the exception of sex. The cohort with both public and private hospital
admissions are significantly older and have significantly higher levels of hospital utilisation (both
mean number of overnight admissions and mean length of stay per admissions) than the group
with only public hospital or only private hospital admissions.

The group of patients with only private hospital admission have the lowest proportion of overnight
admissions (28%) compared to 41% for the public and private hospital use group and 65% for the
group of patients with public hospital use only. For those with public hospital admissions, the
proportion of overnight hospital admissions claimed on PHI is 88% of admissions for the group
with both public and private hospital use and only 19% for the group of patients that only access
public hospitals in the study period. The mean case complexity for the three groups is lowest for
the group with only public hospital admissions. This finding may relate to the high proportion of
elective surgery procedures that occur in private hospitals as surgical procedures tend to have
higher average levels of resource utilisation compared to services provided during other types of
hospital admissions. Admission complexity if further explored in the next section, 7.4.2, which
analyses hospital utilisation by service category.
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In addition to admitted hospital services, emergency department visits were also examined. The
proportion of people with emergency department visits among the group of patients with only
public hospital admissions and both public and private hospital admissions are high (80% and
88% of the group respectively), compared to 30% of individuals in the private hospital only group.
Based on the group criteria, no emergency department visits of the group with private hospital use
only resulting in admitted care in the LHD. As emergency departments in the LHD studied are
only located in public hospitals, the proportion of emergency department visits that resulted in an
admission was also of interest. Of 8,612 visits for the public hospital only group, 3,658 visits
(42%) resulted in admitted patient care in the LHD. For the public and private hospital group,
2,221 of 4,313 visits (51%) resulted in admitted patient care in the LHD.
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Table 7.3 Demographic and resource utilisation characteristics of private only, public only
and private and public hospital users, 2010-2015
Private
hospital use
only

Public
hospital use
only

Private and
public
hospital use

Total study
population

Patients, n (% total)

3,778 (42)

3,628 (40)

1,598 (18)

9,004

Patients with overnight
admission, n (% total)

1,658 (29)

2,702 (47)

1,395 (24)

5,754

Patients with emergency
department visit, n (% total
visits)

1,133 (30)

2,919 (80)

1,410 (88)

5,462

Femalea, n (% group)

2,034ns (54)

1,891ns (52)

817ns (51)

4742 (53)

Patients aged 55 years and
overa, n (% group)

1,035** (27)

738** (20)

644** (40)

2,417 (27)

Hospital admissions, n (%
total)

8,895 (34)

7,153 (27)

10,239 (39)

26,287

Overnight admissions, n (%
group admissions)

2,493 (28)

4,665 (65)

4,233 (41)

11,391 (43)

Overnight admissions
claimed on PHI. n (%
admissions)

2,493 (100)

894 (19)

3,706 (88)

7,093 (62)

Mean overnight admissions
per patientb,c, n (SD)

1.7** (1.9)

1.5** (0.9)

3.0**(3.0)

2.0 (2.1)

Mean length of stay per
overnight admissionb, days
(SD)

3.9** (4.8)

5.5** (14.2)

6.0** (10.0)

5.4 (11.2)

Mean case weight per
overnight admissionb,d, n
(SD)

1.6** (1.3)

1.4** (1.7)

1.6** (1.7)

1.5 (1.6)

Abbreviations. n: Number; SD: Standard deviation
a. Pearson Chi-square (χ2) test used to compare categorical variables
b. Kruskal-Wallis test used to compare means of continuous variables
c. Per patient means calculated based on patients with an overnight admission (n=5,754).
d. 244 admissions without AR-DRG information in public hospital only group and 359 admissions
without AR-DRG information in public and private hospital group
ns
Not significant
** Significant at p < 0.01

7.4.2 Insured individuals’ use of public and private hospitals by admission
service category
Of 11,391 overnight admissions for the insured population in the study period, medical admissions
were the most numerous (47% of admissions), followed by surgical (30%), childbirth (10%),
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mental health (4%) and other (3%). One percent of admissions were assigned error AR-DRG
codes intended for atypical cases or errors in use of the AR-DRG classification system. As
described in Section 7.3.1, 5% of admissions had no DRG information. Hospital utilisation
statistics for each service category are presented in Table 7.4 with admissions for each category
grouped according to the three types of hospital users – private hospital only, public hospital only
and private and public hospital.

Medical admissions
The group with only public hospital admissions account for 70% of overnight medical admissions
with only 30% of admissions for this group claimed on PHI. The group with both private and
public hospital use has the longest average length of stay per overnight admission of 7.8 days
compared to 4.8 days and 4.6 days for the public hospital use group and the private hospital use
group respectively. The average admission case weight, used as a proxy measure of case
complexity, for the private and public hospital use group is 1.1, compared with 1.0 and 0.8 for the
public hospital use group and private hospital use group respectively

Surgical admissions
The group with only private hospital admissions account for 66% of overnight surgical admissions
while the group with public hospital use only group account for 28% of surgical admissions and
the public and private use group account for only 6% of surgical admissions. Despite making up
the highest proportion of overnight admissions, the average length of stay per overnight admission
is lowest for the group with private hospital use only, with an average length of stay of 3.5 days
compared with 5.4 days and 5.1 days for the private and public hospital use group and the public
hospital use only group respectively. The average admission case weight for the group with
private hospital use only is also the lowest for the three groups at 2.0 compared to 2.6 for both the
public hospital use only and the public and private hospital use groups.

Childbirth admissions
The group with only private hospital admissions account for 50% of overnight childbirth
admissions. The group with only public hospital admissions account for 48% of admissions and
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the public and private hospital use group account for only 2% of admissions. For the group with
only public hospital admissions, only 19% of admissions are claimed on PHI. Admission length of
stay is longest for the group with only private hospital admissions (average of 5.6 days per
overnight admission), followed by the group with public and private hospital admissions (average
of 5.3 days) and the group with only public hospital admissions (average of 3.9 days) The average
admission case weight is not significantly different for the three groups.

Mental health admissions
The group with only public hospital admissions account for 63% of overnight mental health
admissions with only 10% of admissions for this group claimed on PHI. Admission length of stay
is longest for the group with only private hospital admissions (average of 23.4 days per overnight
admission), followed by the group with public and private hospital admissions (average of 18.0
days) and then the group with only public hospital admissions (average of 14.5 days). Although
the average length of stay is longest for the group with only private hospital use, this group has the
lowest average admission case weight (2.5.) suggesting a lower average case complexity
compared to admissions for the public hospital use only and private and public hospital use
groups. The average admission case weight for the public hospital use group is highest at 3.0.
followed by 2.8 for private and public hospital use group.

Other admissions
The group with only public hospital admissions account for 56% of overnight other admissions.
The group with only private hospital admission account for 40% of admissions and the public and
private hospital use group only account for 4% of admissions. For the group with only public
hospital admission, 47% of admissions are claimed on PHI. The average length of stay for the
public hospital use only group is 8.6 days with an average admission case weight of 2.1. The
private hospital use only group has an average length of stay of only 1.3 days and average
admission case weight of 1.3. For the small number of patients with both private and public
hospital use (n = 14), average admission case weight is the highest at 2.4, with an average length
of stay of 5.3 days.
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Table 7.4 Overnight hospital utilisation measures by service categories for private only,
public only and private and public hospital users, 2010-2015
Private
hospital use
only

Public
hospital use
only

Private and
public
hospital use

Total study
population

Patients, n (% medical
patients)

496 (15)

2,402 (77)

238 (8)

3,136

Admissions, n (% medical
admissions)

631 (12)

3,797 (70)

966 (18)

5,394

Admissions claimed on
PHI, n (% admissions)

631 (100)

1153 (30)

813 (84)

2,597 (48)

Mean length of stay per
admission, days (SD)a

4.6 (5.6)**

4.8 (13.6)**

7.8 (11.2)**

5.3 (12.5)

Mean case weight per
admission, n (SD)a

0.8 (0.6)**

1.0 (0.7)**

1.1 (0.8)**

1.0 (0.7)

Patients, n (% surgical
patients)

1,652 (65)

822 (32)

87 (3)

2,561

Admissions, n (% surgical
admissions)

2,217 (66)

946 (28)

214 (6)

3,377

Admissions claimed on
PHI, n (% admissions)

2,217 (100)

225 (24)

186 (87)

2,628 (78)

Mean length of stay per
admission, days (SD)a

2.9 (3.5)**

5.1 (8.4)**

5.4 (6.7)**

3.7 (5.6)

Mean case weight per
admission, n (SD)a

2.0 (1.6)**

2.6 (3.7)**

2.6 (2.0)**

2.2 (2.4)

Patients, n (% childbirth
patients)

447 (50)

424 (48)

21 (2)

892

Admissions, n (%
childbirth admissions)

609 (51)

539 (45)

45 (4)

1,193

Admissions claimed on
PHI, n (% admissions)

609 (100)

105 (19)

37 (82)

751 (63)

Mean length of stay per
admission, days (SD)a

5.6 (1.5)**

3.1 (1.8)**

5.0 (3.9)**

4.5 (2.2)

Mean case weight per
admission, n (SD)a

1.7 (0.7)ns

1.5 (0.7)ns

1.5 (0.6)ns

1.6 (0.7)

Medical

Surgical

Childbirth
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Private
hospital use
only

Public
hospital use
only

Private and
public
hospital use

Total study
population

Patients, n (% mental
health patients)

46 (26)

109 (63)

19 (11)

174

Admissions, n (% mental
health admissions)

106 (27)

224 (57)

65 (16)

395

Admissions claimed on
PHI, n (% admissions)

106 (100)

23 (10)

55 (85)

184 (47)

Mean length of stay per
admission, days (SD)a

23.4 (16.3)**

14.5
(21.5)**

18.0 (19.3)**

17.4 (20.2)

Mean case weight per
admission, n (SD)a

2.5 (1.3)**

3.0 (1.6)**

2.8 (1.3)**

2.8 (1.5)

Patients, n (% other
patients)

117 (39)

169 (56)

14 (5)

300

Admissions, n (% other
admissions)

129 (40)

180 (56)

14 (4)

323

Admissions claimed on
PHI, n (% admissions)

129 (100)

84 (47)

13 (93)

226 (70)

Mean length of stay per
admission, days (SD)a

1.3 (1.3)**

8.6 (14.1)**

5.3 (4.5)**

5.6 (11.2)

Mean case weight per
admission, n (SD)a

1.2 (0.4)**

2.1 (1.3)**

2.4 (1.7)**

1.8 (1.2)

99

7

0

106

0

244

359

603

Mental health

Other

Error DRGs
Admissions, n
No DRGs
Admissions, n
Total admissions

11,391

Abbreviations. n: Number; SD: standard deviation
a. Kruskal-Wallis test used to compare means of continuous variables
ns
Not significant
** Significant at p < 0.01

Comparison between service categories of admissions
Figure 7.4 shows the proportion of individuals in each hospital use group for the five service
categories. The majority of patients with a medical admission (85%) receive services in a public
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hospital at least once in the study period (77% of patients only use public hospitals for medical
services and 8% of patients have medical admissions in both public and private hospitals). For
surgical admissions, 68% of patients receive services in a private hospital at least once in the study
period (65% of patients only access private hospitals and 3% use both public and private
hospitals). The use of private and public hospitals for childbirth admissions is roughly equal (50%
of patients only access private hospitals and 48% of patients only access public hospitals). The
proportion of patients accessing both public and private hospitals for a particular service category
is low. Of all the service categories, the greatest proportion of patients accessing both private and
public hospitals is for mental health services (11%).

Despite large variances in the patterns of hospital use for individuals in each of the service
categories as shown in Figure 7.4, Table 7.4 shows that the proportion of hospital admissions for
each service category claimed on PHI shows a similar trend to the use of private hospitals with the
majority of surgical admissions claimed on PHI (78%) and less than 50% of medical and mental
health admissions claimed on PHI (48% and 47% respectively).

The group of patients with both public and private hospital admissions account for the smallest
proportion of admissions but have the longest average length of stay for medical and surgical
admissions (7.8 and 5.4 days respectively), followed by the group with only public hospital
admissions (4.8 and 5.1 days respectively) then the group with only private hospital admissions
(4.6 and 2.9 days respectively). For mental health and childbirth admissions, the average length of
stay is longer for the private hospital group than the other two hospital use groups, but this does
not reflect significantly higher admission case weights.
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Figure 7.4 Proportion of patients in each hospital use group by service category

With the exception of childbirth admissions, the mean admission case weight is significantly
higher for the group with public hospital admissions only and the group with public and private
hospital admissions compared to the group with private hospital admissions only. Figure 7.5
shows grouped boxplots for admission case weight for each hospital use group for the five service
categories showing the median, interquartile range and minimum and maximum scores (extreme
outliers for medical, surgical and other admissions are excluded from Figure 7.5 but are included
in the calculation of mean case weights in Table 7.4).

For medical admissions, the interquartile range of case weights is larger for the private hospital
use only and public and private hospital use groups, although the public hospital use group
displays a long tail of high admissions case weights extending beyond the 75 th quartile. Surgical
admission case weights are distributed more narrowly for admissions in the private hospital use
only group and most broadly for the public and private hospital use group. The biggest difference
in median case weight scores can be seen for mental health admissions with a higher median case
weight in the public hospital use group and the public and private hospital use group compared to
the private hospital use group.

For medical and surgical admissions, that make up the majority of overnight hospital admissions,
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there is a greater variance in the distribution of admission case weights for the group with public
hospital use only and the group with both public and private hospital use suggesting greater
complexity in admissions for these two groups compared to the private hospital use only group.
As shown in Figure 8.5, this trend is most clear for surgical admissions.

Figure 7.5 Boxplots of admission case weights for patients with only private hospital use,
only public hospital use and both public and private hospital use, by service category

7.4.3 High-needs patients’ demographic and service characteristics
The high-needs group with the top 5% of bed days for overnight admissions (n=296) accounts for
16% of all hospital admissions (19% of overnight admissions). Table 7.5 shows the demographic
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and resource utilisation characteristics for the high-needs group, compared with the rest of the
population with a hospital admission. The two groups do not differ significantly in relation to sex
but do differ significantly on age and all resource utilisation characteristics. The high-needs
patient group are significantly older with more than two thirds of the group (69%) aged 55 years
and over compared to only 25% of the non-high-needs patient group who are aged 55 years and
over.

During the study period, the high-needs group have an average of 7.4 overnight admissions (SD.
5.4) and an average length of stay of 13.7 days per overnight admission (SD. 102.81) compared to
an average of 1.7 overnight admissions (SD.1.2) and 3.4 days (SD. 3.6) for the non-high-needs
group. The mean length of stay per overnight admission is four times longer for the high-needs
group compared to the comparison group and the average annual bed days per person is over 100
days for the high-needs group (101.5 days) compared to 5.7 days for the non-high-needs group.
The mean admission case weight per admission is significantly higher for the high-needs group
compared to the comparison group (2.2 and 1.4 respectively) confirming that the high-needs group
receive more complex and resource-intensive health care.

Analysis of insurance status and hospital setting for overnight admissions finds that the two
groups have a similar proportion of overnight admissions claimed on PHI (64% for the high-needs
group and 62% for the non-high-needs group) but 71% of the admissions for the high-needs group
occur in public hospitals (compared to 59% of admissions for the non-high-needs group) and a
higher proportion of overnight admissions in public hospitals for the high-needs groups are
claimed on PHI (49%) compared to the non-high-needs group (21%).
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Table 7.5 Demographic and resource utilisation characteristics of high-needs and non-highneeds patients, 2010-2015
High-needs
patients

Non-high-needs
patients

Total study
population

Patients, n

296

8,708

9,004

Patients with overnight
admission, n

296

5,458

5,754

Femalea, n (% group)

160ns (54)

4,582ns (53)

4742 (53)

Patients aged 55 years and
overa, n (% group)

204** (69)

2,213** (25)

2,417 (27)

Hospital admissions, n (% total)

4,166 (16)

22,121 (84)

26,287

Overnight admissions, n (%
group admissions)

2,191 (53)

9,200 (42)

11,391 (43)

Mean overnight admissions per
patientb,c, n (SD)

7.4** (5.4)

1.7** (1.2)

2.0 (2.1)

Mean length of stay per
overnight admissionb, days (SD)

13.7** (102.8)

3.4** (3.6)

5.4 (11.2)

Mean bed days per patientb,c,
days (SD)

101.5** (22.6)

5.7** (6.6)

10.6 (32.1)

Mean case weight per overnight
admissionb, n (SD)

2.2** (2.7)

1.4** (1.2)

1.5 (1.6)

Abbreviations. n.: Number; SD: Standard deviation
a. Pearson Chi-square (χ2) test used to compare categorical variables
b. Wilcoxon rank-sum (Mann-Whitney) test used to compare means of continuous variables
c. Per patient means calculated based on patients with an overnight episode.
ns
Not significant
** Significant at p < 0.01

Service categories for overnight hospital admissions for the high-needs patient group and
comparison group are shown in Table 7.6. The high-needs group account for a majority of mental
health admissions (63%) and almost a quarter of medical admissions (23%) and other admissions
(24%). The high-needs group account for only 11% of surgical admissions and 1% of childbirth
admissions.

Analysis of the top AR-DRGs for the high-needs group for overnight admissions show the top
reasons for treatments, accounting for 17% of overnight admissions for the high-needs group, are
rehabilitation (Z60), mental health conditions (major affective disorders (U63) and personality
disorders (U67)) and respiratory conditions (E62).
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Table 7.6 Overnight hospital admissions by service categories of high-needs and non-highneeds cohorts, 2010-2015
High-needs
patients

Non-high-needs
patients

Total study
population

Childbirth, n (% cat adm)

9** (1)

1,184** (99)

1,193

Mental health, n (% cat adm)

249** (63)

146** (37)

395

Medical, n (% cat adm)

1,245** (23)

4,149** (77)

5,394

Surgical, n (% cat adm)

355** (11)

3,022** (89)

3,377

Other acute, n (% cat adm)

76** (24)

247** (76)

323

Admissions with error DRG, n (% cat
adm)

25** (24)

81 ** (76)

106

Admissions with missing DRG, n (% cat
adm)

232** (38)

371 ** (62)

603

Total overnight admissions

2,191

9,200

11,391

Abbreviations. % cat adm: Percentage of service category admissions
** Significant at p < 0.01 (Pearson Chi-square (χ2) test)

For the high-needs group, more than half of hospital admissions for all service categories were
claimed on PHI but as shown in Figure 7.6, a higher proportion of surgical and other admissions
(73% and 74% of admissions respectively) are claimed on PHI compared to medical and mental
health admissions (54% and 55% of admissions respectively). Of the service categories, the largest
difference in the proportion of private hospital admissions and the proportion of admissions
claimed on PHI occurs for medical and other admissions. Although only 22% of medical
admissions occur in private hospitals, 54% of admissions are claimed on PHI. Similarly, for other
admissions, only 21% of admissions occur in private hospitals but 74% of admissions are claimed
on PHI.
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Figure 7.6 Proportion of admissions claimed on PHI and proportion of admissions that
occurred in private hospitals for high-need patients, by service category
(Childbirth admissions not shown due to small number of admissions, n=9)

More than 90% of the high-needs group have at least one public hospital admission with 54%
having public and private admission and 39% having only public admissions during the study
period (including both overnight and same-day admissions). In relation to emergency department
utilisation within the LHD, 89% of patients in the high-needs group visit an emergency
department in the study period. There are a total of 1,639 emergency department visits for the
high-needs group (an average of 6.2 visits per person) with 67% visits resulting in admitted patient
services within the LHD.

7.5 Discussion
This study demonstrates the value of linking and analysing multiple data sources to understand
hospital utilisation across public and private hospitals for a privately insured cohort. This study
reveals the complicated interplay of hospital setting and funding mechanisms in Australia’s mixed
public and private health system. PHI is associated with greater access to private hospitals, and
greater patient choice in service provision, but a more detailed examination of the hospital use of a
privately insured population reveals substantial use of public hospitals by privately insured
patients. Despite holding PHI, 40% of people with a hospital admission in the 6-year study period
only accessed services in a public hospital. Although 72% of all hospital admissions for the
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insured population were claimed on PHI, 43% of hospital admissions occurred in public hospitals.
If only overnight admissions are considered, 62% of admissions occur in public hospitals.

The research findings show clear patterns in the use of public and private hospitals based on
service categories for overnight admissions with the majority of medical admissions occurring in
public hospitals and the majority of surgical admissions occurring in private hospitals. Not
surprisingly, surgical admissions are more likely to be claimed on PHI than medical admissions.
This trend may be related to the coverage of PHI and contracting arrangements between private
hospitals and PHI funds (O'Loughlin 2002, pp. 112-4) or differences in the specialisation of public
and private hospitals in Australia (Martins 2009).

In addition to the type of services delivered, the average complexity of admissions is significantly
higher for patients admitted to public hospitals (both patients that only use public hospitals and
patients that use both public and private hospitals) than for patients admitted to private hospitals
only for all service categories, excluding childbirth.

Findings from this study align with previous research examining health services utilisation based
on differences in public and private funding and hospital setting in Australia including that
patients tend to be admitted to the hospital type (public or private) they had used in the past (Gu &
Johar 2017) and patients with both public and private hospital admissions having higher overall
resource utilisation (Cheng et al. 2014).

This study also examined the interaction of both hospital setting and patient insurance status. This
study shows that in relation to the most costly form of hospitalisation, overnight admissions,
resource utilisation in the public sector is greater than the private sector and on average, more
complex admissions are treated in public hospitals, although high-needs patients also claim a
greater proportion of public hospital admissions on PHI.

High-needs patients access a greater proportion of care in public hospitals and their emergency
department visits are more likely to result in admitted care. In this study, the high-needs group
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claim a higher proportion of public hospital admissions on PHI than the rest of the insured
population with a hospital admission. The level of insurance policy held by individuals in the
high-needs patient group may be a factor in differences in claiming on PHI. People with higher
healthcare needs may be more likely to hold comprehensive PHI policies in anticipation of high
levels of health service utilisation.

Both the federal government and PHI funds have raised concerns in relation to the increasing rates
of PHI claims for hospital admissions to the public hospital sector. Admissions to public hospitals
in which the patient uses their PHI should meet certain criteria including the patient having a
choice of doctor and a single, rather than shared, room where available. A counter argument has
also been made that a “loophole” exists for the PHI sector in Australia in funding hospital care for
insured individuals. This “loophole” is that privately insured individuals can receive services as a
public patient at no cost to their insurer (Seah et al. 2013). The patterns of hospital utilisation
reported in this study for privately insured patients lend some weight to the “loophole” argument.
More complex admissions and a greater proportion of admissions for high-needs patients occur in
public hospitals. Debate on the correct proportion of funding contributed by public and private
sources remains unresolved because of the duplicated nature of PHI in funding hospital care in
public hospitals in Australia, which by default, is government-funded.

The findings of this study indicate that it is important to look beyond the total number of hospital
admissions and examine the types of services delivered in public and private hospitals when
considering patients with PHI accessing public hospitals as there are differences in the use of
public hospitals by service category and complexity of admission.

The utilisation patterns for mental health services found in this study are interesting in the context
of the study findings in Chapters 4 and 5. Mental health conditions were one of the top reasons for
hospital claims in the high-needs analysis developed using only insurance claims data reported in
Chapter 4. The findings of the analysis in this study using linked data shows that less than half of
overnight mental health admissions are claimed on PHI in the study population. These findings
suggest that by considering insurance claims data only, insurers may be underestimating both the
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number and the needs of people within the insured population with serious mental health issues.

The design of this study used the conceptual framework developed in Chapter 6 to build a more
comprehensive record of hospital utilisation for an insured population. In addition to records of
hospital admissions not claimed on PHI, missing clinical information on public hospital
admissions claimed on PHI was made available through data linkage. This study demonstrates the
feasibility of linking data across different health organisations but highlighted a number of data
quality and integration considerations. As an example, the concordance between variables with
common names across datasets should not be taken for granted when analysing linked data
sources. An example from this study is the AR-DRG variables from each data source used
different AR-DRG versions resulting in the need to re-code the insurance claims data to allow for
comparison.

The study leveraged available research data infrastructure established for the purpose of
supporting the linkage and analysis of administrative health data. Despite the purpose-built
infrastructure, the approval and linkage processes took more than 18 months so there was a long
lead-time before the researcher accessed the linked data extracts. Additionally, although data were
shared between organisations to allow the linkage to occur, the researcher analysed data using
infrastructure that was not directly integrated with the information systems of either organisation.
These factors should be considered in future linkage and analytic projects designed to inform
healthcare practice and planning.

There are a number of caveats in interpreting the study findings. First, the study population
consists of insured individuals from only one PHI fund in one regional location in Australia and
thus, results may not be generalisable to other populations, particularly as some sub-group
analyses of service categories and high-needs patients had relatively small numbers. Additionally,
hospital admissions for the insured population that were paid for by a third-party payer (such as
the Department of Veterans’ Affairs or workers’ compensation schemes) are only included in the
analysis if they occurred in the LHD. The number of additional admissions occurring outside the
LHD is expected to be small. As noted earlier in this chapter in Section 7.3.1, clinical diagnosis
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information on out-of-region public hospital admissions claimed on PHI (making up 5% of
overnight admissions) was not available.

Finally, although information on whether patients held a PHI policy at the time of hospital
admission was known, the level of PHI coverage held by individuals during the study period is not
known so analysis could not determine the proportion of public hospital admissions not claimed
on PHI that were related to insurance policy exclusions. Future research may investigate factors
affecting choice of hospital setting or patient status, including the extent of coverage of PHI
policies.

7.6 Conclusion
This chapter reports on a successful case of linking administrative data between private and public
health organisations for the first time in Australia. The study provides a regional analysis of
hospital utilisation for a privately insured cohort. With an increasing emphasis on person-centred
care, particularly for supporting high-needs patients with chronic conditions, this type of
comprehensive analysis is beneficial to understanding the mix of hospital utilisation for patients in
Australia.

Although this study found that insurers contribute funding towards more than 70% of hospital
admissions of insured individuals, a large proportion of this care, particularly for high-needs
patients, occurs in public hospitals, for which insurers receive limited clinical information for each
admission. In fact, 40% of people with a hospital admission in the study period only accessed
public hospitals. There were also differences in the service categories claimed on PHI with
surgical, childbirth and other admissions more likely to be claimed than medical or mental health
admissions. In this and previous chapters, the studies analysed administrative data sources to
understand the services provided in hospitals for which insurers pay a benefit for high-needs
patients and the relative contribution of PHI to funding hospital care. To complement these
findings, the final study reported in the next chapter was conducted using qualitative methods to
understand perspectives of PHI representatives on designing and implementing support strategies
for high-needs patients.
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Chapter 8: The emerging role of the Australian PHI
sector in providing CDM programs: Current activities,
challenges and constraints
The study reported in this chapter was conducted for two purposes: (1) to provide PHI sector
representatives with the opportunity to reflect and provide feedback on the findings of the earlier
studies; and (2) to examine the approaches of PHI funds to supporting high-needs patients
including the provision of CDM programs. This chapter presents the final study of the research
presented in this thesis, part of Phase 3 described in Section 3.2 and Figure 3.1 on page 42. This
study uses qualitative methods to expand and contextualise the findings from the studies presented
in previous chapters. In addition to reflecting on the findings of the previous studies reported in
this thesis, the interviews conducted with PHI representatives explored the emerging role of
insurers in developing and implementing CDM strategies including the identification of target
groups and the evaluation of CDM programs.

8.1 Study background
This study seeks insurer feedback on the findings of the studies related to the demographic and
clinical characteristics of high-needs patients, including support for people with mental health
conditions (Chapters 4 and 5), and how insurers are making use of the information they collect
through insurance claims data to inform the design and development of CDM programs (Chapter
6). This study was conducted before the results of the data linkage study reported in Chapter 7
were available, so questions related to the findings of this study were not included in the
interviews with insurer representatives.

As described in Section 2.5 on page 29, PHI funds have been able to offer CDM programs since
2007 following changes in government regulations. However, expenditure on these programs by
the PHI sector is low, with annual benefits paid for CDM programs (A$54 million) representing
only 0.4% of the benefits paid for hospital treatment (A$14.9 billion) (APRA 2018). A challenge
for PHI funds in supporting high-needs patients with chronic conditions is that models of good
practice emphasise continuity and coordination of care across providers and settings, yet PHI
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funds can only cover a defined set of services and a range of services, most notably out-of-hospital
medical services provided by both GPs and specialists, cannot be covered by PHI.

Research into CDM programs offered by the Australian PHI sector has focussed on evaluating
single programs such as the HCF My Health Guardian Program, a CDM program offering a range
of services including telephone and web-based support that commenced in 2009. Evaluation of the
program reported a significant reduction in hospital admissions, readmissions and bed days among
program participants compared to a control group (Hamar et al. 2017; Hamar et al. 2015). The
evaluation of a nurse-led, home-based intervention for secondary prevention of cardiovascular
disease offered by another large PHI fund, Bupa, reported contrasting findings. The trial did not
find a reduction in all-cause hospitalisation in the home-based intervention group compared to the
usual care group (Carrington et al. 2013) and the program was not found to be cost effective
(Byrnes et al. 2015). The Telephonic Complex Care Program offered by another PHI fund in
Australia, whose name was not included in the published article, provided risk assessments,
tailored care plans and regular telephone follow-up to people aged 65 years or over with two or
more hospital admissions in the previous 12 months. The study did not find reductions in hospital
utilisation claims or total benefits paid in the 12 months following program enrolment. There was,
in fact, a modest increase (A$120 per person) in general treatment benefits paid for participants
covering allied health services (Morello et al. 2016).

These evaluations of Australian PHI-supported CDM programs demonstrate mixed results in
relation to the effectiveness of these programs as measured by reductions in health service use,
costs and improvements in health status. Although these research studies demonstrate an
encouraging commitment to testing and evaluating new initiatives, the studies do not provide
insight into the development and implementation of approaches and specific strategies to support
high-needs patients and people with chronic conditions, which is the focus on this study.
Additionally, consistent with recent research on the PHI sector’s involvement in primary health
care and its implications for health equity that documented insurer primary care activities (Windle
et al. 2018), the evaluation studies demonstrate a broad variety of activities offered under the
banner of CDM programs ranging from infrequent telephone and web-based support to regular
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home-based nurse support. The types of CDM activities, including their mode of delivery and
target group, offered by a group of PHI funds are explored in more detail in this study.

As discussed in Section 2.6 on page 32, most qualitative research related to PHI in Australia has
focussed on the consumer perspective, exploring reasons for uptake and use of PHI. The insurer
perspective is not well represented in previous qualitative research, particularly the perspective of
smaller non-profit PHI funds that are the focus of this study. These funds have their origins as
restricted membership organisations and mutual societies. They make up a smaller proportion of
the national insurance market but often have strong representation among specific employee
sectors or geographic locations resulting in distinct membership profiles and operational
environments (Shamsullah 2011, p. 25). As a result of these characteristics, these funds may take a
different approach to designing and implementing CDM programs compared to larger PHI funds
that have published evaluations of CDM programs, many of which are for-profit. Only a single
study reporting interviews with Australian PHI representatives was found in the literature review
for this study and it was conducted before the new legislation for the PHI sector was introduced in
2007. Willcox (2005) examined insurer purchasing of health services through interviews with PHI
fund representatives. This study focussed on the purchasing of hospital-based services and the
author concluded that the complex regulatory environment appeared to impede insurer efforts for
more efficient hospital purchasing.

8.2 Methods
The research in this thesis has a sequential design as described in Chapter 3 and this study was
informed by the findings of the studies presented in Chapters 4, 5, and 6 using insurance claims
data. The study used a qualitative research design with in-depth, semi-structured interviews
conducted with participants to reflect on the findings of the previous studies and to more broadly
investigate PHI sector perspectives on, and approaches to, CDM. Semi-structured interviews were
selected over other qualitative methods such as focus groups because the method allows a depth of
response from each participant (DiCicco-Bloom & Crabtree 2006, p. 315).
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8.2.1 Participant sample
Participant sampling for the interviews was criteria-based. All participants had to be presently
working in the PHI sector and hold a senior management position. Invitations to participate were
sent via email to 19 PHI organisations. A target of eight to ten interviews was set but a principle of
saturation was used whereby interviews would continue until no new themes emerged (Guest et al.
2006, p. 64). Saturation was reached after eight interviews and no new interviews were scheduled.
Participant and fund characteristics are presented in Table 8.1. Participants came from one PHI
industry association and seven different PHI funds that represent approximately 20% of registered
PHI funds in Australia (Private Health Insurance Ombudsman 2018f).

8.2.2 Interviewing procedure
Email invitations sent to potential interview participants described that the purpose of the
interviews was to discuss the design and implementation of CDM programs and stipulated that
interview topics were appropriate for representatives with senior management experience. A copy
of the email invitation is included in Appendix 3. Due to the seniority of the participants,
confirmation to participate in the interview through reply email to schedule an interview time was
deemed consent to participate in the study. As described in Section 3.4 on page 46, the protocol
for this study was reviewed by the University Institute that the PhD researcher is affiliated with
and was deemed to be negligible risk research and thus exempted from ethical review. Interviews
took places between October and December 2017 and were conducted via telephone with the
duration of interviews lasting from 30 to 60 minutes. Explicit consent was received from each
participant at the beginning of the interview to audio-record the interview for the purposes of
transcription. The interview schedule was sent to participants in advance two weeks prior to the
interview.

8.2.3 Interview schedule
Interview questions were based on key issues arising from the findings of the earlier studies
including:
•

Current strategy of PHI funds to support high-need members and people with chronic
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conditions (including a sub-topic specifically related to support for people with mental
health conditions)
•

Data and information requirements for planning and implementing CDM programs

•

Policy constraints and other challenges affecting the role of insurers in CDM.

The interview schedule was piloted with an individual with both research and PHI sector
experience and the final schedule was minimally revised following feedback. A summarised
selection of interview questions are listed below, the full interview schedule is included in
Appendix 4.
1.

What is your perception of the role of PHI funds in CDM?

2.

Can you briefly tell me about the current strategies that your fund uses to support people
living with chronic diseases?

3.

Mental health was strongly represented among the top 1% of privately insured hospital
users in previous analysis. Describe the priorities of your fund in the area of mental
health care.

4.

From your perspective, what is the most important information needed to design and
implement CDM programs?

5.

How does your fund measure success in CDM programs?

6.

Do you have any suggestions for recommendations that would help shape the future that
you want to see for the PHI sector in the area of CDM?

8.2.4 Data analysis
The interviews were transcribed and analysed following the Framework Analysis method (Ritchie
& Spencer 1993). This method was developed for applied policy research and has been described
as particularly suited to qualitative studies with specific questions, a priori issues and a predesigned sample, which aligned with the circumstances of this study (Srivastava & Thomson
2009, p. 72). The five stages of Framework Analysis are familiarisation, identifying a thematic
framework, indexing, charting, mapping and interpretation. Following familiarisation with the
data, a thematic framework was developed, and transcripts were systematically indexed then
charted into a spreadsheet. The mapping and interpretation stages linked the thematic areas back to
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the study aims and key issues of investigation. The interview data were analysed by the PhD
researcher only. Consideration was given to having a second coder but was decided not to be
practical as a PhD research study. There was a deliberate method set for structuring interview
questions based on previous study findings and as a result, concerns for interviewer bias or coding
bias were reduced. Additionally, a process of member checking was conducted whereby analysed
results were returned to participants for their review and validation (Birt et al. 2016). Descriptive
responses were collated and synthesised for the first topic that provides an overview of the
approach of different PHI funds to supporting high-needs patients. Themes are presented for the
remaining issues where the majority of participants demonstrated consensus or there was
collective weight of opinion. In the reporting of direct quotes, participants are denoted by a
number in parentheses after quotes.

8.3 Results
8.3.1 Sample characteristics
The interview participants reflect a diversity of perspectives based on both participant and fund
characteristics as shown in Table 8.1. The majority of participants were females with three
participants employed for less than two years in the PHI sector and five participants employed for
more than two years. The length of PHI sector experience ranged from one year to 20 years, with a
median of four years. Four of the participants interviewed were employed in clinical or healthcarerelated roles, focussed on CDM program development. In relation to the seven PHI funds
represented, four funds had less than 100,000 total members and three funds had between 100,000
and 400,000 members. Four funds were open to all types of members, whereas three funds had
restrictions on members, largely relating to employment sector. Six of the seven funds had a
membership concentration in a specific state, with a concentration of members in the states on the
east coast of Australia (New South Wales, Victoria or Queensland).
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Table 8.1 Participant and insurance fund characteristics
Participant Characteristics

Fund Characteristics1

Sex

Fund size (no. of individual members)

Female

6

Less than 100,000

4

Male

2

100,000 - 400,000

3

Time employed in the PHI sector

Type of fund

Two years or less

3

Open fund

4

Greater than two years

5

Restricted member fund

3

Management level

Concentration of membership
(> 50% members)

CEO

2

New South Wales

2

Executive management insurance

2

Victoria

1

Executive management clinical/health care focus

4

Queensland

3

No geographical concentration

1

1. Fund characteristics are reported for seven funds as one participant came from a PHI industry association
so these questions were not applicable.

8.3.2 Current strategy of PHI funds to support members with chronic
conditions and high healthcare needs
All participants responded that their fund currently offers services to support insured members
with chronic conditions, although these services were at different stages of maturity. Four funds
have established business structures separated from insurer functions to provide health and CDM
programs, while one fund at an early stage of CDM program development currently has only one
person dedicated to supporting the CDM needs of members.

The three main categories of CDM services offered by participant funds, and the service eligibility
criteria, mode of delivery and provider type for each service are shown in Table 8.2. Four funds
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offer telephone-based health navigation services provided by in-house staff. Any health fund
member can call staff working in navigation services to ask specific questions about the health and
aged care systems and for specific healthcare provider referrals. Four funds have contracts with
third party providers to offer telephone-based disease management and health coaching programs.
These programs often focus on specific chronic conditions such as diabetes, cardiovascular disease
and mental health conditions, although some participants offered more general programs referred
to as health coaching. In these programs, tailored care plans are developed with individuals based
on their specific health goals. Participants in these programs are recruited based on hospital claims
data analysis and member self-referral.

Five funds offer care coordination services, predominantly provided via telephone with in-house
staff. Care coordination services have the most detailed eligibility criteria for participation
including age (targeting older members greater than 55 years of age) with at least one chronic
disease diagnosis and high levels of hospital use, such as more than two hospitalisations in the last
two years. Care coordination services are often specifically targeted at patients leaving hospital
with people identified before admission when clarifying patient eligibility for hospital benefits or
after admission when insurance claims are received. These services involve an assessment and
development of a care plan that identifies specific supports that an individual will receive after
hospitalisation including nursing, allied health and meal delivery services.

Table 8.2 CDM services offered by participant funds showing the number of funds offering a
service by mode of delivery and provider type

Service eligibility
criteria

Mode of delivery

Provider type

Telephonebased

Faceto-face

Inhouse

Third
party

Health navigation

Open to all members

4

-

4

-

Disease
management and
health coaching
programs

Member self-referral and
identification through
hospital admissions

4

-

-

4

Care
coordination
services

Specific criteria based on
hospital admission data

4

1

4

1
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Disease management and health coaching programs and care coordination services are offered as
time-limited services, generally lasting from an initial period of six weeks to three months, and
sometimes extending up to 12 months. All funds employ at least one employee with a clinical
background. The type of clinical positions employed varied across funds. The most common
profession is registered nurses, but other clinicians include dieticians, pharmacists and mental
health nurses.

In addition to the three activity categories described in Table 8.2, multiple participants also noted
that their fund offers hospital substitution programs and education activities aimed at improving
health literacy. Hospital substitution programs refer to a range of nursing services delivered at
home. The existence of these services enable patients to be discharged earlier from hospital after
surgical procedures. Education activities to improve health literacy is a broad term used to refer to
both marketing and communication materials provided to the entire insured population and also
targeted information provided to people enrolled in CDM programs that may assist them to selfmanage their condition. There is a focus on fostering independence in the type of materials
disseminated and providing individuals with tools and strategies to help manage their condition.

Participants expressed a level of uncertainty and tension in how CDM services should be provided
by insurers, in terms of resource requirements and the level of guidance provided to individuals.

“I suppose, we’ll have to be careful about the way we frame the message because there’s a
limited capacity for us to deliver services to members and it won’t be open slather but
there’ll be a way I’m sure, for our criteria for the program so that we can communicate to
members, encourage them to participate, without you know, being unmanageable.” (8)

“because we charge the fund, we don’t want people ad infinitum. But the idea is to get people
to be as independent as possible,” (7)

"we don’t want to be seen to be directing care, e.g. the patient should be doing X, Y and Z.
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We’re here to support and complement existing treatment pathways rather than directing
care." (3)

8.3.3 Support for mental health conditions are perceived to be different to
other chronic conditions
A specific question was asked about the funds’ priorities in supporting people with mental health
conditions as mental health conditions were strongly represented in the group with the highest
levels of hospital utilisation in Chapter 4 and was the focus of analysis in Chapter 5. Responding
to mental health conditions was noted as a particularly challenging area with one participant
describing mental health treatment as “the single biggest concern” for their fund.

“there is no silver bullet when it comes to mental health, but I think we still need to hold
ourselves to evidence based treatment and not just frequency measures” (1)

Three respondents noted gaps in out-of-hospital care for people with mental health conditions.

“It is very expensive because it’s chronic and ongoing and I think there is a bit of a gap with
regards to support, mental health support, being offered by the government and by the
healthcare system in general.” (6)

Although three respondents noted that the PHI sector could be doing more in the area of
prevention and early intervention for mental health conditions, there were few specific actions
noted.

“I think a lot more can be done in terms of prevention, especially by the health insurer. In
general, mental health awareness is increasing and people are more aware of looking after
their mental health, I think the issue now is, of course awareness, which is increasing but
also giving them appropriate tools that are scientifically proven and evidence-based.” (3)

Three respondents are currently developing new mental health support programs to be delivered
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by in-house staff to support people post-hospital discharge and three other funds are using third
party providers.

“One of the steps we’re taking is that we’re in the final stages of developing a mental health
program that will be delivered by our care navigation services…that will allow us to capture
those members that are leaving hospital and help them to link up with organisations in the
community.” (8)

8.3.4 Data and information requirements for planning and implementing
CDM programs
Hospital claims data are the main source of data used to identify people to participate in CDM
activities. Six funds run routine reports to identify patients with specific chronic conditions,
determined by a list of clinical diagnosis codes. Funds also review hospital claims data to identify
patients with multiple hospitalisations, long lengths of stay and high cost episodes.

Participant responses related to data and information requirements for CDM frequently included
reference to limitations of current data sources. The major limitation, noted by six respondents, is
information on the health status of people without a hospitalisation, particularly indicators of
disease risk.

“We do need good claiming data, accurate claiming data, and being able to put that all
together, but the bit that we don't have right now is some kind of really good risk identifier.”
(2)

“Realistically, we need GP data, I think, to be effective in fully identifying those people
before they end up with a chronic disease." (8)

Indicators to evaluate and measure the success of CDM programs range from measures of
program awareness, participation and satisfaction to more sophisticated measures to assess the
effectiveness of the program, in terms of both its clinical or health effects and financial effects.
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Clinical measures include changes in bodyweight and stress levels and assessment of quality of
life. Financial measures include changes in service utilisation such as number of hospital
admissions, length of stay, hospital readmission rates and costs of care paid by the insurer. Despite
the broad range of measures described, most participants acknowledge shortcomings in their
approach to evaluating CDM programs and that formal program evaluations, if planned, are in the
early stages.

"There’s no point paying for services that have no ability to realise the benefits, but I do
worry that we are not measuring or assessing the right things when it comes to the evidence
base” (1)

"In terms of a real evaluation or impact framework still very early on. So, that’s a key piece
that we've got scoped up" (4)

The desire to support effective and “evidence-based” programs was expressed by multiple
participants during the interviews although participant responses indicate that this desire is
challenging to fulfil in practice.

"Our priority is on disease management programs that have an evidence base in terms of
health outcomes and within that, there is this challenge about how we contract with service
providers to ensure that they are delivering evidence-based treatment that delivers clinical
outcomes" (1)

"We're actually thinking about cancelling some of the contracts, because we keep seeing the
same people getting put back on these same programs. It's like, ‘Hang on, if you were
successful, why are we seeing the same people year on year?’" (2)

8.3.5 Policy constraints and other challenges affecting the role of insurers in
CDM
Most participants responded that PHI sector regulations constrain aspects of their role in
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supporting people with chronic conditions.

"I think there is a need for simplification of the legislation to support funds in providing
chronic disease management and that’s not without acknowledging, I guess, the complex
dynamics about community rating, risk equalisation, adverse selection and portability." (1)

"Predominantly the Private Health Insurance Act limits the ability for insurers to pay for
things outside of a hospital environment…one example is telehealth, we can’t pay benefits for
that at the moment for allied health professionals, so some flexibility in the way that care is
being delivered in the future will be beneficial" (8)

Participants reported challenges in negotiating an expanded role in offering CDM activities by
PHI funds within the Australian healthcare system.

"Trust and engagement with the health profession no matter where you work... Trying not to
do managed care2, and conveying that message of managed care." (2)

""It’s certainly been one of our biggest hurdles to get some level of respect with GPs and
some level of trust and I think we’re very, very slowly getting there. They’re starting to
recognise that we’re not interested in being ‘pretend doctors’, we’re interested in the best
interests of the members." (7)

Despite these constraints, PHI funds were optimistic about their future role in supporting CDM.

"I think there's a tremendous opportunity for us, and as little funds we might have to band
together to actually make them cost-effective. If we could work effectively with primary
health care and support, like a two-way support of each other, with primary healthcare
providers." (2)

2

A definition for the term, “managed care,” is provided in the Glossary.
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“I'd like to see that we're an insurance and care company and we are actually sharing the
health journey with someone and insurance is one of those products that support you.” (4)

8.4 Discussion
The purpose of this study was to explore the emerging role of Australian PHI funds in developing
and implementing CDM strategies. The study findings indicate that all funds are implementing
strategies to support people with chronic conditions, but these strategies are at different stages of
maturity. Although there are different approaches in relation to organisational arrangements and
in-house versus outsourced service provision, there are similarities in the types of activities
offered with three main service categories reported by participants: (1) health navigation; (2)
disease management and health coaching programs; and (3) care coordination services.

This qualitative study examines topics that were the subject of research in previous chapters of the
thesis that were primarily investigated using administrative claims data. There is alignment
between the findings from this study and the earlier studies. Support for people with mental health
conditions featured strongly in both the clinical profile of high-needs patients and CDM priorities
of insurers. The previous studies noted limitations in using hospital claims data to understand
health services utilisation and the interview participants also responded that data limitations
impact on the identification of suitable participants for CDM programs and the evaluation of
programs, particularly the exclusion of medical care provided outside of hospitals from the scope
of PHI policies.

CDM activities currently supported by PHI funds seem to be guided by a pragmatic approach
based on available data and identified member need. Hospital claims data are the most
comprehensive source of health information available to insurance funds so are the primary source
used to identify participants for these programs, using either specific diagnosis codes documented
in claims records such as diabetes and cardiovascular disease, or levels of service utilisation within
a specific time period (such as length of stay and number of admissions). As such, CDM programs
focus on high-needs patients, rather than the population at-risk of developing a chronic condition
and the intervention supported by PHI funds takes place following hospital discharge. Although
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participants express that their fund wants to more actively support people at risk of developing a
chronic disease, identifying this at-risk group with the current data available to PHI funds is
challenging. Appropriately targeting this group and providing broader CDM services likely
requires linking records from disparate data sources as described and tested in Chapters 6 and 7 to
build a more comprehensive picture of the health and healthcare journey of the target population.

Despite participants being optimistic about the future role of PHI funds in supporting high-needs
patients with chronic conditions, a number of tensions related to the value proposition of CDM
activities provided by PHI funds were reported in this study. Although government regulation has
supported PHI funds having a role in CDM since 2007, the interview responses suggest there are
still questions of legitimacy related to the role of the PHI sector in CDM, especially by healthcare
providers. Most participants responded that they are providing care navigation and care
coordination services but there are other potential providers of these services in the Australian
health system such as enhanced primary care services involving nurses (Parkinson & Parker 2013)
and community pharmacies (McMillan et al. 2013). Ultimately, the CDM services offered by PHI
funds need to be seen by both patients and healthcare providers as effective for them to be taken
up and continue to be sustainable in the future.

Additionally, most current CDM programs supported by PHI funds, both in-house and third-party
services, are yet to be evaluated. Most programs were in an early stage of implementation at the
time of interview so evaluation may not be appropriate. However, data limitations relating to
comprehensive health service use and up-to-date information on the health status of members
presents challenges to conducting rigorous evaluations on the effectiveness of programs that PHI
funds offer. Evidence of effectiveness may be an important component of future viability as from
a resourcing perspective, these programs require an ongoing allocation of financial and human
resources.

This study has a number of limitations and caution needs to be taken in generalising study
findings. The participants interviewed in this study represent only a sample of Australian PHI
funds. The study was not designed to be representative of the entire sector but instead, to present
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the perspectives of smaller, non-profit funds that were involved in the earlier stages of research.
The research design focused on the perspective of PHI funds providing CDM services but the
perspective of other stakeholders, particularly members receiving services funded by PHI would
be a valuable future research direction.

8.5 Conclusion
PHI funds see a clear role for themselves in expanding beyond the traditional role of an insurer to
offer CDM services. However, despite legislation permitting funds to be engaged with CDM
activities for more than ten years, insurers are still in an early stage of implementation and
evaluation of these activities. PHI funds have experienced a number of challenges in establishing
and cementing this new role related to regulatory constraints, information gaps and relationships
with other healthcare stakeholders. The study findings confirm and expand on the findings related
to insurer data limitations from the earlier studies presented in this thesis.

Although participants report introducing a variety of new services to support people with chronic
conditions, these services are yet to be evaluated in terms of return on investment, effectiveness in
improving health outcomes and reduction in insurer costs. There is a need to access and analyse a
broader range of health information to fully implement and evaluate CDM programs. The findings
of this study contribute an important perspective on the extent of the role of insurers in supporting
the care of high-needs patients. The next (and final) chapter synthesises findings from the five
studies and discusses some of the policy recommendations and implications arising from the
research.
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Chapter 9: Discussion and Conclusions
Better understanding the demographic, clinical and service use characteristics of high-needs
patients has become an important area of research given that high levels of service utilisation is
associated with the highest health costs (Long et al. 2017). The overarching aim of the research
presented in this thesis is to contribute new knowledge on the role of the Australian PHI sector in
supporting the care of high-needs patients. There has been little prior research into the services
that high-needs patients claim on their PHI policies or the additional support strategies that PHI
funds now offer to support CDM. The research incorporates five studies using both quantitative
and qualitative methods. Phase 1 of the research analysed the demographic, service utilisation and
clinical characteristics of high-needs patients within a privately insured cohort using insurance
claims data and investigated the strengths and limitations of using claims data for understanding
service utilisation (Chapters 4 and 5). In Phase 2, a conceptual framework of domains to consider
in designing information systems for CDM using multiple data sources was developed and applied
to the Australia PHI sector (Chapter 6). Phase 3 expanded on the findings of the studies from
Phase 1 and 2. Using the conceptual framework, a novel study using linked PHI claims and LHD
hospitalisation data sources was conducted to examine the movement of an insured population
between public and private hospitals and use of PHI across these settings (Chapter 7). In the final
study, interviews were conducted with PHI executives to confirm and reflect on the earlier study
findings, explore the approaches that PHI funds are taking to support high-needs patients with
chronic conditions, and examine the factors that influence the design and implementation of CDM
strategies, given the PHI sector’s role as a supplementary insurer in Australia’s health system
(Chapter 8).

To conclude this thesis, this final chapter synthesises findings from each of the studies in response
to the overall aim and scope of the research. Given the policy relevance of this research, practical
implications and recommendations arising from the research findings that are relevant to both
government policymakers and PHI sector representatives are described. Limitations of the
research are also discussed as well as directions for future research, which were beyond the scope
of this research but that will further understanding of the role of PHI in supporting the care of
high-needs patients.
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9.1 Summary of research findings and implications
Research findings relating to the five research questions outlined in Section 1.3.1 on page 20 are
summarised below. A feature of mixed methods research is the possibility of developing new
findings or inferences that are not possible from single-method studies using only quantitative or
only qualitative research methods. The term “meta-inferences” has been used to describe
theoretical statements or narratives developed through the integration of findings from mixedmethods research (Venkatesh et al 2013). Meta-inferences developed from the integration of
findings from qualitative and quantitative research studies presented in this thesis for research
questions 2 and 3 are discussed below.

Q1: What are the demographic, service utilisation and clinical characteristics of high-needs
patients with PHI?

Three different measures of resource utilisation – number of admissions, number of bed days and
total insurance benefits paid – were used to identify and compare the characteristics of high-need
patients in the first study presented in Chapter 4. Three high-needs patient cohorts defined by the
measures were developed and the resource utilisation of the three groups was analysed.
Demographic and admission characteristics of the three high-needs cohorts were similar with the
three groups being older with higher levels of public hospital use than the rest of the insured
population with a hospital admission. In relation to clinical characteristics, the same top five
principal diagnosis categories – mental health, dialysis, rehabilitation, pharmacotherapy for
neoplasms and neoplasms (with principal diagnosis other than pharmacotherapy) – are found for
the three cohorts and for each cohort, the top five categories account for more than two thirds of
all hospital admissions for the cohorts.

The study results suggest that the top 1% of patients most commonly claim for services related to
a narrow range of conditions – mental health conditions, cancer (including patients receiving
chemotherapy), chronic kidney disease (including patients receiving dialysis) and rehabilitation.
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Among the privately insured population, the highest users of hospital services are seeking services
for a narrow range of conditions that are not the targets of traditional CDM programs offered by
PHI funds, which focus on diabetes and cardiovascular disease. However, frequent hospital
admissions are often a key selection criterion used to target individuals for CDM enrolment. These
findings suggest that private health insurers need to better align CDM programs or provide
appropriate, targeted support to high-needs patients as they represent the highest levels of resource
utilisation and costs to insurers.

The findings of this study highlight the difference between potentially preventable hospitalisations
and potentially preventable conditions. The major reasons for accessing health services in the top
1% of privately insured hospital users in this study, including chemotherapy, dialysis and most
rehabilitation, are not easily preventable. Although the mode of treatment may be modified, via a
same-day visit or even through hospital substitution programs, the ability for insurers to generate
cost savings from CDM programs targets at high users of hospital services should not be assumed.
Rigorous evaluation is required.

Q2: How suitable are current PHI data sources for informing strategies for better
supporting high-needs patients?

Focussing on privately insured patients with claims for mental health-related hospitalisations, the
second study (presented in Chapter 5) examined the type, organisation and frequency of mental
health services accessed. Although only 1.4% of individuals with a hospitalisation in the two-year
study period made a mental health-related claim, resource utilisation was much higher for patients
with mental health-related claims compared to patients with other types of hospitalisations.

The group with mental health-related hospitalisations had significantly more overnight admissions
and same-day visits than the group with other types of hospitalisations and the average length of
stay for overnight admissions was three times longer for the mental health group (15.0 days
compared to 4.6 days). Among the group of patients with mental health-related hospital claims,
the two sub-groups with the highest levels of resource utilisation are those who claim for both
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same-day and overnight hospitalisations and those who claim for both mental health-related and
other types of hospitalisations.

Regulatory arrangements restricting PHI coverage of out-of-hospital services results in PHI funds
having a limited view of service use. The study found that more than two thirds (68%) of patients
with an overnight mental health-related hospitalisation did not make any PHI claims for mental
health services in the 28 days following discharge. As PHI cannot cover certain services for which
Medicare pays a benefit (including out-of-hospital psychiatry and GP consultations), it is
challenging for insurers to proactively monitor and support people with mental health and other
chronic conditions.

In the Australian public hospital sector, receiving community-based treatment and follow-up care
after a hospital discharge are indicators of best-practice mental health treatment (AIHW 2018e).
However, this information is not available to insurers as most treatment funded by PHI occurs in
the private sector. The sporadic nature of claims for mental health-related care highlights how the
PHI sector only plays a partial role in funding health service use for the privately insured
population.

The findings of the first part of the study presented in Chapter 6 demonstrate that PHI funds also
lack information on disease risk factors, in addition to comprehensive information on health
services use. The use of hospital claims data as the primary source of data for identifying target
groups for CDM programs only captures a limited portion of the potential target group. Patients
with a hospitalisation make up a minority of the insured population and the coding of chronic
conditions and risk factors in claims data is dependent on medical documentation and coding
practices of health professionals. The implications of the findings presented in Chapters 5 and 6 is
that the current data sources available to PHI funds does not contain adequate information to build
effective information systems for CDM. Multiple data sources are needed to build a
comprehensive picture of health service use across hospital and community settings.

The data quality issues and information gaps in insurance claims data highlighted in the findings
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of the quantitative studies presented in Chapters 4, 5 and 6 are confirmed and expanded by
integrating these findings with qualitative results from the study presented in Chapter 8. These
findings provide insights into the types of information missing from insurance claims data that
would be beneficial for designing and implementing CDM programs from an insurer perspective
including a robust risk identifier, GP or primary care service utilisation information and measures
evaluating the effectiveness of CDM interventions.

Q3: For PHI funds to play a more proactive role in CDM, what factors need to be
considered when collecting data and developing information systems to support high-needs
patients?

The findings of the analysis presented in Chapters 4 and 5, and the first stage of research presented
in Chapter 6, emphasise that insurance claims are an incomplete data source for understanding
health service use and health status. The findings suggest that insurers that want to enhance their
role in CDM need to not only improve the quality of claims data collected but ensure that data
from multiple sources are used to inform strategies to support high-needs patients and people with,
and at-risk of developing, chronic conditions.

A conceptual framework was developed using a targeted literature review and interviews. The
framework identifies four domains that should be considered in developing information systems
for CDM using multiple data sources. The four domains are to define information requirements,
assess data sources, ensure data quality and integrate information systems and analytics.

Applying this framework to the Australian PHI sector suggests that insurers require a more
structured approach to the collection and use of health data. The role of PHI funds is primarily in
paying claims for health services and as such, insurer information systems are tailored to fulfil this
function. The information requirements, data sources and systems to provide and monitor CDM
programs are different to the current payment focussed systems and require significant changes.

Insurers need to be clear about the goal of CDM programs to identify information and data
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requirements. Insurers should carefully consider how insurance policy design, current information
infrastructure and relationships with healthcare providers and patients affect data collection, data
quality and data analytics and subsequently, impacts the implementation of CDM activities.

The findings of the quantitative studies presented in Chapters 4, 5 and 7 confirm that data
availability, data quality and the primary or original purpose of an information system are key
factors to consider when developing information systems to support high-needs patients. Findings
from the qualitative study presented in Chapter 8 extend considerations beyond the identification
of issues to some of the contextual factors that are important considerations when developing
solutions including government regulation of the PHI sector. Regulations constrains the operations
of the sector in relation to the scope of health services covered (and thus, extent of data on health
service use collected via insurance claims data). Additionally, contractual, payment-focussed
relationships guide the interaction of the PHI sector with healthcare providers which limits
opportunities for collaborative data sharing for care coordination for high-needs patients.

Q4: What is the relative contribution of a PHI fund to paying for hospital services for an
insured population, relative to publicly funded hospital services?

The study in Chapter 7 linking PHI claims and LHD hospital data sources reveals the complicated
interplay of funding and service delivery in Australia’s mixed public and private health system.
The study found that insurers contribute to funding more than 70% of hospital admissions of
insured individuals. However, a large proportion of this care, including a majority of overnight
admissions (62%) and more complex admissions, occurs in public hospitals for which insurers
currently receive limited clinical information. Despite the study population holding PHI, 40% of
people with a hospital admission were only admitted to a public hospital in the six-year study
period. The use of PHI among this group was low with PHI used for only 19% of hospital
admissions for the group.

There are differences in claiming patterns based on service categories with surgical, childbirth and
other admissions more likely to be claimed on PHI than medical or mental health admissions. The
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group of patients with both public and private hospital admissions account for the smallest
proportion of admissions but have the longest average length of stay for medical and surgical
admissions compared to the group of patients with only private hospital admissions or the group
with only public hospital admissions. For mental health and childbirth admissions, the average
length of stay is longer for the private hospital use group than the public hospital use or the public
and private hospital use groups, but this does not reflect significantly higher admission complexity
as measured by admission case weights.

For the high-needs group, 64% of overnight admissions are claimed on PHI even though 71% of
overnight admissions occur in public hospitals. Consistent with the findings of earlier studies,
mental health admissions are strongly represented in the utilisation of the high-needs group with
the group accounting for 63% of all mental health admissions for the study population (compared
with 23% of all medical admissions and only 11% of all surgical admissions). This study shows
that in relation to the most costly form of hospital treatment, overnight admissions, resource
utilisation in the public sector is greater than the private sector and on average, more complex
admissions are treated in public hospitals, although the high-needs group also claim a greater
proportion of public hospital admissions on PHI.

Q5: What strategies are PHI funds using to support CDM, especially for high-needs patients,
and what are the factors influencing the design and implementation of strategies?

All PHI fund representatives interviewed expressed a desire for their fund to have a more active
role in CDM. Funds have adopted different approaches to implementing CDM strategies with a
key distinction between funds that have built an in-house team to support CDM and those that rely
on outsourced service provision. The major CDM activities that PHI funds offer are (1) health
navigation services; (2) structured CDM and health coaching programs; and (3) developing and
monitoring care coordination plans. PHI funds stress their role should support but not direct care
and assist the role of GPs who are the centre of care for a person with a chronic condition. Insurer
CDM activities are targeted at members with diagnosed chronic conditions and high levels of
service utilisation. This is a pragmatic response given the scope of PHI coverage being primarily
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for hospital-based care.

Participant responses suggest that current activities are affected by data limitations. Although
participants report a number of ways in which they are making use of available data sources to
support CDM program implementation, a number of challenges due to data limitations remain
including targeting interventions and evaluating programs. Participant observations are consistent
with the interpretation of findings from the studies in the first phase of research (Chapters 4 and
5). PHI representatives want their fund to play a greater role in CDM but most participants in the
interviews did not clearly express a vision of how this expanded role would be achieved within the
current regulatory and business constraints of the PHI sector, which in particular, affect the
collection and effective use of health data.

Summary of findings on the role of the PHI sector on supporting the care of high-needs
patients

High-needs patients, as defined by the quantum of hospital resources utilised, use their PHI to
claim for services for a narrow range of conditions that are not aligned to the conditions that are
the focus of most CDM programs. Mental-health related conditions account for a high proportion
of service use among the top users. Although insurers pay for services across both public and
private hospital sectors, they are not a comprehensive insurer of hospital care with findings for one
PHI fund that approximately one third of hospital care is not claimed on PHI. Although, highneeds patients receive a greater proportion of hospital care in public hospitals, they are also more
likely to claim care in public hospitals on PHI than the rest of the insured population with a public
hospital admission. PHI funds are increasingly offering a range of CDM services including care
coordination services, health navigation hotlines and telephone-based disease management
programs. These programs are delivered by a combination of in-house staff and contracted third
parties. PHI representatives reported challenges in identifying target groups for CDM
interventions and evaluating the effectiveness of interventions due to the regulated scope of PHI
coverage, which limits data collected by insurers on the health status and service utilisation of
insured individuals.
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9.2 Contributions of thesis
This thesis makes a substantial contribution to knowledge and to practice with its aim to better
understand the role of the PHI sector in supporting the care of high-needs patients. This new
knowledge was summarised for each research questions in Section 9.1. Although the thesis
presents research of an applied nature and there is a focus on practical contributions, these
contributions would not have been possible without the theoretical and methodological
contributions of the research.

The thesis makes a theoretical contribution in the development of a conceptual framework
identifying four domains that should be considered when developing information systems for
CDM using multiple data sources in real-world practice settings. In addition to a theoretical
consideration of how the framework can be applied to the PHI sector in Chapter 6, the framework
is practically used in Chapter 7 to inform the design of the data linkage study, a methodological
contribution of the research. In this study, administrative data from a PHI fund and a LHD are
linked together. This is an Australian first. This novel study demonstrates a rigorous method for
undertaking data linkage that protects privacy and data security while also involving the
organisations contributing data, building their data management knowledge and capabilities and
improving the quality of information available to inform analysis and planning.

9.3 Observations and recommendations for future policy and
practice
Taken together, the findings of this research suggest that the role of the PHI sector in supporting
the care of high-needs patients is fairly narrow. Interpretation of the research findings suggests a
number of factors are contributing to the extent of the PHI sector’s role in supporting the care of
high-needs patients. Observations and recommendations for future policy and practice are
described below.

Observation 1: Broader health cover reforms have made the role of PHI in the Australian
health system less clear
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Previous research has noted that legislative and policy changes relating to the PHI sector have
been layered on top of one another for several decades, resulting in a lack of clarity in relation to
the role of PHI in Australia’s health system (Boxall & Gillespie 2013, p. 182). Government
incentives to increase PHI membership across the Australian population introduced in the late
1990s has seen the emergence of a large number of hospital insurance policies with service or
procedure exclusions, restricted levels of benefits and patient co-payments (Thomas 2012, pp.
273-4). These restricted insurance policies may erode the government policy objective of PHI
reducing the burden on the public hospital system. The findings from the study in Chapter 7 show
that PHI is not comprehensively funding the hospital access of a privately insured population.
Although a majority of hospitalisations for patients with PHI are claimed on PHI, nearly one in
three (28%) of admissions occur as a public patient. Furthermore, for high-need patients, only two
thirds (64%) of overnight hospital admissions are claimed on PHI.

Legislative reforms in 2007 introduced opportunities for insurers to both offer and pay benefits for
new services to support people with chronic conditions. However, the continuing restrictions on
insurers covering out-of-hospital medical care mean that insurers lack visibility of comprehensive
health service utilisation and early stage chronic disease risk factors. These restrictions make
targeting CDM interventions challenging. The promise and potential of the role of the PHI sector
in supporting high-needs patients remains largely unfulfilled, with insurers offering time-limited
programs to a small number of people with complex, chronic conditions. Despite the relatively
small scale of operations, many insurers are starting to frame their businesses as both insurance
provider and providers of health and disease management services.

There is a tension in the current coverage of PHI policies that on one hand have expanded
coverage for CDM programs, while on the other hand, have coverage restrictions and/or member
co-payment requirements for health services for an increasing number of insurance policies. While
insurers express a view that they want to be involved in more actively supporting the health and
disease management needs of their members, as reported in the fifth study (reported in Chapter 8),
both regulatory arrangements and insurer business decisions on policy coverage prevent insurers
having access to comprehensive information on health service use. This information is needed to
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effectively plan, monitor and evaluate CDM programs.

Recommendations
1.

The Australian Government should clarify what the role of PHI should be within Australia’s
health system and identify the necessary enablers to achieve this role. The Australian
government subsidies of PHI in the future should be based on this clarified role.

This recommendation is consistent with calls from multiple health advocacy bodies in Australia
(Consumers Health Forum of Australia 2018; Australian Healthcare and Hospitals Association
2018) and pertinent given the large ongoing financial contribution that the government makes to
the PHI sector through the PHI rebate, totalling more than A$6 billion per year (Commonwealth
of Australia 2017). The review should clearly address the government policy objectives for the
role of PHI in Australia’s health system and delineate the future role of PHI funds. This includes
insurers’ potential future role as a funder of health services through their insurance function and
their role as health service providers.

Observation 2: Private health insurers face regulatory constraints in more actively supporting
high-needs patients but also lack accountability mechanisms to ensure improved health
outcomes

Insurers report that the role of private health insurers in supporting health and disease management
is constrained by the regulated scope of the PHI sector in Australia. In particular, PHI funds
cannot pay benefits for GP and other specialist medical services provided outside of hospital
settings. As a result, CDM programs supported by insurers tend to be poorly integrated with
primary care services and insurer CDM activities tend to target people with high levels of hospital
use, rather than people at earlier stages of illness.

However, Australia’s dual health insurance environment also reduces the accountability of private
health insurers for bearing the full costs of poorly managed high-needs patients. In addition to the
exclusion of out-of-hospital medical services from insurance policies, the government-funded
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public hospital system also effectively acts as a “safety net” for privately insured individuals who
cannot or do not want to access services as a private patient due to the cost or availability of
services. This phenomenon has been referred to as a “loophole” for the PHI sector (Seah et al.
2013), and if an insured individual with high health service utilisation drops or downgrades their
insurance cover, it is likely to improve the financial position of the PHI fund. The findings of the
study in Chapter 7 found that high-needs patients have a greater proportion of hospital activity
occur in public hospitals compared to the general insured population, although they also claim a
higher proportion of public hospital admissions on PHI compared to the rest of the insured
population with a public hospital admission.

Although, private health insurers may strive to improve the health of members as a social goal,
they currently have little business imperative to improve care. Despite generous government
subsidies for PHI premiums via the PHI rebate, insurers are not accountable for the quality of
services they are funding or whether they are being delivered in the most efficient way. Current
government performance indicators for the PHI sector prioritise population coverage, in terms of
the number of insured individuals, and benefits paid (Podger 2007). There are no metrics related to
the quality or efficiency of services funded, or the value of services funded in terms of improving
health status.

The current PHI regulatory system also has few incentives for insurers to offer evidence-based
CDM services for high-needs patients. Australia’s risk equalisation scheme reimburses PHI funds
for the costs of elderly and chronically ill patients (Connelly et al. 2010). However, the scheme’s
existence also reduces incentives for PHI funds to closely monitor the effectiveness of the
programs they are supporting in terms of reductions in health services use.

Private health insurers could be doing more to understand and improve the quality and outcomes
of services for which they pay benefits. Current payment models do not facilitate insurers
capturing data on quality and outcomes, often focussing on the outputs of care in terms of number
of bed days and services delivered. To improve legitimacy as a partner in CDM for both patients
and providers, insurers need to demonstrate that they are interested in funding quality, value-based
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care.

Recommendations
2.

The review of the role of the PHI sector should explicitly consider the following areas
relevant to the support of high-needs patients
•

Implications of the current exclusion of out-of-hospital medical services and
pharmaceuticals from PHI coverage

•

Accountability mechanisms to ensure the effectiveness and clinical utility of the
services that private health insurers are funding if government subsidies of the sector
are to continue.

3.

PHI funds should introduce mechanisms to monitor and report on the effectiveness of
services they are funding, particularly for services that are provided in-house or by insureraffiliated companies.

Observation 3: Private health insurer ambitions in health and disease management are not well
supported by their current information systems strategy

The research presented in this thesis highlights that many aspects of insurer’s current information
systems are not well suited to designing and implementing health and disease management
strategies. High quality health information is not an optional extra for CDM, it is an integral
component of successful programs with information required to identify areas of health need
within the insured population, target interventions, monitor health outcomes, and evaluate the
success of interventions. Yet, the analysis of insurance claims data in Chapters 4, 5 and 6 found a
number of limitations of using this data source to understand health status and service utilisation.
The variability in the recording of diagnosis information is due to differences in PHI payments
models across PHI funds, and also within PHI funds for treatment in public and private hospitals.
Health services providers, both hospitals and allied health professionals, are only required to
submit information to PHI funds that the fund uses for payment.
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The current information systems used by insurers and the data collected are not aligned with the
information requirements for effective CDM programs. Current information systems focus on
insurance claims payment primarily for hospital-based services, paid on a retrospective, fee-forservice model.

Despite limitations on the information available to PHI funds for CDM programs based on current
data sources, insurers could still be making better use of available data by developing a clear
strategy about the information required for designing, targeting and evaluating their programs. The
traditional role of a health insurer as a payer of health services cannot be ignored. The lack of data
on health status and health outcomes in insurance claims data reflects the absence of these
indicators in current insurer payment models. Greater focus on these indicators could enhance the
value and utility of insurance claims data.

Recommendations
4.

PHI funds should have an information strategy for CDM programs that clearly sets out what
information is required, how data will be collected to meet information requirements and
how information systems will be developed or enhanced to ensure meaningful analysis of
data to inform CDM programs.

5.

PHI funds should consider a minimum dataset of hospital admission information, linked to
payment models for services, that is required from all service providers. As discussed in
Section 4.2.3 on page 51, it is now a requirement that full Hospital Casemix Protocol (HCP)
data are sent to private health insurers for all hospital admissions (public and private) that
they fund. However, this applies only to future hospital claims from 1 July 2018. PHI funds
should consider how this data will be used to inform the design and delivery of programs.
Additionally, PHI should consider what further information is needed to both design and
evaluate health services and outcomes, and how this information can be gathered via data
collected from other funded services including CDM program providers, dental and allied
health.
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9.4 Future research directions
The findings of this research suggest several areas of further research. The data linkage study in
Chapter 7 that analysed hospital-based care for a privately insured population could be expanded
to provide a more comprehensive picture of health services utilisation and medication history for
high-needs patients. Additional administrative data sources that are already used in health services
research in Australia include the Medical Benefits Schedule capturing a range of governmentsubsidised medical consultations, tests and procedures and the Pharmaceutical Benefits Scheme
that records prescribed medications that receive government subsidies. A study linking and
analysing these data sources with the claims and hospital records could provide further
information on health service and medication use of high needs patients.

The qualitative study in Chapter 8 presents an industry perspective from the PHI sector on
approaches to designing and implementing CDM programs. This study did not include the
perspective of privately insured, high-needs patients with chronic conditions. Previous research
has explored the perspective of older Australians with chronic illness in relation to PHI but this
study focussed on motivators for people to maintain PHI and financial pressure associated with
PHI premium costs (Jeon et al. 2012). Future research could examine the experiences of privately
insured high-needs patients with chronic conditions accessing CDM services funded by PHI and
more broadly, their experience navigating the healthcare system and dual health insurance
arrangements in Australia to manage their health.

Further research could also be conducted on the impact of PHI policy design and insurer-hospital
contracting arrangements on the support provided to high-needs patients. There is a high degree of
variation in the coverage of PHI policies, ranging from basic to comprehensive coverage. The
impact of policy coverage and provider contracting arrangements on the use of PHI for hospital
care could be examined. With the exception of a study examining insurer perspectives on hospital
purchasing conducted more than a decade ago (Willcox 2005), these topics have not been explored
in Australia.
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9.5 Generalisability
The data sources used in the quantitative research presented in Chapters 4, 5 and 6 are broadly
representative of the hospital claims of the insured population in Australia. The group of PHI
funds represent approximately 10% of the Australian PHI market. The insurance claims sample
used in this research is comparable to the national PHI market, with regard to member age (69%
hospital admissions in the sample are for people aged 55 years and over versus 64% nationally),
sex (females account for 55% admissions versus 54% nationally) and location of residence (36%
hospital admissions occur in New South Wales versus 32% nationally) (APRA 2017).

More caution is required in interpreting the findings of the studies presented in Chapters 7 and 8.
The study in Chapter 7 uses a sample population from one PHI fund in one region in Australia.
Given geographic differences in the organisation of the Australian health system, service
utilisation patterns and movement between private and public hospitals may not reflect patterns in
other parts of Australia.

As discussed in Chapter 8, the qualitative interviews with PHI fund representatives were not
designed to be representative of the Australian PHI sector as a whole. Instead, the interview
participants reflect the perspective of smaller, non-profit PHI funds and were from a subset of
funds that contributed data analysed in the earlier studies. These insurers may have different
approaches to, and challenges in, providing CDM support for high-needs patients, compared with
larger funds due to funds’ concentration of members in specific geographic locations and/or
restricted membership eligibility based on employment in a specific occupational sector.

Although this research project focuses on the Australian health system, which has distinct health
insurance arrangements compared with other countries, the findings from this study may provide
lessons for other countries. Many countries such as Canada, the United Kingdom and Italy have
supplementary PHI systems to cover specific services and reduce pressure on governmentoperated health services, and other countries such as the United States have both government and
PHI systems that people move between depending on their social circumstances.
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9.6 Research limitations
Limitations of this research have been discussed throughout the thesis in each chapter. This
section will not repeat these limitations but instead, will highlight the most important limitations in
the context of the overall research topic. The research focussed on how PHI funds support the care
of high-needs patients. Direct measures of need were not available in the data sources analysed as
they are not commonly collected in administrative data. Instead, resource utilisation measures
were used as proxies for defining high-need patients, an approach consistent with previous
research as confirmed by the United States National Academy Medicine in a recent report on highcost, high-needs patients (Long et al. 2017).

This research sought to leverage administrative data sources not commonly used in research to
understand the role of PHI in supporting the care of high-needs patients. The use of administrative
data has many benefits including gaining access to data on a large population that would be
infeasible using other research data collection methods but there are also important limitations that
should be considered in the interpretation of results. Most of the administrative data analysed were
originally collected for the purpose of service payment. Hospitals employ clinical coders to
analyse medical records and code clinical information such as disease diagnoses and procedures
performed to receive funding. There are auditing processes that exist to check these records but
clinical information contained in these administrative data sources is only as good as the original
medical records on which the coding is based. There may be errors or omissions in these codes
reflected in this analysis but due to the large number of records analysed, it is unlikely that any
errors would produce a systematic bias in the study results.

An additional limitation of the insurance claims data sources is the completeness of records sent
from hospitals to private health insurers. The research identified differences in clinical information
contained within the claims records based on the type of hospital and model of payment. These
limitations did modify some of the ways in which analyses were conducted. For example, the
study in Chapter 4 only reported clinical information from private hospital admissions claimed on
PHI. This limitation reflects the applied nature of the research and the real-world challenges that
both health service providers and payers face in trying to generate meaningful insights from their
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data to inform policy and planning activities such as assessing needs, targeting interventions and
evaluating services.

These data limitations drove new lines of enquiry in the research process to better understand the
data and information system requirements for informing CDM programs as presented in Chapter
6. The study in Chapter 7, in which data from a PHI fund and a LHD were linked, was designed to
gather more comprehensive information on both the service utilisation and clinical characteristics
of hospital use of a privately insured cohort.

9.7 Conclusions
The overall aim of the research presented in this thesis is to use disparate data sources to
contribute new knowledge on the role of PHI in supporting the care of high-needs patients in
Australia. The thesis demonstrates that the primary role of insurers is in paying benefits for
hospital-based services with a majority of high-need patients’ hospital use occurring for a small
number of conditions, mental health conditions, cancer, rehabilitation and dialysis which differ
from the focus of CDM programs. Although the role of the PHI sector has started to change in the
last decade following legislation changes to enhance CDM support, this process of change has
been slow, and the role of insurers is still narrow. PHI funds are hampered in expanding their role
in CDM of the insured population by regulatory constraints, resource availability and relationships
with both patients and healthcare providers, which result in a lack of comprehensive, quality
health information on the privately insured population. Accurate information on the health needs
of the insured population is crucial for designing and implementing effective strategies to support
high-need patients.

Private health insurers express a desire to have a more active role in CDM but there is a lack of
clarity on what this role currently is, or should be. Currently, although a reduction in health service
utilisation is often the justification cited by insurers for investment in CDM programs, there is a
misalignment between hospital claims of high-needs patients and the target groups of CDM
programs. The PHI sector’s supplementary role in funding health services in the Australian health
system also results in a lack of accountability for the quality and effectiveness of the CDM
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services that insurers offer.

The research findings suggest that the Australian government needs to clarify the role of PHI in
Australia’s health system into the future. This includes the accountability of the PHI sector to
contributing to health system goals set by the Australian government, given the large subsidy paid
to the sector through the PHI rebate. For the PHI sector, the research findings suggest that more
attention needs to be paid to the development of information strategies that can inform CDM
approaches, and the infrastructure needed to meaningfully analyse data and support insurer
ambitions to play a more active role in supporting high-needs patients and people with chronic
conditions.

This mixed method research has asked important questions about the role of the private health
insurance sector, a significant part of the Australian health system that receives an annual $6
billion public subsidy. The research has used both quantitative and qualitative methods to offer
five perspectives on the research topic including the first ever Australian study analysing the
hospital utilisation and insurance status of a cohort of privately insured people, examining the
relative contribution of PHI to funding hospital care. This research supports the view that PHI is
an important component of the Australian health system. That said, PHI is making a niche
contribution to the health system rather than being a core funder of a comprehensive suite of
health services for those people with PHI. While the research presented in this thesis has generated
new knowledge on the sector, it has also identified a range of issues and challenges that reflect on
the future viability of the sector. These issues include the role of insurers in effectively supporting
CDM care for their members within a constrained regulatory environment and the need for vast
improvements in insurer information systems including data collection and use to better
understand and support the health needs of the insured population. Data collection issues are
closely linked to the payment models used by insurers to fund services and the design of insurance
policies including which services are paid for. These issues suggest important policy challenges
and research questions that will require priority attention in the future.
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Appendices
Appendix 1
1. AR-DRG version 6.0x (short description)
Available from the Australian Consortium for Classification Development
(https://www.accd.net.au/Downloads.aspx, viewed 2 November 2018)
801A OR PR UNREL TO PDX+CCC
801B OR PR UNREL TO PDX+SMCC
801C OR PR UNREL TO PDX-CC
960Z UNGROUPABLE
961Z UNACCEPTABLE PRINCIPAL DX
963Z NEONATAL DX NOT CONSNT AGE/WGT
A01Z LIVER TRANSPLANT
A03Z LUNG OR HEART/LUNG TRANSPLANT
A05Z HEART TRANSPLANT
A06A TRACHEOSTOMY W VENT>95 +CCC
A06B TRCH&VNT-CCC OR TRCH/VNT+CCC
A06C VENTILATION>95 - CCC
A06D TRACHEOSTOMY -CCC
A07Z ALLOG BONE MARROW TRANSPLANT
A08A AUTO BONE MARROW TRANSPLNT+CCC
A08B AUTO BONE MARROW TRANSPLNT-CCC
A09A RENAL TRANSPLANT+PANCREAS/+CCC
A09B RENAL TRANSPLANT -PANCREAS-CCC
A10Z INSERTION OF VAD
A11A INS IMPLNT SP INFUS DEV+CCC
A11B INS IMPLNT SP INFUS DEV-CCC
A12Z INS NEUROSTIMULATOR DEV
A40Z ECMO
B01A VENTRICULAR SHUNT REV+CSCC
B01B VENTRICULAR SHUNT REV-CSCC
B02A CRANIAL PROCEDURES + CCC
B02B CRANIAL PROCEDURES + SCC
B02C CRANIAL PROCEDURES - CSCC
B03A SPINAL PROCEDURES + CSCC
B03B SPINAL PROCEDURES - CSCC
B04A EXTRACRANIAL VASCULAR PR +CCC
B04B EXTRACRANIAL VASCULAR PR -CCC
B05Z CARPAL TUNNEL RELEASE
B06A CBL PSY,MUS DYSY,NPTHY PR +CC
B06B CBL PSY,MUS DYSY,NPTHY PR -CC
B07A PRPHL & CRANL NERV & OTH PR+CC
B07B PRPHL & CRANL NERV & OTH PR-CC
B40Z PLASMAPHERESIS + NEURO DIS SD
B41Z TELEMETRIC EEG MONITORING
B42A NERV SYS DX W VENT SUPPORT+CCC
B42B NERV SYS DX W VENT SUPPORT-CCC
B60A ACUTE PARA/QUAD+/-OR PR +CCC
B60B ACUTE PARA/QUAD+/-OR PR -CCC
B61A SPINAL CORD COND+/-OR PR +CSCC
B61B SPINAL CORD COND+/-OR PR -CSCC
B62Z APHERESIS
B63Z DMNTIA&CHRNIC DISTURB CRBRL FN
B64A DELIRIUM+CCC
B64B DELIRIUM-CCC
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B65Z CEREBRAL PALSY
B66A NERVOUS SYSTEM NEOPLASM+CSCC
B66B NERVOUS SYSTEM NEOPLASM-CSCC
B67A DEGNRTV NERV SYS DIS+CSCC
B67B DEGNRTV NERV SYS DIS+MCC
B67C DEGNRTV NERV SYS DIS-CC
B68A MLT SCLROSIS&CEREBEL ATAXIA+CC
B68B MLT SCLROSIS&CEREBEL ATAXIA-CC
B69A TIA & PRECEREBRAL OCCLUSN+CSCC
B69B TIA & PRECEREBRAL OCCLUSN-CSCC
B70A STROKE & OTH CEREB DIS +CCC
B70B STROKE & OTH CEREB DIS +SCC
B70C STROKE & OTH CEREB DIS -CSCC
B70D STRKE&OTH CEREB DIS DIE/TRN<5D
B71A CRANIAL & PERIPHL NERV DSRD+CC
B71B CRANIAL & PERIPHL NERV DSRD-CC
B72A NRVS SYS INF EX VRL MNGTS+CSCC
B72B NRVS SYS INF EX VRL MNGTS-CSCC
B73Z VIRAL MENINGITIS
B74A NONTRAUMATIC STUPOR & COMA +CC
B74B NONTRAUMATIC STUPOR & COMA -CC
B75Z FEBRILE CONVULSIONS
B76A SEIZURE + CSCC
B76B SEIZURE - CSCC
B77Z HEADACHE
B78A INTRACRANIAL INJURY+CSCC
B78B INTRACRANIAL INJURY-CSCC
B79A SKULL FRACTURES+CSCC
B79B SKULL FRACTURES-CSCC
B80Z OTHER HEAD INJURY
B81A OTHER DSRD OF NERVOUS SYS+CSCC
B81B OTHER DSRD OF NERVOUS SYS-CSCC
B82A CHR UNSP PARA/QUAD+/-OR PR+CCC
B82B CHR UNSP PARA/QUAD+/-PR+SCC
B82C CHR UNSP PARA/QUAD+/- PR -CSCC
C01Z PROC FOR PENETRATNG EYE INJURY
C02Z ENUCLEATIONS & ORBITAL PROCS
C03Z RETINAL PROCEDURES
C04Z MAJOR CORN, SCLERAL&CONJNCT PR
C05Z DACRYOCYSTORHINOSTOMY
C10Z STRABISMUS PROCEDURES
C11Z EYELID PROCEDURES
C12Z OTHER CORN, SCLERAL&CONJNCT PR
C13Z LACRIMAL PROCEDURES
C14Z OTHER EYE PROCEDURES
C15A GLAUCOMA/CX CATARACT PROCS
C15B GLAUCOMA/CX CATARACT PROCS, SD
C16Z LENS PROCEDURES
C60A AC & MJR EYE INFECTN +CC
C60B AC & MJR EYE INFECTN -CC
C61A NEUROLOGICAL&VASCLR EYE DIS+CC
C61B NEUROLOGICAL&VASCLR EYE DIS-CC
C62Z HYPHEMA &MED MANAGD EYE TRAUMA
C63Z OTHER DISORDERS OF THE EYE
D01Z COCHLEAR IMPLANT
D02A HEAD & NECK PR +CSCC
D02B HEAD & NECK PR+MALIGNANCY/MCC
D02C HEAD & NECK PR -MALIGNANCY -CC
D03Z SURGCL RPR CLEFT LIP/PALATE DX
D04A MAXILLO SURGERY + CC
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D04B MAXILLO SURGERY - CC
D05Z PAROTID GLAND PROCEDURES
D06Z SINUS &CMPLX MDDL EAR PR
D10Z NASAL PROCEDURES
D11Z TONSILLECTOMY, ADENOIDECTOMY
D12Z OTH EAR,NOSE,MOUTH & THROAT PR
D13Z MYRINGOTOMY +TUBE INSERTION
D14Z MOUTH & SALIVARY GLAND PROCS
D15Z MASTOID PROCEDURES
D40Z DENTAL EXTRACT & RESTORATIONS
D60A EAR NOSE MOUTH&THROAT MAL+CSCC
D60B EAR NOSE MOUTH&THROAT MAL-CSCC
D61Z DYSEQUILIBRIUM
D62Z EPISTAXIS
D63Z OTITIS MEDIA AND URI
D64Z LARYNGOTRACHEITIS&EPIGLOTTITIS
D65Z NASAL TRAUMA & DEFORMITY
D66A OTH EAR,NOSE,MOUTH&THRT DX +CC
D66B OTH EAR,NOSE,MOUTH&THRT DX -CC
D67A ORAL&DNTAL DIS-EXTRCT&RESTN
D67B ORAL&DNTAL DIS-EXTRCT&RESTN,SD
E01A MAJOR CHEST PROCEDURE + CCC
E01B MAJOR CHEST PROCEDURE - CCC
E02A OTHER RESPIRATRY SYS OR PR+CCC
E02B OTH RESPIRATRY SYS OR PR+SMCC
E02C OTHER RESPIRATY SYS OR PR -CC
E40A RESP DX W VENTILATOR SUPPT+CCC
E40B RESP DX W VENTILATOR SUPPT-CCC
E41Z RESP SYS DX +NON-INVAS VENTILN
E42A BRONCHOSCOPY +CCC
E42B BRONCHOSCOPY -CCC
E42C BRONCHOSCOPY SAMEDAY
E60A CYSTIC FIBROSIS +CSCC
E60B CYSTIC FIBROSIS -CSCC
E61A PULMONARY EMBOLISM + CCC
E61B PULMONARY EMBOLISM - CCC
E62A RESPIRATRY INFECTN/INFLAMM+CCC
E62B RESPIRATRY INFECTN/INFLAM+SMCC
E62C RESPIRATORY INFECTN/INFLAMM-CC
E63Z SLEEP APNOEA
E64A PULMONRY OEDEMA &RESP FAIL+CCC
E64B PULMONRY OEDEMA &RESP FAIL-CCC
E65A CHRNIC OBSTRCT AIRWAY DIS +CCC
E65B CHRNIC OBSTRCT AIRWAY DIS -CCC
E66A MAJOR CHEST TRAUMA +CCC
E66B MJR CHEST TRMA +SMCC
E66C MAJOR CHEST TRAUMA -CC
E67A RESPIRATRY SIGNS & SYMPTM+CSCC
E67B RESPIRTRY SIGNS & SYMPTM -CSCC
E68A PNEUMOTHORAX +CC
E68B PNEUMOTHORAX -CC
E69A BRONCHITIS & ASTHMA +CC
E69B BRNCHTS&ASTHMA -CC
E70A WHOOPNG CGH &ACTE BRNCHIO+CC
E70B WHOOPNG CGH &ACTE BRNCHIO-CC
E71A RESPIRATORY NEOPLASMS +CCC
E71B RESPIRATORY NEOPLASMS -CCC
E72Z RESP PROBS FROM NEONATL PERIOD
E73A PLEURAL EFFUSION + CCC
E73B PLEURAL EFFUSN + SMCC
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E73C PLEURAL EFFUSION - CC
E74A INTERSTITAL LUNG DIS +CCC
E74B INTERSTITIAL LUNG DIS +SMCC
E74C INTERSTITIAL LUNG DIS -CC
E75A OTHER RESP SYS DX +CCC
E75B OT RESP SYS DX +SMCC
E75C OTHER RESP SYS DX - CC
E76Z RESPIRATORY TUBERCULOSIS
F01A IMPLNTN/REPLCMNT AICD TTL+CCC
F01B IMPLNTN/REPLCMNT AICD TTL-CCC
F02Z OTHER AICD PROCEDURES
F03A CRDC VALV PR+PMP+INV INVES+CCC
F03B CRDC VALV PR+PMP+INV INVES-CCC
F04A CRD VLV PR+PMP-INV INVES+CCC
F04B CRD VLV PR+PMP-INV INVES-CCC
F05A CRNRY BYPSS+INV INVES+REOP/CCC
F05B CRNRY BYPSS+INV INVES-REOP-CCC
F06A CRNRY BYPSS-INV INVS+REOP/CSCC
F06B CRNRY BYPSS-INV INVS-REOP-CSCC
F07A OTHER CARDTHOR/VASC PR+PMP+CCC
F07B OTH CARDTHOR/VASC PR+PMP+SMCC
F07C OTHER CARDTHOR/VASC PR+PMP-CC
F08A MJR RECONSTRC VASC PR-PUMP+CCC
F08B MJR RECONSTRC VASC PR-PUMP-CCC
F09A OTH CARDIOTHOR PR-PMP+CCC
F09B OTH CARDIOTHOR PR-PMP +SMCC
F09C OTH CARDIOTHOR PR-PMP -CC
F10A INTERVENTN CORONARY PR+AMI+CCC
F10B INTERVENTN CORONARY PR+AMI-CCC
F11A AMPUTN CIRC SYS-UP LMB&TOE+CCC
F11B AMPUTN CIRC SYS-UP LMB&TOE-CCC
F12A IMPLANT/REPLACE PM,TOT SYS+CCC
F12B IMPLANT/REPLACE PM,TOT SYS-CCC
F13A UP LIMB&TOE AMP CIRC DIS +CSCC
F13B UP LIMB&TOE AMP CIRC DIS -CSCC
F14A VASC PR-MJR RECONSTRC-PUMP+CCC
F14B VASC PR-MJR RECONSTR-PUMP+SMCC
F14C VASC PR-MJR RECONSTR-PUMP-CC
F15A INTER CORONARY PR-AMI+STN+CSCC
F15B INTER CORONRY PR-AMI+STNT-CSCC
F16A INTERVN CORONARY PR-AMI-STN+CC
F16B INTERV CORONARY PR-AMI-STNT-CC
F17A INSERT/REPLACE PM GENERTR+CSCC
F17B INSERT/REPLACE PM GENERTR-CSCC
F18A OTHER PACEMAKER PROCEDURES+CC
F18B OTHER PACEMAKER PROCEDURES-CC
F19Z TRNS-VSCLR PERC CRDC INTRV
F20Z VEIN LIGATION & STRIPPING
F21A OTH CIRC SYS OR PR+CCC
F21B OTH CIRC SYS OR PR -CCC
F40A CIRC SYS DX+VENTILTR SUPPT+CCC
F40B CIRC SYS DX+VENTILTR SUPPT-CCC
F41A CRC DSRD+AMI+INVA INVE PR+CSCC
F41B CRC DSRD+AMI+INVA INVE PR-CSCC
F42A CRC DSRD-AMI+IC IN PR +CSCC
F42B CRC DSRD-AMI+IC IN PR -CSCC
F42C CRC DSRD-AMI+IC IN PR SD
F43Z CIRC SYS DIAG W NIV
F60A CRC DSRD+AMI-INVA INVE PR+CCC
F60B CRC DSRD+AMI-INVA INVE PR-CCC
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F61A INFECTIVE ENDOCARDITIS +CCC
F61B INFECTIVE ENDOCARDITIS -CCC
F62A HEART FAILURE & SHOCK + CCC
F62B HEART FAILURE & SHOCK - CCC
F63A VENOUS THROMBOSIS + CSCC
F63B VENOUS THROMBOSIS - CSCC
F64A SKN ULCERS CIRC DISORD +CSCC
F64B SKN ULCERS CIRC DISORD -CSCC
F65A PERIPHERAL VASCULAR DSRD +CSCC
F65B PERIPHERAL VASCULAR DSRD -CSCC
F66A CORONARY ATHEROSCLEROSIS +CSCC
F66B CORONARY ATHEROSCLEROSIS -CSCC
F67A HYPERTENSION + CSCC
F67B HYPERTENSION - CSCC
F68A CONGENITAL HEART DISEASE +CC
F68B CONGENITAL HEART DISEASE -CC
F69A VALVULAR DISORDERS + CSCC
F69B VALVULAR DISORDERS - CSCC
F72A UNSTABLE ANGINA + CSCC
F72B UNSTABLE ANGINA - CSCC
F73A SYNCOPE & COLLAPSE + CSCC
F73B SYNCOPE & COLLAPSE - CSCC
F74Z CHEST PAIN
F75A OTHER CIRCULATRY SYSTEM DX+CCC
F75B OTH CIRCULATRY SYSTEM DX+SMCC
F75C OTHER CIRCULATY SYSTEM DX-CC
F76A ARRHY, CARD & COND DISDR +CSCC
F76B ARRHY, CARD & COND DISDR -CSCC
G01A RECTAL RESECTION +CCC
G01B RECTAL RESECTION -CCC
G02A MJR SMALL & LARGE BOWEL PR+CCC
G02B MJR SMALL & LARGE BOWEL PR-CCC
G03A STOMCH,OESPH&DUODNL PR+MAL/CCC
G03B STMCH,OESPHGL&DDNL PR-MAL+SMCC
G03C STMCH,OESPHGL&DDNL PR-MAL-CC
G04A PERITONEAL ADHESOLYSIS +CCC
G04B PRTNL ADHLY +SMCC
G04C PERITONEAL ADHESOLYSIS -CC
G05A MNR SMALL&LARGE BOWEL PR +CCC
G05B MNR SMALL&LARGE BOWEL PR +SMCC
G05C MNR SMALL & LARGE BOWEL PR -CC
G06Z PYLOROMYOTOMY PROCEDURE
G07A APPENDCTMY +MALIG/PERITON/CSCC
G07B APPENDCTMY -MALIG-PERITON-CSCC
G10A HERNIA PROCEDURES +CC
G10B HERNIA PROCEDURES -CC
G11Z ANAL & STOMAL PROCEDURES
G12A OTH DIGEST SYS OR PR+CCC
G12B OTH DIGEST SYS OR PR+SMCC
G12C OTH DIGEST SYS OR PR-CC
G46A COMPLEX GASTROSCOPY+CCC
G46B COMPLEX GASTROSCOPY-CCC
G46C COMPLEX GASTROSCOPY,SD
G47A OTH GASTROSCOPY +CCC
G47B OTH GASTROSCOPY -CCC
G47C OTH GASTROSCOPY, SD
G48A COLONSCOPY +CSCC
G48B COLONSCOPY - CSCC
G48C COLONSCOPY, SD
G60A DIGESTIVE MALIGNANCY + CCC
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G60B DIGESTIVE MALIGNANCY - CCC
G61A GI HAEMORRHAGE +CSCC
G61B GI HAEMORRHAGE - CSCC
G62Z COMPLICATED PEPTIC ULCER
G63Z UNCOMPLICATED PEPTIC ULCER
G64A INFLAMMATORY BOWEL DISEASE +CC
G64B INFLAMMATORY BOWEL DISEASE-CC
G65A GI OBSTRUCTION + CSCC
G65B GI OBSTRUCTION - CSCC
G66Z ABDMNL PAIN/MESENTRC ADENTS
G67A OESPHS, GASTR +CSCC
G67B OESPHS, GASTR -CSCC
G70A OTHER DIGESTIVE SYS DIAG +CSCC
G70B OTHER DIGESTIVE SYS DIAG -CSCC
H01A PANCREAS, LIVER & SHUNT PR+CCC
H01B PANCREAS, LIVER &SHUNT PR-CCC
H02A MJR BILIARY TRACT PR +CCC
H02B MJR BILIARY TRACT PR +SCC
H02C MJR BILIARY TRACT PR -CSCC
H05A HEPATOBILIARY DIAGNTIC PR +CCC
H05B HEPATOBILIARY DIAGNTIC PR -CCC
H06A OTH HEPTOBILRY & PANCRS PR+CCC
H06B OTH HEPTOBILRY &PANCRS PR-CCC
H07A OPEN CHOLECYSTECTOMY+CDE/+CCC
H07B OPEN CHOLECYSTECTOMY-CDE-CCC
H08A LAP CHOLECYSTECTMY+CDE/+CSCC
H08B LAP CHOLECYSTECTMY-CDE-CSCC
H40A ENDO PR BLEED OES VARICES +CCC
H40B ENDO PR BLEED OES VARICES -CCC
H43A ERCP PROCEDURE +CSCC
H43B ERCP PROCEDURE -CSCC
H60A CIRRHOSIS & ALC HEPATITIS +CCC
H60B CIRRHOSIS & ALC HEPATITIS+SMCC
H60C CIRRHOSIS & ALC HEPATITIS -CC
H61A MALG HEPATOBILIARY SYS PAN+CCC
H61B MALG HEPATOBILIAY SYS PANC-CCC
H62A DISORDERS PANCREAS-MALIG+CSCC
H62B DISORDERS PANCREAS-MALIG-CSCC
H63A DSRD LVR-MAL,CIRR,ALC HEP+CSCC
H63B DSRD LVR-MAL,CIRR,ALC HEP-CSCC
H64A DISORDERS OF BILIARY TRACT +CC
H64B DISORDERS OF BILIARY TRACT -CC
I01A BL/MLT MJ JT PR LWR EXT+RV/CCC
I01B BL/MLT MJ JT PR LWR EXT-RV-CCC
I02A MCRVAS TT/SKIN GRAFT+CSCC-HAND
I02B SKIN GRAFT -CSCC -HAND
I03A HIP REPLACEMENT + CCC
I03B HIP REPLACEMENT - CCC
I04A KNEE REPLACEMT +CSCC
I04B KNEE REPLACEMT -CSCC
I05A OTH JNT REPLACEMENT +CSCC
I05B OTH JNT REPLACEMENT -CSCC
I06Z SPINAL FUSION + DEFORMITY
I07Z AMPUTATION
I08A OTHER HIP & FEMUR PROC +CCC
I08B OTHER HIP & FEMUR PR -CCC
I09A SPINAL FUSION +CCC
I09B SPINAL FUSION -CCC
I10A OTHER BACK & NECK PROCS + CSCC
I10B OTHER BACK & NECK PROCS - CSCC
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I11Z LIMB LENGTHENING PROCEDURES
I12A INFC/INFM BONE/JNT+MISC PR+CCC
I12B INFC/INFM BNE/JNT+MISC PR+SMCC
I12C INFC/INFM BNE/JNT+MISC PR-CC
I13A HUMER,TIBIA,FIBUL,ANKL PR+CC
I13B HUMER,TIBIA,FIBUL,ANKL PR-CC
I15Z CRANIO-FACIAL SURGERY
I16Z OTHER SHOULDER PROCEDURES
I17A MAXILLO-FACIAL SURGERY +CC
I17B MAXILLO-FACIAL SURGERY -CC
I18Z OTHER KNEE PROCEDURES
I19A OTHER ELBOW, FOREARM PROCS +CC
I19B OTHER ELBOW, FOREARM PROCS -CC
I20Z OTHER FOOT PROCEDURES
I21Z LOC EX, REM INT FIX DEV HP&FMR
I23Z LOC EX,REM INT FIX-HP&FMR
I24Z ARTHROSCOPY
I25A BNE,JNT DXTIC PR INC BIOPSY+CC
I25B BNE,JNT DXTIC PR INC BIOPSY-CC
I27A SOFT TISSUE PROCEDURES +CC
I27B SOFT TISSUE PROCEDURES -CC
I28A OTH MUSCULOSKELETAL PR+CC
I28B OTH MUSCULOSKELETAL PR-CC
I29Z KNEE RECONSTRUCTION/REVISION
I30Z HAND PROCEDURES
I31A HIP REVISION +CCC
I31B HIP REVISION -CCC
I32A KNEE REVISION +CCC
I32B KNEE REVISION +SCC
I32C KNEE REVISION -CSCC
I60Z FEMORAL SHAFT FRACTURES
I61A DISTAL FEMORAL FRACTURES +CC
I61B DISTAL FEMORAL FRACTURES -CC
I63A SPR,STR&DSLC HIP,PELV&THIGH+CC
I63B SPR,STR&DSLC HIP,PELV&THIGH-CC
I64A OSTEOMYELITIS +CSCC
I64B OSTEOMYELITIS -CSCC
I65A MUSCSKEL MALIG NEO+CCC
I65B MUSCSKEL MALIG NEO -CCC
I66A INFLM MUSCL DSR +CSCC
I66B INFLM MUSCULSKTL DSR -CSCC
I67A SEPTIC ARTHRITIS + CSCC
I67B SEPTIC ARTHRITIS - CSCC
I68A NON-SURG SPINAL DISORDERS +CC
I68B NON-SURG SPINAL DISORDERS -CC
I68C NON-SURG SPINAL DISORDERS, SD
I69A BONE DISEASES AND ARTHRO +CSCC
I69B BONE DISEASES AND ARTHROP-CSCC
I71A OTH MUSCTENDIN DISRD +CSCC
I71B OTH MUSCTENDIN DISRD -CSCC
I72A SPEC MUSCTEND DISRD +CSCC
I72B SPEC MUSCTEND DISRD -CSCC
I73A AFTCARE MUSCSK IMPL +CSCC
I73B AFTCARE MUSCSK IMPL -CSCC
I74Z INJ FOREARM, WRIST, HAND, FOOT
I75A INJ SH,ARM,ELB,KN,LEG,ANKL +CC
I75B INJ SH,ARM,ELB,KN,LEG,ANKL -CC
I76A OTH MUSCULOSKELETL DSRD +CSCC
I76B OTH MUSCULOSKELETAL DSRD -CSCC
I77A FRACTURE OF PELVIS+CSCC
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I77B FRACTURE OF PELVIS -CSCC
I78A FRACTURE NECK FEMUR+CSCC
I78B FRACTURE OF NECK FEMUR-CSCC
I79A PATHOLOGICAL FRACTURE +CCC
I79B PATHOLOGICAL FRACTURE -CCC
J01A MICRVS TSS TRNSF SKN/BRST+CSCC
J01B MICRVS TSS TRNSF SKN/BRST-CSCC
J06A MAJOR PR MALIG BREAST CONDTNS
J06B MAJOR PR NON-MALIG BREAST CNDS
J07A MINOR PR MALIG BREAST CONDNS
J07B MINOR PR NON-MALIG BREAST CNDS
J08A OTH SKN GRF&/DBRDMNT PR +CC
J08B OTH SKN GRF&/DBRDMNT PR -CC
J09Z PERIANAL & PILONIDAL PR
J10Z SKN,SUBC TIS & BRST PLASTIC PR
J11Z OTHER SKIN, SUBC TIS & BRST PR
J12A L LMB PR +ULCR/CELS+CCC
J12B L LMB PR+ULCR/CELS-CCC+GRAFT
J12C L LMB PR+ULCR/CELS-CCC-GRAFT
J13A L LMB PR-ULC/CEL+CCC/(GFT+SCC)
J13B L LMB PR-ULC/CEL-CCC-(GFT+SCC)
J14Z MAJOR BREAST RECONSTRUCTIONS
J60A SKIN ULCERS +CCC
J60B SKIN ULCERS -CCC
J60C SKIN ULCERS, SAMEDAY
J62A MALIGNANT BREAST DISORDERS +CC
J62B MALIGNANT BREAST DISORDERS -CC
J63A NON-MALIGNANT BREAST DISORD+CC
J63B NON-MALIGNANT BREAST DISORD-CC
J64A CELLULITIS +CSCC
J64B CELLULITIS -CSCC
J65A TRAUMA TO SKN,SUB TIS&BST+CSCC
J65B TRAUMA TO SKN,SUB TIS&BST-CSCC
J67A MINOR SKIN DISORDERS
J67B MINOR SKIN DISORDERS, SAMEDAY
J68A MAJOR SKIN DISORDERS +CSCC
J68B MAJOR SKIN DISORDERS -CSCC
J68C MAJOR SKIN DISORDERS, SAMEDAY
J69A SKIN MALIGNANCY +CCC
J69B SKIN MALIGNANCY -CCC
J69C SKIN MALIGNANCY, SAMEDAY
K01A OR PR DIABETIC COMPLICATNS+CCC
K01B OR PR DIABETIC COMPLICATNS-CCC
K02A PITUITARY PROCEDURES +CC
K02B PITUITARY PROCEDURES -CC
K03Z ADRENAL PROCEDURES
K04A MAJOR PROCS FOR OBESITY +CC
K04B MAJOR PROCS FOR OBESITY -CC
K05A PARATHYROID PROCEDURES +CSCC
K05B PARATHYROID PROCEDURES -CSCC
K06A THYROID PROCEDURES +CSCC
K06B THYROID PROCEDURES -CSCC
K07Z OBESITY PROCEDURES
K08Z THYROGLOSSAL PROCEDURES
K09A OTH ENDCRN, NUTR& META PR +CCC
K09B OTH ENDCRN, NUTR& META PR+SMCC
K09C OTH ENDCRN, NUTR & META PR -CC
K40A ENDO/INVEST PR METAB DIS +CCC
K40B ENDO/INVEST PR METAB DIS -CCC
K40C ENDO/INVEST PR METAB DIS, SD
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K60A DIABETES + CSCC
K60B DIABETES - CSCC
K61Z SEVERE NUTRITIONAL DISTURBANCE
K62A MISC METABOLIC DISORDERS +CSCC
K62B MISC METABOLIC DISORDERS -CSCC
K63A INBORN ERRORS OF METABOLISM+CC
K63B INBORN ERRORS OF METABOLISM-CC
K64A ENDOCRINE DISORDERS + CSCC
K64B ENDOCRINE DISORDERS - CSCC
L02A OP INS PERI CATH DIALYSIS+CSCC
L02B OP INS PERI CATH DIALYSIS-CSCC
L03A KDNY,URT&MJR BLDR PR NPSM +CCC
L03B KDNY,URT&MJR BLDR PR NPSM +SCC
L03C KDNY,URT&MJR BLDR PR NPSM-CSCC
L04A KDY,URT&MJR BLDR PR N-NPM+CCC
L04B KDY,URT&MJR BLDR PR N-NPM+SCC
L04C KDY,URT&MJR BLDR PR N-NPM-CSCC
L05A TRANURETH PROSTATECTOMY +CSCC
L05B TRANURETH PROSTATECTOMY -CSCC
L06A MINOR BLADDER PROCEDURES+CSCC
L06B MINOR BLADDER PROCEDURES -CSCC
L07A TRANSURETHRAL PROCS +CC
L07B TRANSURETHRAL PROCS -CC
L08A URETHRAL PROCEDURES + CC
L08B URETHRAL PROCEDURES - CC
L09A OTH KIDNY & URNRY TRACT PR+CCC
L09B OTH KIDNY & URNRY TRACT PR+SCC
L09C OTH KIDNY & URNRY TRCT PR-CSCC
L40Z URETEROSCOPY
L41Z CYSTOURETHROSCOPY, SAMEDAY
L42Z ESW LITHOTRIPSY+URINARY STONES
L60A RENAL FAILURE +CCC
L60B RENAL FAILURE +SCC
L60C RENAL FAILURE -CSCC
L61Z HAEMODIALYSIS
L62A KDNY&UNRY TRCT NEOPLASMS +CSCC
L62B KDNY&UNRY TRCT NEOPLASMS -CSCC
L63A KDNY & UNRY TRCT INF +CSCC
L63B KDNY & UNRY TRCT INF -CSCC
L64Z URINARY STONES & OBSTRUCTION
L65A KDNY & UNRY TR SGNS&SYMPS+CSCC
L65B KDNY & UNRY TR SGNS&SYMPS-CSCC
L66Z URETHRAL STRICTURE
L67A OTH KIDNY & URNRY TRCT DX+CSCC
L67B OTH KIDNY & URNRY TRCT DX-CSCC
L68Z PERITONEAL DIALYSIS
M01A MAJOR MALE PELVIC PROCS +CSCC
M01B MAJOR MALE PELVIC PROCS -CSCC
M02A TRANSURETHRAL PROSTECTOMY+CSCC
M02B TRANSURETHRAL PROSTECTOMY-CSCC
M03Z PENIS PROCEDURES
M04Z TESTES PROCEDURES
M05Z CIRCUMCISION
M06A OTH MALE REPROD SYS OR PR +CC
M06B OTH MALE REPROD SYS OR PR -CC
M40Z CYSTOURETHROSCOPY, SAMEDAY
M60A MALIGNANCY, MALE REPR SYS+CSCC
M60B MALIGNANCY, MALE REPR SYS-CSCC
M61Z BENIGN PROSTATIC HYPERTROPHY
M62Z INFLAMMATION MALE REPRD SYSTEM
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M63Z STERILISATION, MALE
M64Z OTHER MALE REPRODUCTIVE SYS DX
N01Z PELVIC EVSCRTN & RADCL VLVCTMY
N04A HYSTERECTOMY FOR NON-MALG+CSCC
N04B HYSTERECTOMY FOR NON-MALG-CSCC
N05A OOPH&COM FAL TUBE PR NMAL+CSCC
N05B OOPH&COM FAL TUBE PR NMAL-CSCC
N06A FEM REP SYS RECONSTRCT PR+CSCC
N06B FEM REP SYS RECONSTRCT PR-CSCC
N07Z OTH UTERN & ADNEXA PR FOR NMAL
N08Z ENDOS & LAPAR PR, FEM REPR SYS
N09Z CONISTN,VAGINA,CERVIX&VULVA PR
N10Z DXC CURETTGE, DXC HYSTEROSCOPY
N11Z OTH FEMALE REPRODUCTIVE SYS PR
N12A UTRN & ADNX PR FOR MAL+CCC
N12B UTRN & ADNX PR FOR MAL-CCC
N60A MALIGNANCY FEM REPROD SYS +CCC
N60B MALIGNANCY FEM REPROD SYS -CCC
N61Z INFECTIONS, FEMALE REPROD SYST
N62Z MNSTRL & OTH FEM REPR SYS DIS
O01A CAESAREAN DELIVERY +CCC
O01B CAESAREAN DELIVERY +SCC
O01C CAESAREAN DELIVERY -CSCC
O02A VAGINAL DELIVERY +OR PR +CSCC
O02B VAGINAL DELIVERY +OR PR -CSCC
O03A ECTOPIC PREGNANCY +CC
O03B ECTOPIC PREGNANCY -CC
O04A POSTPARTUM&POST ABORTN+PR+CSCC
O04B POSTPARTUM&POST ABORTN+PR-CSCC
O05Z ABORTION+ OR PROC
O60A VAGINAL DELIVERY +CSCC
O60B VAGINAL DELIVERY -CSCC
O60C VAGINAL DEL SINGLE UNCOMPL
O61Z POSTPARTUM & POST ABORTN-OR PR
O63Z ABORTION-OR PROC
O64A FALSE LABOUR <37 WK/+CCC
O64B FALSE LABOUR >=37 WK -CCC
O66A ANTENATAL&OTH OBSTETRIC ADM
O66B ANTENATAL&OTH OBSTETRIC ADM,SD
P01Z NEONATE,D/T<5DAY ADM+SIG OR PR
P02Z NEO,CARDIOTHORACIC/VASCULAR PR
P03Z NEO,ADMWT 1000-1499G+SIG OR PR
P04Z NEO,ADMWT 1500-1999G+SIG OR PR
P05Z NEO,ADMWT 2000-2499G+SIG OR PR
P06A NEO,ADMWT >2499G+SIG OR PR+MMP
P06B NEO,ADMWT >2499G+SIG OR PR-MMP
P60A NEO,D/TR<5D ADM-SIG PR+NEWBORN
P60B NEO,D/TR<5D ADM-SIG PR-NEWBORN
P61Z NEONATE, ADMISSION WT <750 G
P62Z NEONATE, ADMISSION WT 750-999G
P63Z NEO,ADMWT 1000-1249G-SIG OR PR
P64Z NEO,ADMWT 1250-1499G-SIG OR PR
P65A NEO,ADMWT 1500-1999G-SG OR+MMP
P65B NEO,ADMWT 1500-1999G-SG OR+MJP
P65C NEO,ADMWT 1500-1999G-SG OR+OTP
P65D NEO,ADMWT 1500-1999G-SG OR-PRB
P66A NEO,ADMWT 2000-2499G-SG OR+MMP
P66B NEO,ADMWT 2000-2499G-SG OR+MJP
P66C NEO,ADMWT 2000-2499G-SG OR+OTP
P66D NEO,ADMWT 2000-2499G-SG OR-PRB
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P67A NEO,ADMWT >2499G-SIG OR PR+MMP
P67B NEO,ADMWT >2499G-SIG OR PR+MJP
P67C NEO,ADMWT >2499G-SIG OR PR+OTP
P67D NEO,ADMWT >2499G-SIG OR PR-PRB
Q01Z SPLENECTOMY
Q02A OTH OR PR BLD&BLD FRM ORG+CSCC
Q02B OTH OR PR BLD&BLD FRM ORG-CSCC
Q60A RETICLENDO&IMNTY DIS+CSCC
Q60B RETICLENDO&IMNTY DIS-CSCC+MAL
Q60C RETICLENDO&IMNTY DIS-CSCC-MAL
Q61A RED BLOOD CELL DISDERS + CSCC
Q61B RED BLOOD CELL DISDERS - CSCC
Q62Z COAGULATION DISORDERS
R01A LYMPHMA&LEUKMA+MJR OR PR +CSCC
R01B LYMPHMA&LEUKMA+MJR OR PR -CSCC
R02A OTH NPLSTC DSRD+MJR OR PR+CCC
R02B OTH NPLSTC DSRD+MJR OR PR+SMCC
R02C OTH NPLSTC DSRD+MJR OR PR-CC
R03A LYMPHMA LEUKMA+OTH OR PR +CSCC
R03B LYMPHMA LEUKMA+OTH OR PR -CSCC
R04A OTH NPLSTC DSRD+OTH OR PR +CC
R04B OTH NPLSTC DSRD+OTH OR PR -CC
R60A ACUTE LEUKAEMIA + CCC
R60B ACUTE LEUKAEMIA - CCC
R61A LYMPHMA &N-ACUTE LEUKAEMIA+CCC
R61B LYMPHMA &N-ACUTE LEUKAEMIA-CCC
R61C LYMPHOMA/N-A LEUKAEMIA,SAMEDAY
R62A OTHER NEOPLASTIC DISORDERS +CC
R62B OTHER NEOPLASTIC DISORDERS -CC
R63Z CHEMOTHERAPY
R64Z RADIOTHERAPY
S60Z HIV, SAMEDAY
S65A HIV-RELATED DISEASES +CCC
S65B HIV-RELATED DISEASES +SCC
S65C HIV-RELATED DISEASES -CSCC
T01A OR PROC INFECT& PARAS DIS+CCC
T01B OR PROC INFECT& PARAS DIS+SMCC
T01C OR PROC INFECT & PARAS DIS-CC
T40Z INFECT&PARAS DIS+VENT SUPPORT
T60A SEPTICAEMIA + CCC
T60B SEPTICAEMIA - CCC
T61A POSTOP & POSTTRAUM INFECT+CSCC
T61B POSTOP & POSTTRAUM INFECT-CSCC
T62A FEVER OF UNKNOWN ORIGIN + CC
T62B FEVER OF UNKNOWN ORIGIN - CC
T63Z VIRAL ILLNESS
T64A OTH INFECTOUS&PARSTIC DIS +CCC
T64B OTH INFECTOUS&PARSTIC DIS+SMCC
T64C OTH INFECTOUS & PARSTIC DIS-CC
U40Z MENTAL HEALTH TREAT,SAMEDY+ECT
U60Z MENTAL HEALTH TREAT,SAMEDY-ECT
U61A SCHIZOPHRENIA DISORDERS+MHLS
U61B SCHIZOPHRENIA DISORDERS-MHLS
U62A PAR&ACUTE PSYCH DSRD+CSCC/MHLS
U62B PAR&ACUTE PSYCH DSRD-CSCC-MHLS
U63A MJR AFFECT DSRD A>69/+CSCC
U63B MAJOR AFFECTIVE DSRD A<70-CSCC
U64Z OTH AFFECT & SOMATOFORM DSRD
U65Z ANXIETY DISORDERS
U66Z EATING & OBSESSV-COMPULSV DSRD
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U67Z PERSONLTY DSRD&ACUTE REACTIONS
U68Z CHILDHOOD MENTAL DISORDERS
V60A ALCOHOL INTOXICATN&WITHDRWL+CC
V60B ALCOHOL INTOXICATN&WITHDRWL-CC
V61Z DRUG INTOXICTN & WITHDRAWAL
V62A ALCOHOL USE DSRD & DEPENDENCE
V62B ALCOHOL USE DSRD & DEPENDNC+SD
V63Z OPIOID USE DSRD & DEPENDENCE
V64Z OTHER DRUG USE DISORD & DEPEND
W01Z VENTILN/CRANIA MULT SIG TRAUMA
W02A HIP,FEMR&LIMB PR MLT TRMA+CSCC
W02B HIP,FEMR&LIMB PR MLT TRMA-CSCC
W03Z ABDOMINAL PR MULT SIG TRAUMA
W04A OTH OR PR MULT SIG TRAUMA+CSCC
W04B OTH OR PR MULT SIG TRAUMA-CSCC
W60Z MULTIPLE TRAUMA, DIED/TRANSF<5
W61A MULTIPLE TRAUMA-SIGNIF PR+CSCC
W61B MULTIPLE TRAUMA-SIGNIF PR-CSCC
X02A MVTT/SKIN GFT+CSCC INJUR HAND
X02B SKIN GRAFT INJURIES HAND -CSCC
X04A OTHER PR INJ LWR LMB +CSCC
X04B OTHER PR INJ LOWR LIMB -CSCC
X05A OTH PR FOR INJURIES TO HAND+CC
X05B OTH PR FOR INJURIES TO HAND-CC
X06A OTHER PR OTHER INJURIES + CSCC
X06B OTHER PR OTHER INJURIES - CSCC
X07A SK GRAFT INJ-HAND+MIC TT/+CSCC
X07B SK GRAFT INJ-HAND-MIC TT-CSCC
X40Z INJ,POIS,TOX EFF DRUG W VENT
X60A INJURIES + CSCC
X60B INJURIES - CSCC
X61Z ALLERGIC REACTIONS
X62A POISNG/TOXC EFF DRUGS +CSCC
X62B POISNG/TOXC EFF DRUGS -CSCC
X63A SEQUELAE OF TREATMNT+CSCC
X63B SEQUELAE OF TREATMNT-CSCC
X64A OTH INJ, POIS & TOX EF DX+CSCC
X64B OTH INJ, POIS &TOX EFF DX-CSCC
Y01Z VENT BURN&SEV FULL THICK BURN
Y02A OTHER BURNS + SKIN GRAFT +CC
Y02B OTHER BURNS + SKIN GRAFT -CC
Y03Z OTHER OR PROCS FOR OTHER BURNS
Y60Z BURNS,TRANS OTH ACUT CARE <5 D
Y61Z SEVERE BURNS
Y62A OTHER BURNS +CC
Y62B OTHER BURNS -CC
Z01A OR PR+DX OTH CNT HLTH SRV+CSCC
Z01B OR PR+DX OTH CNT HLTH SRV-CSCC
Z40Z ENDO+DX OTH CNT HLTH SRV SD
Z60A REHABILITATION + CCC
Z60B REHABILITATION - CCC
Z60C REHABILITATION, SAMEDAY
Z61A SIGNS AND SYMPTOMS
Z61B SIGNS AND SYMPTOMS, SAMEDAY
Z63A OTH SURG FU & MED CARE + CCC
Z63B OTH SURG FU & MED CARE - CCC
Z64A OTH FACTOR INFL HEALTH STATUS
Z64B OTH FCTR INFL HEALTH STATUS,SD
Z65Z CNGNTL & PRB ARISING FRM NNT
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Appendix 2
2. Variables used in data linkage study
Private health insurance hospital claims data
•

Person identifier

•

Membership joining date

•

Membership termination date

•

Sex

•

Age group at admission (five-year age groups)

•

Hospital admission identifier

•

Hospital admission date

•

Hospital separation date

•

Hospital type

•

Diagnosis related group (AR-DRG)

•

Principal ICD-10 diagnosis (used for recoding AR-DRG codes)

•

Additional ICD-10 diagnosis (used for recoding AR-DRG codes)

•

Mode of separation (used for recoding AR-DRG codes)

•

Procedure codes (used for recoding AR-DRG codes)

Local Health District hospital admission data
•

Person identifier

•

Sex

•

Age group at admission (five-year age groups)

•

Hospital admission identifier

•

Hospital admission date

•

Hospital separation date

•

Diagnosis related group (AR-DRG)

•

DRG version

•

Health insurance status
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Local Health District emergency department data
• Person identifier
• Visit identifier
• Visit date
• Mode of separation – ED (lists whether or not patient was admitted to hospital)
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Appendix 3
3. Participant email for telephone interviews
Dear Colleague
I am writing to invite you and/or a member of your senior Executive team to participate in a
telephone interview as part of the CMCRC-supported PhD research project, “The role of private
health insurance in supporting the care needs of people with chronic illness.” The supervisor for
this research is Professor Kathy Eagar, Director of the Australian Health Services Research
Institute at the University of Wollongong. The industry partner for this research project is
HAMBS Systems Ltd.
The project examines the burden of disease and health service use among people with chronic
conditions, investigates the data and information requirements for chronic disease management
and explores policy and service delivery challenges that influence the involvement of the private
health insurance sector in chronic disease management. The aim of this specific research study is
to gather perspectives of senior executives in private health insurance funds on the factors
influencing the design and implementation of strategies to support people with chronic disease.
Participation in this study will involve a 30-45 minute telephone interview that will be scheduled
between October and December 2017. In the interview, I will ask about your views on the current
and future role of the private health insurance sector in chronic disease management in the
Australian health system. An indicative list of questions will be supplied prior to the interview.
With your consent, the interview will be audio-recorded for the purposes of transcription and data
analysis. Audio-recordings will be destroyed at the conclusion of the study. Any publications
arising from this study will not identify individual participants or organisations and will be subject
to CMCRC and HAMBS publication review processes. Participant email confirmation and
scheduling of an interview for the project will be deemed consent to participate in the research
study.
It is anticipated that findings from the study will benefit the participants by presenting a
comprehensive view of chronic disease management strategy and programs occurring across the
private health insurance sector in Australia. The study will also seek participant views on earlier
analysis of insurance claims data conducted as part of the project and seek input into
recommendations for the project overall.
The protocol for this research study has been reviewed by the management of the Australian
Health Services Research Institute at the University of Wollongong and classified as negligible
risk research. As such, this study is exempted from ethical review by a Human Research Ethics
Committee.
I look forward to speaking with you. If you had any questions or require further information,
please contact me on jkhoo@cmcrc.com or 0401 XXX XXX. Alternatively, if you have any
concerns, the supervisor of this research, Professor Eagar can be contacted on kexx@uow.edu.au
or 02 4221 XXXX.
Kind regards
Jo Khoo
PhD Candidate
Australian Health Services Research Institute, University of Wollongong and CRCMC
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Appendix 4
4. Interview questions: Perspectives of private health insurance funds on the
factors influencing the design and implementation of strategies to support
people with chronic illness
General questions (to understand the membership profile of your fund)
1. How long have you worked in your current position?
2. How long have you worked in the private health insurance sector?
3. How many members in your health fund?
4. What is the geographic distribution of your membership?
5. Are there any features that make your fund membership distinct from the national population?
Or from other health insurance funds?

Overview of chronic disease management strategy
6. What is your perception of the role of private health insurers in chronic disease management?
7. Can you briefly tell me about the current strategies that your fund uses to support people with
chronic diseases?

Strategies to support health care needs of the chronically ill
Analysis of insurance claims data among the top 1% of hospital users showed that this group was
responsible for a large proportion of total resource utilisation for the insured population and were
being admitted to hospital primarily for a small number of conditions or treatment interventions –
mental health, cancers, rehabilitation and dialysis.
8. Do the findings concur with your own experience or internal analysis?
9. What is your fund’s approach to people with high claims history?

Mental health was strongly represented among the top 1% of hospital users.
10. Describe the priorities of your fund in the area of mental health care.
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Data and information requirements for chronic disease management
11. From your perspective, what is the most important information needed to design and
implement chronic disease management programs?
12. Can you comment on the adequacy of the data sources currently used by your fund to inform
chronic disease management programs?
13. What additional data sources would be valuable to inform chronic disease management
programs?
14. How does your fund measure success in chronic disease management programs?

Future and recommendations
15. Thinking about the future in 5-10 years’ time:
a) what would you like the approach of private health insurance funds’ to chronic disease
management to look like?
b) what do you think it will actually look like?

There has been recent media and government attention on the number of privately insured
admissions in public hospitals. This may be particularly relevant to people with chronic disease
and high health care needs.
16. If you had the opportunity to influence the conditions under which privately insured
individuals went to public or private hospitals, what position would you take?

17. Do you have any suggestions for recommendations that would help shape the future that you
want to see for the private health insurance sector in the area of chronic disease management?
18. Do you have any final thoughts on this topic that you would like to share?
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